Initiation	B-protein
binding	I-protein
repressor	I-protein
,	O
a	O
factor	O
that	O
binds	O
to	O
the	O
transcription	B-DNA
initiation	I-DNA
site	I-DNA
of	O
the	O
histone	B-DNA
h5	I-DNA
gene	I-DNA
,	O
is	O
a	O
glycosylated	B-protein
member	I-protein
of	O
a	O
family	O
of	O
cell	B-protein
growth	I-protein
regulators	I-protein
[	O
corrected	O
]	O
[	O
published	O
erratum	O
appears	O
in	O
Mol	O
Cell	O
Biol	O
1996	O
Feb	O
;	O
16	O
(	O
2	O
)	O
:	O
735	O
]	O

Initiation	B-protein
binding	I-protein
repressor	I-protein
[	O
corrected	O
]	O
(	O
IBR	B-protein
)	O
is	O
a	O
chicken	B-protein
erythrocyte	I-protein
factor	I-protein
(	O
apparent	O
molecular	O
mass	O
,	O
70	O
to	O
73	O
kDa	O
)	O
that	O
binds	O
to	O
the	O
sequences	O
spanning	O
the	O
transcription	B-DNA
initiation	I-DNA
site	I-DNA
of	O
the	O
histone	B-DNA
h5	I-DNA
gene	I-DNA
,	O
repressing	O
its	O
transcription	O
.	O

A	O
variety	O
of	O
other	O
cells	O
,	O
including	O
transformed	B-cell_type
erythroid	I-cell_type
precursors	I-cell_type
,	O
do	O
not	O
have	O
IBR	B-protein
but	O
a	O
factor	O
referred	O
to	O
as	O
IBF	B-protein
(	O
68	O
to	O
70	O
kDa	O
)	O
that	O
recognizes	O
the	O
same	O
IBR	B-protein
sites	O
.	O

We	O
have	O
cloned	O
the	O
IBR	B-DNA
cDNA	I-DNA
and	O
studied	O
the	O
relationship	O
of	O
IBR	B-protein
and	O
IBF	B-protein
.	O

IBR	B-protein
is	O
a	O
503-amino-acid-long	B-protein
acidic	I-protein
protein	I-protein
which	O
is	O
99.0	O
%	O
identical	O
to	O
the	O
recently	O
reported	O
human	B-protein
NRF-1/alpha-Pal	I-protein
factor	I-protein
and	O
highly	O
related	O
to	O
the	O
invertebrate	O
transcription	B-protein
factors	I-protein
P3A2	B-protein
and	O
erected	B-protein
wing	I-protein
gene	I-protein
product	I-protein
(	O
EWG	B-protein
)	O
.	O

We	O
present	O
evidence	O
that	O
IBR	B-protein
and	O
IBF	B-protein
are	O
most	O
likely	O
identical	O
proteins	O
,	O
differing	O
in	O
their	O
degree	O
of	O
glycosylation	O
.	O

We	O
have	O
analyzed	O
several	O
molecular	O
aspects	O
of	O
IBR/F	B-protein
and	O
shown	O
that	O
the	O
factor	O
associates	O
as	O
stable	O
homodimers	B-protein
and	O
that	O
the	O
dimer	B-protein
is	O
the	O
relevant	B-protein
DNA-binding	I-protein
species	I-protein
.	O

The	O
evolutionarily	O
conserved	O
N-terminal	B-protein
half	I-protein
of	O
IBR/F	B-protein
harbors	O
the	O
DNA-binding/dimerization	B-protein
domain	I-protein
(	O
outer	O
limits	O
,	O
127	O
to	O
283	O
)	O
,	O
one	O
or	O
several	O
casein	B-protein
kinase	I-protein
II	I-protein
sites	I-protein
(	O
37	O
to	O
67	O
)	O
,	O
and	O
a	O
bipartite	B-protein
nuclear	I-protein
localization	I-protein
signal	I-protein
(	O
89	O
to	O
106	O
)	O
which	O
appears	O
to	O
be	O
necessary	O
for	O
nuclear	O
targeting	O
.	O

Binding	O
site	O
selection	O
revealed	O
that	O
the	O
alternating	B-protein
RCGCRYGCGY	I-protein
consensus	I-protein
constitutes	O
high-affinity	O
IBR/F	B-DNA
binding	I-DNA
sites	I-DNA
and	O
that	O
the	O
direct-repeat	B-DNA
palindrome	I-DNA
TGCGCATGCGCA	O
is	O
the	O
optimal	B-DNA
site	I-DNA
.	O

A	O
survey	O
of	O
genes	B-DNA
potentially	O
regulated	O
by	O
this	O
family	O
of	O
factors	B-protein
primarily	O
revealed	O
genes	B-DNA
involved	O
in	O
growth-related	O
metabolism	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
Dec.	NULL
1995	NULL
,	NULL
p.	NULL
6670-6685	NULL
0270-7306/95/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

15	NULL
,	NULL
No	NULL
.	NULL

12	NULL
Initiation	NULL
Binding	NULL
Receptor	NULL
,	NULL
a	NULL
Factor	NULL
That	NULL
Binds	NULL
to	NULL
the	NULL
Transcription	NULL
Initiation	NULL
Site	NULL
of	NULL
the	NULL
Histone	NULL
A5	NULL
Gene	NULL
,	NULL
Is	NULL
a	NULL
Glycosylated	NULL
Member	NULL
of	NULL
a	NULL
Family	NULL
of	NULL
Cell	NULL
Growth	NULL
Regulators	NULL
ALICIA	NULL
GOMEZ-CUADRADO	NULL
,	NULL
MERCE	NULL
MARTIN	NULL
,	NULL
MICHELINE	NULL
NOEL	NULL
,	NULL
anp	NULL
ADOLF	NULL
RUIZ-CARRILLO®*	NULL
Cancer	NULL
Research	NULL
Center	NULL
and	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Medical	NULL
School	NULL
of	NULL
Laval	NULL
University	NULL
,	NULL
L'Hotel-Dieu	NULL
de	NULL
Québec	NULL
,	NULL
Québec	NULL
,	NULL
Québec	NULL
GIR	NULL
216	NULL
,	NULL
Canada	NULL
Received	NULL
2	NULL
June	NULL
1995/Returned	NULL
for	NULL
modification	NULL
1	NULL
August	NULL
1995/Accepted	NULL
28	NULL
August	NULL
1995	NULL
Initiation	NULL
binding	NULL
receptor	NULL
(	NULL
IBR	NULL
)	NULL
is	NULL
a	NULL
chicken	NULL
erythrocyte	NULL
factor	NULL
(	NULL
apparent	NULL
molecular	NULL
mass	NULL
,	NULL
70	NULL
to	NULL
73	NULL
kDa	NULL
)	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
sequences	NULL
spanning	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
histone	NULL
A5	NULL
gene	NULL
,	NULL
repressing	NULL
its	NULL
transcription	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
other	NULL
cells	NULL
,	NULL
including	NULL
transformed	NULL
erythroid	NULL
precursors	NULL
,	NULL
do	NULL
not	NULL
have	NULL
IBR	NULL
but	NULL
a	NULL
factor	NULL
referred	NULL
to	NULL
as	NULL
IBF	NULL
(	NULL
68	NULL
to	NULL
70	NULL
kDa	NULL
)	NULL
that	NULL
recognizes	NULL
the	NULL
same	NULL
IBR	NULL
sites	NULL
.	NULL

We	NULL
have	NULL
cloned	NULL
the	NULL
IBR	NULL
cDNA	NULL
and	NULL
studied	NULL
the	NULL
relationship	NULL
of	NULL
IBR	NULL
and	NULL
IBF	NULL
.	NULL

IBR	NULL
is	NULL
a	NULL
503-amino-acid-long	NULL
acidic	NULL
protein	NULL
which	NULL
is	NULL
99.0	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
recently	NULL
reported	NULL
human	NULL
NRF-1/a-Pal	NULL
factor	NULL
and	NULL
highly	NULL
related	NULL
to	NULL
the	NULL
invertebrate	NULL
transcription	NULL
factors	NULL
P3A2	NULL
and	NULL
erected	NULL
wing	NULL
gene	NULL
product	NULL
(	NULL
EWG	NULL
)	NULL
.	NULL

We	NULL
present	NULL
evidence	NULL
that	NULL
IBR	NULL
and	NULL
IBF	NULL
are	NULL
most	NULL
likely	NULL
identical	NULL
proteins	NULL
,	NULL
differing	NULL
in	NULL
their	NULL
degree	NULL
of	NULL
glycosylation	NULL
.	NULL

We	NULL
have	NULL
analyzed	NULL
several	NULL
molecular	NULL
aspects	NULL
of	NULL
IBR/F	NULL
and	NULL
shown	NULL
that	NULL
the	NULL
factor	NULL
associates	NULL
as	NULL
stable	NULL
homodimers	NULL
and	NULL
that	NULL
the	NULL
dimer	NULL
is	NULL
the	NULL
relevant	NULL
DNA-binding	NULL
species	NULL
.	NULL

The	NULL
evolutionarily	NULL
conserved	NULL
N-terminal	NULL
half	NULL
of	NULL
IBR/F	NULL
harbors	NULL
the	NULL
DNA-binding/dimerization	NULL
domain	NULL
(	NULL
outer	NULL
limits	NULL
,	NULL
127	NULL
to	NULL
283	NULL
)	NULL
,	NULL
one	NULL
or	NULL
several	NULL
casein	NULL
kinase	NULL
II	NULL
sites	NULL
(	NULL
37	NULL
to	NULL
67	NULL
)	NULL
,	NULL
and	NULL
a	NULL
bipartite	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
89	NULL
to	NULL
106	NULL
)	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
nuclear	NULL
targeting	NULL
.	NULL

Binding	NULL
site	NULL
selection	NULL
revealed	NULL
that	NULL
the	NULL
alternating	NULL
RCGCRYGCGY	NULL
consensus	NULL
constitutes	NULL
high-affinity	NULL
IBR/F	NULL
binding	NULL
sites	NULL
and	NULL
that	NULL
the	NULL
direct-repeat	NULL
palindrome	NULL
TGCGCATGCGCA	NULL
is	NULL
the	NULL
optimal	NULL
site	NULL
.	NULL

A	NULL
survey	NULL
of	NULL
genes	NULL
potentially	NULL
regulated	NULL
by	NULL
this	NULL
family	NULL
of	NULL
factors	NULL
primarily	NULL
revealed	NULL
genes	NULL
involved	NULL
in	NULL
growth-related	NULL
metabolism	NULL
.	NULL

Histone	NULL
HS	NULL
is	NULL
a	NULL
specific	NULL
linker	NULL
histone	NULL
of	NULL
the	NULL
erythroid	NULL
lineage	NULL
which	NULL
is	NULL
expressed	NULL
during	NULL
the	NULL
maturation	NULL
of	NULL
embryonic	NULL
and	NULL
adult	NULL
avian	NULL
erythrocytes	NULL
(	NULL
reference	NULL
2	NULL
and	NULL
references	NULL
there-in	NULL
)	NULL
.	NULL

The	NULL
chromatin	NULL
levels	NULL
of	NULL
HS	NULL
increase	NULL
progressively	NULL
following	NULL
activation	NULL
of	NULL
the	NULL
A5	NULL
gene	NULL
,	NULL
so	NULL
that	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
maturation	NULL
process	NULL
,	NULL
the	NULL
stoichiometry	NULL
of	NULL
linker	NULL
histones	NULL
(	NULL
HS	NULL
plus	NULL
H1	NULL
)	NULL
per	NULL
core	NULL
histone	NULL
octamer	NULL
is	NULL
more	NULL
than	NULL
1	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
ectopic	NULL
expression	NULL
of	NULL
HS	NULL
in	NULL
nonerythroid	NULL
cells	NULL
,	NULL
to	NULL
levels	NULL
comparable	NULL
to	NULL
those	NULL
found	NULL
in	NULL
erythrocytes	NULL
,	NULL
argues	NULL
for	NULL
a	NULL
direct	NULL
role	NULL
of	NULL
HS	NULL
in	NULL
the	NULL
condensation	NULL
and	NULL
inactivity	NULL
of	NULL
the	NULL
erythrocyte	NULL
nucleus	NULL
(	NULL
81	NULL
,	NULL
82	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
gene	NULL
is	NULL
already	NULL
set	NULL
in	NULL
an	NULL
active	NULL
chromatin	NULL
conformation	NULL
in	NULL
early	NULL
erythroid	NULL
precursors	NULL
(	NULL
69	NULL
)	NULL
,	NULL
its	NULL
transcription	NULL
is	NULL
not	NULL
activated	NULL
until	NULL
the	NULL
preerythroblast-to-erythroblast	NULL
transition	NULL
(	NULL
2	NULL
,	NULL
72	NULL
)	NULL
,	NULL
coincident	NULL
with	NULL
the	NULL
decline	NULL
in	NULL
the	NULL
proliferation	NULL
potential	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

The	NULL
mechanisms	NULL
that	NULL
bring	NULL
about	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
A5	NULL
gene	NULL
are	NULL
not	NULL
fully	NULL
elucidated	NULL
but	NULL
appear	NULL
to	NULL
reflect	NULL
alterations	NULL
in	NULL
the	NULL
balance	NULL
between	NULL
positive	NULL
and	NULL
negative	NULL
effectors	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
£5	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
complex	NULL
assortment	NULL
of	NULL
ubiquitous	NULL
and	NULL
blood	NULL
cell-specific	NULL
factors	NULL
acting	NULL
at	NULL
the	NULL
promoter	NULL
and	NULL
three	NULL
differentiation-specific	NULL
enhancers	NULL
located	NULL
upstream	NULL
and	NULL
downstream	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
72	NULL
,	NULL
73	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
majority	NULL
of	NULL
these	NULL
factors	NULL
contribute	NULL
to	NULL
transcriptional	NULL
activity	NULL
,	NULL
one	NULL
of	NULL
them	NULL
,	NULL
IBR	NULL
,	NULL
was	NULL
found	NULL
to	NULL
repress	NULL
A5	NULL
transcription	NULL
in	NULL
vitro	NULL
(	NULL
25	NULL
)	NULL
.	NULL

IBR	NULL
from	NULL
immature	NULL
and	NULL
mature	NULL
adult	NULL
erythrocyte	NULL
nuclei	NULL
is	NULL
a	NULL
protein	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
70	NULL
to	NULL
73	NULL
kDa	NULL
that	NULL
specifically	NULL
binds	NULL
to	NULL
the	NULL
GC-rich	NULL
sequences	NULL
spanning	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
£5	NULL
gene	NULL
.	NULL

IBR	NULL
repression	NULL
of	NULL
£5	NULL
transcription	NULL
appears	NULL
to	NULL
occur	NULL
by	NULL
interference	NULL
with	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
complex	NULL
(	NULL
25	NULL
)	NULL
.	NULL

*	NULL
Corresponding	NULL
author	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
418	NULL
)	NULL
691-5550	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
418	NULL
)	NULL
691-5439	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
Adolf	NULL
.	NULL

Ruiz-Carrillo	NULL
@	NULL
bcx.ulaval.ca	NULL
.	NULL

6670	NULL
IBR	NULL
was	NULL
not	NULL
found	NULL
in	NULL
HD3	NULL
cells	NULL
(	NULL
avian	NULL
erythroblastosis	NULL
virus	NULL
[	NULL
AEV	NULL
]	NULL
-transformed	NULL
erythroid	NULL
precursors	NULL
)	NULL
,	NULL
which	NULL
instead	NULL
contain	NULL
a	NULL
protein	NULL
of	NULL
68	NULL
to	NULL
70	NULL
kDa	NULL
that	NULL
recognized	NULL
the	NULL
IBR	NULL
sites	NULL
of	NULL
the	NULL
A5	NULL
gene	NULL
with	NULL
a	NULL
similar	NULL
degree	NULL
of	NULL
specificity	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
work	NULL
did	NULL
not	NULL
distinguish	NULL
whether	NULL
IBR	NULL
was	NULL
a	NULL
matura-tion-specific	NULL
form	NULL
of	NULL
IBF	NULL
or	NULL
a	NULL
different	NULL
protein	NULL
expressed	NULL
in	NULL
maturing	NULL
erythrocytes	NULL
.	NULL

We	NULL
report	NULL
here	NULL
the	NULL
cloning	NULL
of	NULL
IBR	NULL
cDNA	NULL
and	NULL
present	NULL
evidence	NULL
indicating	NULL
that	NULL
IBR	NULL
and	NULL
IBF	NULL
are	NULL
differentially	NULL
glycosylated	NULL
products	NULL
of	NULL
the	NULL
same	NULL
gene	NULL
.	NULL

IBR/F	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
family	NULL
of	NULL
evolutionarily	NULL
related	NULL
transcription	NULL
factors	NULL
that	NULL
includes	NULL
sea	NULL
urchin	NULL
P3A2	NULL
(	NULL
11	NULL
)	NULL
,	NULL
the	NULL
Drosophila	NULL
erect	NULL
wing	NULL
gene	NULL
product	NULL
(	NULL
EWG	NULL
)	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
the	NULL
recently	NULL
reported	NULL
human	NULL
NRF-1/	NULL
«	NULL
-Pal	NULL
factor	NULL
(	NULL
18	NULL
,	NULL
88	NULL
)	NULL
.	NULL

The	NULL
invertebrate	NULL
members	NULL
of	NULL
this	NULL
family	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
development	NULL
of	NULL
muscle	NULL
and	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
.	NULL

In	NULL
vertebrates	NULL
,	NULL
they	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
mitochondrial	NULL
energy	NULL
transduction	NULL
(	NULL
88	NULL
)	NULL
and	NULL
protein	NULL
synthesis	NULL
(	NULL
18	NULL
)	NULL
.	NULL

We	NULL
argue	NULL
that	NULL
these	NULL
factors	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
growth-related	NULL
metabolism	NULL
.	NULL

We	NULL
also	NULL
present	NULL
a	NULL
structural	NULL
analysis	NULL
of	NULL
IBR/F	NULL
and	NULL
show	NULL
that	NULL
it	NULL
associates	NULL
as	NULL
stable	NULL
homodimers	NULL
and	NULL
that	NULL
the	NULL
dimer	NULL
is	NULL
the	NULL
relevant	NULL
DNA-binding	NULL
species	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
show	NULL
that	NULL
the	NULL
N-terminal	NULL
half	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
harboring	NULL
the	NULL
DNA-binding/	NULL
dimerization	NULL
domain	NULL
,	NULL
the	NULL
necessary	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
NLS	NULL
)	NULL
,	NULL
and	NULL
several	NULL
potential	NULL
casein	NULL
kinase	NULL
II	NULL
(	NULL
CK-II	NULL
)	NULL
sites	NULL
,	NULL
has	NULL
been	NULL
conserved	NULL
during	NULL
evolution	NULL
,	NULL
whereas	NULL
the	NULL
C-terminal	NULL
half	NULL
has	NULL
diverged	NULL
considerably	NULL
.	NULL

A	NULL
detailed	NULL
study	NULL
of	NULL
the	NULL
transcriptional	NULL
effect	NULL
of	NULL
IBR	NULL
and	NULL
IBF	NULL
on	NULL
the	NULL
25	NULL
gene	NULL
will	NULL
be	NULL
presented	NULL
in	NULL
a	NULL
separate	NULL
communication	NULL
(	NULL
242	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Nuclear	NULL
extracts	NULL
and	NULL
factor	NULL
purification	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
IBR	NULL
from	NULL
5	NULL
x	NULL
10	NULL
mature	NULL
hen	NULL
erythrocytes	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
before	NULL
(	NULL
25	NULL
)	NULL
.	NULL

IBF	NULL
was	NULL
obtained	NULL
from	NULL
1.5	NULL
x	NULL
104	NULL
HD3	NULL
cells	NULL
essentially	NULL
as	NULL
described	NULL
before	NULL
(	NULL
25	NULL
)	NULL
with	NULL
the	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
following	NULL
modifications	NULL
.	NULL

The	NULL
nuclear	NULL
extract	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
25	NULL
mM	NULL
HEPES	NULL
[	NULL
N-2-hydroxyethylpiperazine-V'-2-ethanesulfonic	NULL
acid	NULL
,	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
uM	NULL
ZnCl	NULL
,	NULL
0.2	NULL
mM	NULL
EGTA	NULL
[	NULL
ethylene	NULL
glycol	NULL
tetraacetic	NULL
acid	NULL
]	NULL
,	NULL
6	NULL
mM	NULL
2-mercaptocthanol	NULL
,	NULL
5	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
1	NULL
M	NULL
leupeptin	NULL
,	NULL
1	NULL
wM	NULL
pepstatin	NULL
)	NULL
containing	NULL
0.3	NULL
M	NULL
KCl	NULL
was	NULL
chromatographed	NULL
through	NULL
a	NULL
35-ml	NULL
heparin-agarose	NULL
column	NULL
(	NULL
Pharmacia	NULL
)	NULL
with	NULL
a	NULL
0.3	NULL
to	NULL
0.6	NULL
M	NULL
KCI	NULL
gradient	NULL
in	NULL
buffer	NULL
A	NULL
.	NULL

The	NULL
0.4	NULL
to	NULL
0.5	NULL
M	NULL
KCI	NULL
fractions	NULL
were	NULL
pooled	NULL
,	NULL
dialyzed	NULL
against	NULL
0.2	NULL
M	NULL
KCl	NULL
in	NULL
buffer	NULL
A	NULL
,	NULL
and	NULL
loaded	NULL
in	NULL
a	NULL
5-ml	NULL
wheat	NULL
germ	NULL
agglutinin	NULL
(	NULL
WGA	NULL
)	NULL
-Sepharose	NULL
4B	NULL
column	NULL
.	NULL

The	NULL
flowthrough	NULL
was	NULL
loaded	NULL
in	NULL
a	NULL
10-ml	NULL
double-stranded	NULL
DNA-cellulose	NULL
column	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
eluted	NULL
with	NULL
a	NULL
0.2	NULL
to	NULL
0.6	NULL
M	NULL
KCI	NULL
gradient	NULL
in	NULL
buffer	NULL
A	NULL
.	NULL

The	NULL
0.5	NULL
M	NULL
KCI	NULL
fraction	NULL
containing	NULL
IBF	NULL
was	NULL
further	NULL
purified	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
affinity	NULL
chromatography	NULL
with	NULL
oligomerized	NULL
cognate	NULL
oligonucleotides	NULL
bound	NULL
to	NULL
Sepharose	NULL
.	NULL

For	NULL
columns	NULL
containing	NULL
the	NULL
histone	NULL
A5	NULL
sequence	NULL
,	NULL
the	NULL
sample	NULL
was	NULL
loaded	NULL
in	NULL
0.2	NULL
M	NULL
KCI	NULL
,	NULL
and	NULL
IBF	NULL
was	NULL
eluted	NULL
with	NULL
0.5	NULL
M	NULL
KCI	NULL
in	NULL
buffer	NULL
A	NULL
.	NULL

For	NULL
columns	NULL
containing	NULL
the	NULL
palindrome	NULL
(	NULL
PAL	NULL
)	NULL
sequence	NULL
AGCTTTGCGCATGCGCAA	NULL
,	NULL
the	NULL
sample	NULL
was	NULL
loaded	NULL
in	NULL
0.5	NULL
M	NULL
KCI	NULL
,	NULL
and	NULL
IBF	NULL
was	NULL
eluted	NULL
with	NULL
1.2	NULL
M	NULL
KCI	NULL
in	NULL
buffer	NULL
A.	NULL
IBF	NULL
from	NULL
HeLa	NULL
cells	NULL
was	NULL
purified	NULL
by	NULL
chromatography	NULL
of	NULL
nuclear	NULL
extracts	NULL
through	NULL
oligomerized	NULL
PAL-Sepharose	NULL
as	NULL
described	NULL
for	NULL
the	NULL
IBF	NULL
of	NULL
HD3	NULL
.	NULL

For	NULL
glycosylation	NULL
assays	NULL
,	NULL
the	NULL
DNA	NULL
affinity-purified	NULL
proteins	NULL
were	NULL
fractionated	NULL
by	NULL
chromatography	NULL
through	NULL
succinylated	NULL
WGA-Sepharose	NULL
(	NULL
Vector	NULL
Laborato-ries	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
analyzed	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-7.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-7.5	NULL
%	NULL
PAGE	NULL
)	NULL
and	NULL
stained	NULL
with	NULL
silver	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
purified	NULL
IBR	NULL
and	NULL
IBF	NULL
was	NULL
estimated	NULL
in	NULL
stained	NULL
gels	NULL
or	NULL
Western	NULL
immunoblots	NULL
by	NULL
comparison	NULL
to	NULL
recombinant	NULL
IBR	NULL
(	NULL
r	NULL
[	NULL
BR	NULL
)	NULL
standards	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
extracts	NULL
and	NULL
rIBR	NULL
was	NULL
determined	NULL
with	NULL
the	NULL
Micro	NULL
BCA	NULL
reagent	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

IBR	NULL
sequencing	NULL
and	NULL
peptide	NULL
mapping	NULL
.	NULL

Purified	NULL
IBR	NULL
(	NULL
26	NULL
ug	NULL
)	NULL
was	NULL
precipitated	NULL
with	NULL
10	NULL
volumes	NULL
of	NULL
acetone-acetic	NULL
acid-triethylamine	NULL
(	NULL
90:5:5	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
was	NULL
cleaved	NULL
with	NULL
CNBr	NULL
and	NULL
trypsin	NULL
,	NULL
and	NULL
several	NULL
peptides	NULL
separated	NULL
by	NULL
high-pressure	NULL
liquid	NULL
chromatography	NULL
(	NULL
HPLC	NULL
)	NULL
were	NULL
sequenced	NULL
(	NULL
W.	NULL
M.	NULL
Keck	NULL
Foundation	NULL
,	NULL
Yale	NULL
University	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
obtained	NULL
were	NULL
:	NULL
KRPHVFESNPSIR	NULL
,	NULL
VFGAAPLEN	NULL
VVR	NULL
,	NULL
ESCKPIXWPXDIPXANVR	NULL
,	NULL
and	NULL
VSWTQALR	NULL
.	NULL

Purified	NULL
IBR	NULL
,	NULL
IBF	NULL
,	NULL
and	NULL
rIBR	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
1	NULL
%	NULL
SDS	NULL
were	NULL
reacted	NULL
with	NULL
60	NULL
l	NULL
of	NULL
1.3-mg/ml	NULL
2-	NULL
(	NULL
2'-nitrophenylsulfenyl	NULL
)	NULL
-3-methyl-3'-bromoindolenine	NULL
(	NULL
BNPS-ska-tole	NULL
;	NULL
Pierce	NULL
)	NULL
in	NULL
acetic	NULL
acid	NULL
for	NULL
60	NULL
min	NULL
at	NULL
47°C	NULL
,	NULL
conditions	NULL
which	NULL
are	NULL
specific	NULL
for	NULL
cleavage	NULL
at	NULL
tryptophan	NULL
residues	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
peptides	NULL
were	NULL
separated	NULL
by	NULL
SDS-14	NULL
%	NULL
PAGE	NULL
and	NULL
visualized	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
anti-rIBR	NULL
antibodies	NULL
.	NULL

Construction	NULL
of	NULL
cDNA	NULL
libraries	NULL
and	NULL
cloning	NULL
of	NULL
IBR	NULL
cDNA	NULL
.	NULL

Double-stranded	NULL
cDNA	NULL
was	NULL
synthesized	NULL
from	NULL
immature	NULL
hen	NULL
erythrocyte	NULL
or	NULL
HD3	NULL
polyadenylated	NULL
[	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
]	NULL
RNA	NULL
(	NULL
67	NULL
)	NULL
.	NULL

A	NULL
partial	NULL
hen	NULL
erythrocyte	NULL
cDNA	NULL
library	NULL
was	NULL
constructed	NULL
with	NULL
AZap	NULL
II	NULL
(	NULL
Stratagene	NULL
)	NULL
,	NULL
and	NULL
double-stranded	NULL
cDNA	NULL
was	NULL
fractionated	NULL
by	NULL
size	NULL
by	NULL
low-melting-point	NULL
agarose	NULL
electrophoresis	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
nonamplified	NULL
library	NULL
was	NULL
screened	NULL
with	NULL
a	NULL
partial	NULL
IBR	NULL
cDNA	NULL
clone	NULL
obtained	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
erythrocyte	NULL
double-stranded	NULL
cDNA	NULL
with	NULL
the	NULL
sense	NULL
primer	NULL
GGAATTCC	NULL
(	NULL
A/C/G	NULL
)	NULL
CCNCACGTNTT	NULL
(	NULL
C/T	NULL
)	NULL
GA	NULL
and	NULL
the	NULL
reverse	NULL
primer	NULL
GCTCTAGAGC	NULL
(	NULL
C/A	NULL
)	NULL
A	NULL
(	NULL
G/A	NULL
)	NULL
TGC	NULL
(	NULL
T/C	NULL
)	NULL
TG	NULL
(	NULL
G/T/A	NULL
)	NULL
GTCCA	NULL
,	NULL
corresponding	NULL
to	NULL
peptides	NULL
PVHFE	NULL
and	NULL
WTQAL	NULL
,	NULL
respectively	NULL
.	NULL

PCR	NULL
conditions	NULL
were	NULL
as	NULL
described	NULL
before	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Two	NULL
IBR	NULL
cDNA	NULL
clones	NULL
were	NULL
isolated	NULL
,	NULL
pe	NULL
[	NULL
BR1	NULL
and	NULL
peIBR2	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
that	NULL
contained	NULL
incomplete	NULL
open	NULL
reading	NULL
frames	NULL
(	NULL
ORFs	NULL
)	NULL
(	NULL
pc	NULL
[	NULL
BR1	NULL
encompassing	NULL
nucleotides	NULL
281	NULL
to	NULL
1691	NULL
,	NULL
and	NULL
peIBR2	NULL
encompassing	NULL
738	NULL
to	NULL
2029	NULL
)	NULL
.	NULL

The	NULL
missing	NULL
5	NULL
'	NULL
sequences	NULL
were	NULL
obtained	NULL
by	NULL
ligation-mediated	NULL
PCR	NULL
(	NULL
LMPCR	NULL
)	NULL
(	NULL
59	NULL
)	NULL
with	NULL
the	NULL
reverse	NULL
primers	NULL
pri	NULL
(	NULL
GCTCTTGTACTTGCGTACC	NULL
)	NULL
,	NULL
pr2	NULL
(	NULL
TACCACATTCTCCAAGGGTGCAG	NULL
CTC	NULL
)	NULL
,	NULL
and	NULL
pr3	NULL
(	NULL
GAAGACAGGGTTGGGTTTGGAGGGTGA	NULL
)	NULL
and	NULL
the	NULL
forward	NULL
linker	NULL
primer	NULL
(	NULL
GCGGTGACCCGGGAGATCTGAATTC	NULL
)	NULL
.	NULL

Double-stranded	NULL
cDNA	NULL
from	NULL
immature	NULL
hen	NULL
erythrocyte	NULL
or	NULL
HD3	NULL
cells	NULL
was	NULL
denatured	NULL
,	NULL
annealed	NULL
to	NULL
pri	NULL
,	NULL
elongated	NULL
with	NULL
T7	NULL
DNA	NULL
polymerase	NULL
,	NULL
and	NULL
ligated	NULL
to	NULL
the	NULL
common	NULL
linker	NULL
.	NULL

Elongated	NULL
products	NULL
were	NULL
amplified	NULL
with	NULL
Tag	NULL
polymerase	NULL
,	NULL
using	NULL
10	NULL
pmol	NULL
each	NULL
of	NULL
pr2	NULL
and	NULL
forward	NULL
linker	NULL
primer	NULL
.	NULL

The	NULL
PCR	NULL
conditions	NULL
were	NULL
1	NULL
min	NULL
at	NULL
94°C	NULL
,	NULL
2	NULL
min	NULL
at	NULL
63°C	NULL
,	NULL
and	NULL
3	NULL
min	NULL
at	NULL
76°C	NULL
for	NULL
25	NULL
cycles	NULL
in	NULL
a	NULL
Perkin	NULL
Elmer/Cetus	NULL
DNA	NULL
thermal	NULL
cycler	NULL
.	NULL

One-hundredth	NULL
of	NULL
the	NULL
reaction	NULL
was	NULL
reamplified	NULL
with	NULL
pr3	NULL
and	NULL
the	NULL
forward	NULL
linker	NULL
primer	NULL
(	NULL
PCR	NULL
conditions	NULL
were	NULL
as	NULL
above	NULL
except	NULL
that	NULL
the	NULL
annealing	NULL
temperature	NULL
was	NULL
67°C	NULL
)	NULL
.	NULL

The	NULL
IBR	NULL
cDNA-	NULL
(	NULL
peIBR3	NULL
)	NULL
and	NULL
IBF	NULL
cDNA-specific	NULL
products	NULL
were	NULL
purified	NULL
by	NULL
gel	NULL
electrophoresis	NULL
and	NULL
cloned	NULL
in	NULL
pCR-1000	NULL
(	NULL
Invitro-gen	NULL
)	NULL
.	NULL

A	NULL
cDNA	NULL
containing	NULL
the	NULL
complete	NULL
ORF	NULL
of	NULL
IBR	NULL
was	NULL
reconstructed	NULL
by	NULL
swapping	NULL
the	NULL
appropriate	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
regions	NULL
of	NULL
pe	NULL
[	NULL
BR1	NULL
and	NULL
pe	NULL
[	NULL
BR3	NULL
at	NULL
a	NULL
unique	NULL
MiuI	NULL
site	NULL
of	NULL
the	NULL
overlapping	NULL
sequences	NULL
.	NULL

The	NULL
reconstructed	NULL
plasmid	NULL
is	NULL
hereafter	NULL
referred	NULL
to	NULL
as	NULL
pcIBR	NULL
.	NULL

Dideoxy	NULL
nucleotide	NULL
sequencing	NULL
of	NULL
the	NULL
two	NULL
DNA	NULL
strands	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
a	NULL
T7	NULL
DNA	NULL
polymerase	NULL
kit	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Band	NULL
ambiguities	NULL
were	NULL
resolved	NULL
by	NULL
substituting	NULL
dGTP	NULL
with	NULL
7-deaza-dGTP	NULL
or	NULL
by	NULL
posttreatment	NULL
of	NULL
the	NULL
elongated	NULL
products	NULL
with	NULL
terminal	NULL
deoxynucleotidyl	NULL
transferase	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Computer	NULL
DNA	NULL
and	NULL
protein	NULL
sequence	NULL
analyses	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
Genetics	NULL
Computer	NULL
Group	NULL
software	NULL
.	NULL

Recombinant	NULL
proteins	NULL
.	NULL

IBR	NULL
and	NULL
several	NULL
deletion	NULL
mutants	NULL
were	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
(	NULL
79	NULL
)	NULL
with	NULL
the	NULL
vector	NULL
pET15b	NULL
(	NULL
Novagen	NULL
)	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

For	NULL
the	NULL
full-length	NULL
recombinant	NULL
protein	NULL
,	NULL
rIBR	NULL
,	NULL
the	NULL
parental	NULL
pe	NULL
[	NULL
BR	NULL
was	NULL
modified	NULL
to	NULL
introduce	NULL
a	NULL
FLAG	NULL
epitope	NULL
(	NULL
6	NULL
)	NULL
at	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
IBR	NULL
and	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
T	NULL
antigen	NULL
epitope	NULL
,	NULL
recognized	NULL
by	NULL
monoclonal	NULL
antibody	NULL
kt3	NULL
(	NULL
49	NULL
)	NULL
,	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IBR	NULL
.	NULL

This	NULL
was	NULL
achieved	NULL
by	NULL
PCR	NULL
of	NULL
40	NULL
ng	NULL
of	NULL
peIBR	NULL
with	NULL
the	NULL
forward	NULL
(	NULL
CGGGATCCCGCCATGGACTACAAGG	NULL
MOLECULAR	NULL
CHARACTERIZATION	NULL
OF	NULL
IBR/F	NULL
(	NULL
GRF-1	NULL
)	NULL
6671	NULL
ACGATGAAGAACACGGCGTGAC	NULL
)	NULL
and	NULL
reverse	NULL
(	NULL
CGGGATCCTCATGTT	NULL
TCTGGTTCTGGTGGAGGTGTCTGTTCCAAAGTTACCAC	NULL
)	NULL
primers	NULL
.	NULL

The	NULL
forward	NULL
primer	NULL
provided	NULL
a	NULL
BemHI	NULL
site	NULL
followed	NULL
by	NULL
a	NULL
consensus	NULL
translation	NULL
initiation	NULL
sequence	NULL
(	NULL
44	NULL
)	NULL
and	NULL
coded	NULL
for	NULL
the	NULL
additional	NULL
peptide	NULL
MDTKDD	NULL
that	NULL
was	NULL
fused	NULL
to	NULL
the	NULL
Glu	NULL
at	NULL
position	NULL
2	NULL
of	NULL
the	NULL
IBR	NULL
reading	NULL
frame	NULL
.	NULL

The	NULL
reverse	NULL
primer	NULL
deleted	NULL
the	NULL
natural	NULL
termination	NULL
codon	NULL
of	NULL
IBR	NULL
mRNA	NULL
and	NULL
added	NULL
the	NULL
sequence	NULL
TPPPEPET	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
termination	NULL
codon	NULL
and	NULL
a	NULL
BamHI	NULL
site	NULL
.	NULL

The	NULL
amplification	NULL
conditions	NULL
were	NULL
1	NULL
min	NULL
at	NULL
94°C	NULL
,	NULL
1.5	NULL
min	NULL
at	NULL
55°C	NULL
,	NULL
and	NULL
1	NULL
min	NULL
at	NULL
72°C	NULL
for	NULL
7	NULL
cycles	NULL
,	NULL
followed	NULL
by	NULL
1	NULL
min	NULL
at	NULL
94°C	NULL
,	NULL
1.5	NULL
min	NULL
at	NULL
65°C	NULL
,	NULL
and	NULL
1	NULL
min	NULL
at	NULL
72°C	NULL
for	NULL
an	NULL
additional	NULL
18	NULL
cycles	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
cloned	NULL
in	NULL
pBluescript	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
peIBRFT	NULL
.	NULL

DNA	NULL
sequencing	NULL
indicated	NULL
that	NULL
peIBRFT	NULL
contained	NULL
a	NULL
T	NULL
-	NULL
>	NULL
A	NULL
transversion	NULL
at	NULL
position	NULL
333	NULL
,	NULL
producing	NULL
an	NULL
F	NULL
-	NULL
>	NULL
I	NULL
mutation	NULL
.	NULL

To	NULL
regenerate	NULL
the	NULL
wild-type	NULL
sequence	NULL
,	NULL
the	NULL
fragment	NULL
SphI-M/ul	NULL
(	NULL
155	NULL
to	NULL
369	NULL
)	NULL
of	NULL
the	NULL
PCR	NULL
product	NULL
was	NULL
replaced	NULL
by	NULL
the	NULL
same	NULL
fragment	NULL
of	NULL
pelBR	NULL
.	NULL

The	NULL
cDNA	NULL
insert	NULL
of	NULL
pcIBRFT	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
cloned	NULL
at	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
pET15b	NULL
.	NULL

To	NULL
construct	NULL
N-terminal	NULL
deletion	NULL
mutants	NULL
of	NULL
rIBR	NULL
,	NULL
the	NULL
insert	NULL
of	NULL
pc	NULL
[	NULL
BRFT	NULL
was	NULL
cleaved	NULL
with	NULL
Aval	NULL
(	NULL
AN49	NULL
)	NULL
,	NULL
M/ul	NULL
(	NULL
AN110	NULL
)	NULL
,	NULL
BsfXI	NULL
(	NULL
AN127	NULL
)	NULL
,	NULL
and	NULL
Heell	NULL
(	NULL
AN172	NULL
)	NULL
.	NULL

Mutant	NULL
AN79	NULL
was	NULL
constructed	NULL
from	NULL
peIBR1	NULL
.	NULL

The	NULL
corresponding	NULL
cDNA	NULL
fragments	NULL
were	NULL
inserted	NULL
in	NULL
a	NULL
pET15b	NULL
vector	NULL
appropriately	NULL
modified	NULL
to	NULL
permit	NULL
in-frame	NULL
fusions	NULL
of	NULL
the	NULL
different	NULL
mutants	NULL
to	NULL
the	NULL
tag	NULL
of	NULL
six	NULL
His	NULL
residues	NULL
(	NULL
His	NULL
,	NULL
)	NULL
provided	NULL
by	NULL
the	NULL
vector	NULL
.	NULL

To	NULL
construct	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
,	NULL
the	NULL
peIBRFT	NULL
insert	NULL
was	NULL
digested	NULL
with	NULL
Earl	NULL
(	NULL
AC424	NULL
)	NULL
,	NULL
BsaHI	NULL
(	NULL
AC333	NULL
)	NULL
,	NULL
BanI	NULL
(	NULL
AC300	NULL
)	NULL
,	NULL
Sau3aI	NULL
(	NULL
AC283	NULL
)	NULL
,	NULL
and	NULL
Fspl	NULL
(	NULL
AC247	NULL
)	NULL
.	NULL

The	NULL
corresponding	NULL
cDNA	NULL
fragments	NULL
were	NULL
inserted	NULL
at	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
a	NULL
modified	NULL
pET15b	NULL
vector	NULL
that	NULL
provided	NULL
termination	NULL
codons	NULL
in	NULL
the	NULL
three	NULL
reading	NULL
frames	NULL
,	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
insertion	NULL
site	NULL
.	NULL

The	NULL
recombinant	NULL
proteins	NULL
were	NULL
extracted	NULL
under	NULL
nondenaturing	NULL
conditions	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

rIBR	NULL
and	NULL
the	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
were	NULL
purified	NULL
by	NULL
heparin-agarose	NULL
chromatography	NULL
because	NULL
translation	NULL
started	NULL
at	NULL
the	NULL
AUG	NULL
of	NULL
cIBRFT	NULL
rather	NULL
than	NULL
at	NULL
the	NULL
vector	NULL
AUG	NULL
,	NULL
resulting	NULL
in	NULL
proteins	NULL
that	NULL
did	NULL
not	NULL
contain	NULL
the	NULL
His	NULL
,	NULL
tag	NULL
.	NULL

N-terminal	NULL
deletion	NULL
mutants	NULL
were	NULL
purified	NULL
by	NULL
affinity	NULL
chromatography	NULL
on	NULL
Ni**	NULL
nitrilotriacetic	NULL
acid-agarose	NULL
(	NULL
Qiagen	NULL
)	NULL
.	NULL

pRC/RSV	NULL
(	NULL
Invitrogen	NULL
)	NULL
was	NULL
used	NULL
to	NULL
construct	NULL
eukaryotic	NULL
expression	NULL
vectors	NULL
of	NULL
IBR	NULL
.	NULL

DNAs	NULL
coding	NULL
for	NULL
full-size	NULL
rIBR	NULL
or	NULL
N-terminally	NULL
and	NULL
C-terminally	NULL
truncated	NULL
proteins	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
pET15b	NULL
constructs	NULL
and	NULL
inserted	NULL
at	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
pRC/RSV	NULL
by	NULL
blunt-end	NULL
ligation	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
optimal	NULL
IBR	NULL
recognition	NULL
sequence	NULL
.	NULL

Affinity-purified	NULL
IBR	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
mg	NULL
of	NULL
the	NULL
double-stranded	NULL
oligonucleotide	NULL
mixture	NULL
CGTTGAATTCCGTAGG	NULL
(	NULL
N	NULL
)	NULL
,	NULL
,	NULL
CAGGCTGAATTCGCAC	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
30-fold	NULL
molar	NULL
excess	NULL
of	NULL
probe	NULL
)	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

After	NULL
3	NULL
h	NULL
at	NULL
4°C	NULL
,	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
pg/ml	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
loaded	NULL
on	NULL
a	NULL
100-pl	NULL
WGA-Sepharose	NULL
column	NULL
equilibrated	NULL
with	NULL
binding	NULL
buffer	NULL
containing	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

The	NULL
flowthrough	NULL
fraction	NULL
was	NULL
discarded	NULL
,	NULL
and	NULL
the	NULL
column	NULL
was	NULL
successively	NULL
washed	NULL
with	NULL
10	NULL
volumes	NULL
of	NULL
binding	NULL
buffer	NULL
,	NULL
0.2	NULL
M	NULL
KCI-containing	NULL
binding	NULL
buffer	NULL
,	NULL
and	NULL
binding	NULL
buffer	NULL
.	NULL

Oligonucleotide-protein	NULL
complexes	NULL
were	NULL
eluted	NULL
with	NULL
0.3	NULL
M	NULL
N-acetylglucosamine	NULL
in	NULL
binding	NULL
buffer	NULL
,	NULL
and	NULL
DNA	NULL
was	NULL
purified	NULL
by	NULL
phenol	NULL
extraction	NULL
.	NULL

One-fifteenth	NULL
of	NULL
the	NULL
DNA	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
in	NULL
a	NULL
reaction	NULL
containing	NULL
20	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
2.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.01	NULL
%	NULL
gelatin	NULL
,	NULL
50	NULL
wM	NULL
each	NULL
of	NULL
the	NULL
four	NULL
deoxynucleoside	NULL
triphosphates	NULL
,	NULL
5	NULL
U	NULL
of	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
,	NULL
and	NULL
200	NULL
pmol	NULL
each	NULL
of	NULL
forward	NULL
(	NULL
CGTTGAATTCCGTAGG	NULL
)	NULL
and	NULL
reverse	NULL
(	NULL
GTGCGAATTCAGCCTG	NULL
)	NULL
primers	NULL
.	NULL

The	NULL
PCR	NULL
conditions	NULL
were	NULL
92°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
43°C	NULL
for	NULL
2	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
0.5	NULL
min	NULL
for	NULL
19	NULL
cycles	NULL
.	NULL

Then	NULL
300	NULL
ng	NULL
of	NULL
amplified	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
cIBR	NULL
as	NULL
indicated	NULL
above	NULL
,	NULL
and	NULL
the	NULL
procedure	NULL
was	NULL
repeated	NULL
five	NULL
or	NULL
eight	NULL
times	NULL
.	NULL

Oligonucleotides	NULL
selected	NULL
by	NULL
IBR	NULL
were	NULL
digested	NULL
with	NULL
EcoRI	NULL
(	NULL
sites	NULL
underlined	NULL
in	NULL
the	NULL
original	NULL
sequence	NULL
)	NULL
and	NULL
inserted	NULL
at	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pUC12N23	NULL
,	NULL
which	NULL
contains	NULL
an	NULL
(	NULL
N	NULL
)	NULL
;	NULL
,	NULL
signature	NULL
sequence	NULL
at	NULL
the	NULL
Xbel	NULL
site	NULL
of	NULL
pUC12	NULL
to	NULL
permit	NULL
identification	NULL
of	NULL
independent	NULL
re-combinants	NULL
.	NULL

Cross-linking	NULL
.	NULL

Purified	NULL
IBR	NULL
or	NULL
partially	NULL
purified	NULL
IBF	NULL
(	NULL
50	NULL
to	NULL
60	NULL
ng	NULL
in	NULL
a	NULL
25-pl	NULL
reaction	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
glutaraldehyde	NULL
(	NULL
0	NULL
to	NULL
0.1	NULL
%	NULL
)	NULL
in	NULL
25	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
-0.1	NULL
M	NULL
KCl-1	NULL
mM	NULL
EDTA-5	NULL
mM	NULL
MgCl	NULL
,	NULL
-8	NULL
%	NULL
glycerol	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
quenched	NULL
with	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
50	NULL
mM	NULL
.	NULL

Insulin	NULL
(	NULL
10	NULL
ag	NULL
)	NULL
was	NULL
added	NULL
as	NULL
the	NULL
carrier	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
precipitated	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
anti-rIBR	NULL
antibodies	NULL
.	NULL

DNA-binding	NULL
assays	NULL
and	NULL
kinetic	NULL
measurements	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
and	NULL
gel	NULL
retardation	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
before	NULL
(	NULL
25	NULL
,	NULL
72	NULL
)	NULL
.	NULL

Where	NULL
indi-cated	NULL
,	NULL
the	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
immunoglobulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
from	NULL
preimmune	NULL
or	NULL
immune	NULL
anti-IBR	NULL
serum	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
prior	NULL
to	NULL
incubation	NULL
with	NULL
the	NULL
labeled	NULL
oligonucleotide	NULL
probes	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
mutant	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
sequences	NULL
from	NULL
-20	NULL
to	NULL
+14	NULL
and	NULL
-10	NULL
to	NULL
+14	NULL
of	NULL
the	NULL
A5	NULL
gene	NULL
have	NULL
been	NULL
described	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Additional	NULL
oligonucleotides	NULL
were	NULL
PAL	NULL
(	NULL
GTAGACTGCGCATGCGCATCT	NULL
)	NULL
and	NULL
1/2	NULL
PAL	NULL
(	NULL
GATGTAGACTGCGCAT	NULL
CTGTATGC	NULL
)	NULL
.	NULL

On-rate	NULL
determinations	NULL
were	NULL
carried	NULL
out	NULL
at	NULL
0°C	NULL
with	NULL
a	NULL
probe	NULL
concentration	NULL
of	NULL
6	NULL
x	NULL
10~°	NULL
M	NULL
and	NULL
purified	NULL
IBR	NULL
at	NULL
1.2	NULL
x	NULL
10~°	NULL
M.	NULL
Aliquots	NULL
were	NULL
loaded	NULL
at	NULL
different	NULL
times	NULL
in	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
running	NULL
at	NULL
20	NULL
V/cm	NULL
,	NULL
and	NULL
it	NULL
took	NULL
3	NULL
min	NULL
for	NULL
the	NULL
DNA	NULL
complex	NULL
to	NULL
enter	NULL
the	NULL
gel	NULL
.	NULL

For	NULL
off-rate	NULL
measurements	NULL
,	NULL
the	NULL
reaction	NULL
mixtures	NULL
6672	NULL
GOMEZ-CUADRADO	NULL
ET	NULL
AL	NULL
.	NULL

were	NULL
incubated	NULL
to	NULL
virtual	NULL
equilibrium	NULL
for	NULL
up	NULL
to	NULL
4	NULL
h	NULL
at	NULL
0°C	NULL
,	NULL
at	NULL
which	NULL
time	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
nonlabeled	NULL
probe	NULL
was	NULL
added	NULL
.	NULL

Incubation	NULL
was	NULL
continued	NULL
for	NULL
0	NULL
,	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
20	NULL
,	NULL
40	NULL
,	NULL
60	NULL
,	NULL
105	NULL
,	NULL
and	NULL
135	NULL
min	NULL
(	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
A5	NULL
probe	NULL
)	NULL
or	NULL
for	NULL
0	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
20	NULL
,	NULL
40	NULL
,	NULL
60	NULL
,	NULL
90	NULL
,	NULL
120	NULL
,	NULL
180	NULL
,	NULL
360	NULL
,	NULL
480	NULL
,	NULL
570	NULL
,	NULL
and	NULL
720	NULL
min	NULL
(	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
PAL	NULL
probe	NULL
)	NULL
before	NULL
immediately	NULL
loading	NULL
the	NULL
reaction	NULL
mixtures	NULL
in	NULL
a	NULL
gel	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
dissociation	NULL
constant	NULL
of	NULL
the	NULL
IBR	NULL
dimers	NULL
,	NULL
increasing	NULL
concentrations	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
0.72	NULL
X	NULL
10~°	NULL
to	NULL
7.2	NULL
x	NULL
10~°	NULL
M	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
binding	NULL
buffer	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
*°P-labeled	NULL
DNA	NULL
probe	NULL
(	NULL
7.2	NULL
X	NULL
10~®	NULL
M	NULL
)	NULL
,	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
.	NULL

Gels	NULL
were	NULL
fixed	NULL
for	NULL
90	NULL
min	NULL
with	NULL
40	NULL
%	NULL
methanol-10	NULL
%	NULL
acetic	NULL
acid	NULL
and	NULL
dried	NULL
.	NULL

The	NULL
radioactivity	NULL
of	NULL
bound	NULL
and	NULL
free	NULL
probes	NULL
was	NULL
quantified	NULL
with	NULL
a	NULL
PhosphorImager	NULL
445SI	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Cells	NULL
and	NULL
transfection	NULL
.	NULL

Chicken	NULL
erythroid	NULL
HD3	NULL
cells	NULL
AEV-transformed	NULL
CFU	NULL
(	NULL
E	NULL
)	NULL
]	NULL
and	NULL
H32	NULL
cells	NULL
(	NULL
transformed	NULL
quail	NULL
fibroblasts	NULL
)	NULL
were	NULL
grown	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
72	NULL
,	NULL
73	NULL
)	NULL
.	NULL

HD3	NULL
cells	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
at	NULL
41°C	NULL
with	NULL
15	NULL
wM	NULL
H7	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

H32	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
(	NULL
RSV	NULL
)	NULL
-IBR	NULL
expression	NULL
vectors	NULL
with	NULL
Lipofectamine	NULL
(	NULL
GIBCO-BRL	NULL
)	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Cells	NULL
were	NULL
processed	NULL
at	NULL
48	NULL
h	NULL
posttransfection	NULL
for	NULL
indirect	NULL
immunofluorescence	NULL
assays	NULL
.	NULL

Antibodies	NULL
.	NULL

Antibodies	NULL
against	NULL
affinity	NULL
DNA-purified	NULL
chicken	NULL
IBR	NULL
were	NULL
elicited	NULL
in	NULL
rabbits	NULL
injected	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
containing	NULL
20	NULL
pg	NULL
of	NULL
affinity-purified	NULL
protein	NULL
and	NULL
200	NULL
pg	NULL
of	NULL
insulin	NULL
with	NULL
0.5	NULL
ml	NULL
of	NULL
Inject	NULL
Alum	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

Rabbits	NULL
were	NULL
boosted	NULL
after	NULL
3	NULL
weeks	NULL
with	NULL
the	NULL
same	NULL
mixture	NULL
,	NULL
and	NULL
IgG	NULL
was	NULL
purified	NULL
from	NULL
antisera	NULL
by	NULL
protein	NULL
A-Sepharose	NULL
chromatography	NULL
.	NULL

Antibody	NULL
reaction	NULL
was	NULL
not	NULL
noticeably	NULL
affected	NULL
by	NULL
periodate	NULL
oxidation	NULL
of	NULL
cIBR	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
antibodies	NULL
were	NULL
not	NULL
specific	NULL
for	NULL
carbohydrate	NULL
epitopes	NULL
(	NULL
92	NULL
)	NULL
.	NULL

Rabbit	NULL
anti-rIBR	NULL
antibodies	NULL
were	NULL
obtained	NULL
by	NULL
injection	NULL
of	NULL
untagged	NULL
AN79-IBR	NULL
and	NULL
purified	NULL
by	NULL
affinity	NULL
chromatography	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
kt3	NULL
,	NULL
specific	NULL
for	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
SV40	NULL
T	NULL
antigen	NULL
(	NULL
49	NULL
)	NULL
,	NULL
was	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
J.	NULL
Landry	NULL
.	NULL

Indirect	NULL
immunofluorescence	NULL
and	NULL
confocal	NULL
microscopy	NULL
were	NULL
done	NULL
as	NULL
described	NULL
before	NULL
(	NULL
15	NULL
)	NULL
with	NULL
anti-r	NULL
[	NULL
BR	NULL
or	NULL
kt3	NULL
as	NULL
the	NULL
primary	NULL
antibody	NULL
.	NULL

Texas	NULL
red-conjugated	NULL
anti-rabbit	NULL
Ig	NULL
or	NULL
fluorescein-conjugated	NULL
anti-mouse	NULL
Ig	NULL
antibodies	NULL
were	NULL
used	NULL
as	NULL
secondary	NULL
reagents	NULL
.	NULL

IBR	NULL
phosphorylation	NULL
.	NULL

Purified	NULL
immature	NULL
erythrocytes	NULL
(	NULL
64	NULL
)	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
anemic	NULL
hens	NULL
were	NULL
resuspended	NULL
in	NULL
2	NULL
ml	NULL
(	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
)	NULL
of	NULL
phosphate-free	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
GIBCO-BRL	NULL
)	NULL
supplemented	NULL
with	NULL
dialyzed	NULL
8	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
2	NULL
%	NULL
chicken	NULL
serum	NULL
and	NULL
labelled	NULL
with	NULL
2.5	NULL
mCi	NULL
of	NULL
carrier-free	NULL
*°P	NULL
;	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
[	NULL
NEN	NULL
]	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
17	NULL
h	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
and	NULL
lysed	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.5	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
0.10	NULL
M	NULL
NaCl	NULL
,	NULL
40	NULL
mM	NULL
NaF	NULL
,	NULL
1.5	NULL
mM	NULL
B-naph-thylIphosphate	NULL
,	NULL
10	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.4	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
mM	NULL
benzamidine	NULL
,	NULL
1	NULL
M	NULL
leupeptin	NULL
,	NULL
and	NULL
1	NULL
M	NULL
pepstatin	NULL
)	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
crude	NULL
nuclear	NULL
pellet	NULL
was	NULL
suspended	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
buffer	NULL
B	NULL
supplemented	NULL
with	NULL
0.5	NULL
%	NULL
deoxycholate	NULL
and	NULL
1	NULL
%	NULL
SDS	NULL
and	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
diluted	NULL
with	NULL
900	NULL
pl	NULL
of	NULL
buffer	NULL
B	NULL
supplemented	NULL
with	NULL
0.2	NULL
mM	NULL
EDTA	NULL
and	NULL
0.2	NULL
mM	NULL
EGTA	NULL
and	NULL
centrifuged	NULL
for	NULL
1	NULL
h	NULL
at	NULL
40,000	NULL
rpm	NULL
in	NULL
an	NULL
SW50.1	NULL
rotor	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
precleared	NULL
by	NULL
incubation	NULL
with	NULL
40	NULL
wl	NULL
of	NULL
neutral	NULL
rabbit	NULL
IgG	NULL
cross-linked	NULL
(	NULL
78	NULL
)	NULL
to	NULL
protein	NULL
A-Sepharose	NULL
for	NULL
18	NULL
h	NULL
at	NULL
4°C	NULL
and	NULL
reacted	NULL
with	NULL
10	NULL
pl	NULL
of	NULL
affinity-purified	NULL
anti-rIBR	NULL
IgG	NULL
cross-linked	NULL
to	NULL
protein	NULL
A-Sepharose	NULL
for	NULL
an	NULL
additional	NULL
18	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
0.1	NULL
%	NULL
SDS	NULL
containing	NULL
buffer	NULL
B	NULL
,	NULL
resuspended	NULL
in	NULL
1	NULL
volume	NULL
of	NULL
2	NULL
%	NULL
electrophoresis	NULL
sample	NULL
buffer	NULL
,	NULL
and	NULL
boiled	NULL
for	NULL
3	NULL
min	NULL
before	NULL
loading	NULL
the	NULL
gel	NULL
.	NULL

Proteins	NULL
separated	NULL
by	NULL
electrophoresis	NULL
were	NULL
transferred	NULL
onto	NULL
a	NULL
0.2-wm	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Schleicher	NULL
and	NULL
Schiill	NULL
)	NULL
.	NULL

After	NULL
*°P	NULL
detection	NULL
by	NULL
autoradiography	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
reacted	NULL
with	NULL
anti-rIBR	NULL
antibodies	NULL
.	NULL

For	NULL
CK-II	NULL
assays	NULL
,	NULL
500	NULL
ng	NULL
of	NULL
rIBR	NULL
or	NULL
AN79-IBR	NULL
in	NULL
10	NULL
pl	NULL
of	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
-0.1	NULL
M	NULL
NaCl-10	NULL
mM	NULL
MgCl	NULL
,	NULL
-60	NULL
uM	NULL
ATP-1	NULL
M	NULL
leupeptin-1	NULL
M	NULL
pepstatin	NULL
,	NULL
0.4	NULL
mM	NULL
PMSF	NULL
containing	NULL
5	NULL
Ci	NULL
of	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
JATP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
NEN	NULL
)	NULL
was	NULL
treated	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
CK-II	NULL
(	NULL
Kinetek	NULL
Biotechnology	NULL
Corp.	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

Reactions	NULL
were	NULL
terminated	NULL
by	NULL
addition	NULL
of	NULL
electrophoresis	NULL
sample	NULL
buffer	NULL
and	NULL
boiling	NULL
for	NULL
2	NULL
min	NULL
.	NULL

CK-II	NULL
was	NULL
omitted	NULL
from	NULL
control	NULL
reactions	NULL
.	NULL

For	NULL
p424	NULL
``	NULL
*	NULL
kinase	NULL
(	NULL
ERK2	NULL
)	NULL
assays	NULL
,	NULL
CCL39	NULL
hamster	NULL
fibroblasts	NULL
were	NULL
mock	NULL
transfected	NULL
or	NULL
transfected	NULL
with	NULL
pEXV-ERK2-Tag	NULL
,	NULL
a	NULL
vector	NULL
expressing	NULL
mouse	NULL
ERK2	NULL
tagged	NULL
with	NULL
a	NULL
c-Myc	NULL
epitope	NULL
recognized	NULL
by	NULL
monoclonal	NULL
antibody	NULL
9E10	NULL
(	NULL
34	NULL
)	NULL
.	NULL

At	NULL
60	NULL
h	NULL
posttransfection	NULL
,	NULL
cells	NULL
were	NULL
deprived	NULL
of	NULL
serum	NULL
for	NULL
24	NULL
h	NULL
and	NULL
induced	NULL
or	NULL
not	NULL
with	NULL
1	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
immediately	NULL
prepared	NULL
in	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
vanadate	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
1	NULL
M	NULL
leupeptin	NULL
)	NULL
and	NULL
reacted	NULL
with	NULL
antibody	NULL
9E10	NULL
bound	NULL
to	NULL
protein	NULL
A-Sepharose	NULL
.	NULL

Then	NULL
2	NULL
mg	NULL
of	NULL
rIBR	NULL
or	NULL
myelin	NULL
basic	NULL
protein	NULL
was	NULL
mixed	NULL
with	NULL
aliquots	NULL
of	NULL
the	NULL
immunoprecipitates	NULL
in	NULL
a	NULL
30-pl	NULL
reaction	NULL
for	NULL
25	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
reaction	NULL
cocktail	NULL
contained	NULL
1.5	NULL
Ci	NULL
of	NULL
[	NULL
y-	NULL
>	NULL
°P	NULL
]	NULL
JATP	NULL
,	NULL
25	NULL
wM	NULL
ATP	NULL
,	NULL
15	NULL
mM	NULL
MOPS	NULL
(	NULL
mor-pholinepropanesulfonic	NULL
acid	NULL
,	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
60	NULL
mM	NULL
pere-nitrophenyl	NULL
phosphate	NULL
,	NULL
15	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
wM	NULL
leupeptin	NULL
,	NULL
0.1	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
0.3	NULL
ug	NULL
of	NULL
cyclic	NULL
AMP	NULL
(	NULL
cAMP	NULL
)	NULL
-dependent	NULL
protein	NULL
kinase	NULL
inhibitor	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
quenched	NULL
by	NULL
addition	NULL
of	NULL
electrophoresis	NULL
sample	NULL
buffer	NULL
and	NULL
boiling	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Blot	NULL
analyses	NULL
.	NULL

Western	NULL
blot	NULL
analyses	NULL
were	NULL
done	NULL
as	NULL
described	NULL
before	NULL
(	NULL
74	NULL
)	NULL
except	NULL
that	NULL
chemiluminescence	NULL
was	NULL
used	NULL
for	NULL
detection	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
(	NULL
RNA	NULL
blot	NULL
)	NULL
analysis	NULL
,	NULL
total	NULL
RNA	NULL
from	NULL
undifferentiated	NULL
and	NULL
differentiated	NULL
HD3	NULL
cells	NULL
and	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
immature	NULL
hen	NULL
erythrocytes	NULL
were	NULL
sep-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

arated	NULL
by	NULL
electrophoresis	NULL
in	NULL
formaldehyde-agarose	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
Hybond-N	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
Southern	NULL
analysis	NULL
,	NULL
restriction	NULL
nuclease-digested	NULL
erythrocyte	NULL
DNA	NULL
was	NULL
separated	NULL
by	NULL
electrophoresis	NULL
in	NULL
0.5	NULL
%	NULL
agarose	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
Hybond-N	NULL
membrane	NULL
.	NULL

Blotted	NULL
nucleic	NULL
acids	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
insert	NULL
of	NULL
pcIBR1	NULL
labeled	NULL
by	NULL
random	NULL
priming	NULL
with	NULL
a	NULL
DNA	NULL
labeling	NULL
kit	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
proteins	NULL
,	NULL
RNA	NULL
,	NULL
or	NULL
DNA	NULL
were	NULL
estimated	NULL
from	NULL
those	NULL
of	NULL
appropriate	NULL
standards	NULL
run	NULL
in	NULL
parallel	NULL
lanes	NULL
.	NULL

RESULTS	NULL
IBR	NULL
and	NULL
IBF	NULL
are	NULL
related	NULL
proteins	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
indicated	NULL
that	NULL
HeLa	NULL
cells	NULL
contain	NULL
a	NULL
nuclear	NULL
protein	NULL
which	NULL
formed	NULL
a	NULL
specific	NULL
complex	NULL
with	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
histone	NULL
A5	NULL
gene	NULL
.	NULL

The	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
the	NULL
complex	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
formed	NULL
by	NULL
IBR	NULL
from	NULL
chicken	NULL
erythrocytes	NULL
and	NULL
IBF	NULL
from	NULL
HD3	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
IBR/IBF	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
complex	NULL
made	NULL
by	NULL
the	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
band	NULL
X	NULL
)	NULL
was	NULL
nonspecific	NULL
,	NULL
since	NULL
its	NULL
formation	NULL
was	NULL
prevented	NULL
by	NULL
competition	NULL
with	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
IBR/IBF	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Similar	NULL
assays	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
chicken	NULL
brain	NULL
and	NULL
T	NULL
lymphoblas-toma	NULL
cells	NULL
(	NULL
MSB-1	NULL
)	NULL
,	NULL
transformed	NULL
H32	NULL
quail	NULL
fibroblasts	NULL
,	NULL
mouse	NULL
L	NULL
cells	NULL
,	NULL
and	NULL
rat	NULL
liver	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
further	NULL
indicated	NULL
that	NULL
all	NULL
the	NULL
systems	NULL
studied	NULL
contained	NULL
a	NULL
DNA-binding	NULL
protein	NULL
related	NULL
to	NULL
IBR	NULL
or	NULL
IBF	NULL
.	NULL

Therefore	NULL
,	NULL
IBR	NULL
or	NULL
IBF	NULL
appears	NULL
to	NULL
be	NULL
ubiquitous	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
relationship	NULL
among	NULL
these	NULL
specific	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
the	NULL
erythrocyte	NULL
,	NULL
HD3	NULL
,	NULL
and	NULL
HeLa	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
purified	NULL
rabbit	NULL
anti-IBR	NULL
IgG	NULL
prior	NULL
to	NULL
incubation	NULL
with	NULL
the	NULL
£5	NULL
probe	NULL
.	NULL

Pretreatment	NULL
with	NULL
the	NULL
antibodies	NULL
reduced	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
specific	NULL
complexes	NULL
in	NULL
a	NULL
concentra-tion-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

At	NULL
the	NULL
lower	NULL
antibody	NULL
dos-age	NULL
,	NULL
a	NULL
supershifted	NULL
complex	NULL
was	NULL
clearly	NULL
observed	NULL
for	NULL
each	NULL
of	NULL
the	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
SS	NULL
)	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
which	NULL
was	NULL
related	NULL
to	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
specific	NULL
DNA-binding	NULL
protein	NULL
of	NULL
the	NULL
extract	NULL
.	NULL

At	NULL
higher	NULL
antibody	NULL
dosages	NULL
,	NULL
the	NULL
complexes	NULL
were	NULL
probably	NULL
immunoprecipitated	NULL
and	NULL
did	NULL
not	NULL
enter	NULL
the	NULL
gel	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
preincubation	NULL
of	NULL
the	NULL
extracts	NULL
with	NULL
preimmune	NULL
IgG	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
specific	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Figure	NULL
1C	NULL
shows	NULL
that	NULL
the	NULL
anti-IBR	NULL
IgG	NULL
also	NULL
recognized	NULL
the	NULL
proteins	NULL
from	NULL
the	NULL
three	NULL
nuclear	NULL
extracts	NULL
after	NULL
purification	NULL
by	NULL
affinity	NULL
chromatography	NULL
with	NULL
the	NULL
oligomerized	NULL
A5	NULL
oligonucle-otide	NULL
.	NULL

IBR	NULL
from	NULL
erythrocytes	NULL
showed	NULL
a	NULL
slower	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
70	NULL
to	NULL
73	NULL
kDa	NULL
)	NULL
than	NULL
IBF	NULL
from	NULL
HD3	NULL
(	NULL
68	NULL
to	NULL
70	NULL
kDa	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
in	NULL
accordance	NULL
with	NULL
our	NULL
previous	NULL
results	NULL
(	NULL
25	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
HeLa	NULL
protein	NULL
had	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
IBF	NULL
,	NULL
although	NULL
the	NULL
relative	NULL
proportion	NULL
of	NULL
the	NULL
70-kDa	NULL
species	NULL
was	NULL
higher	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
heterogeneity	NULL
of	NULL
the	NULL
proteins	NULL
could	NULL
reflect	NULL
their	NULL
posttranslational	NULL
modifications	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
the	NULL
68-kDa	NULL
component	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
proteolytic	NULL
product	NULL
of	NULL
the	NULL
70-kDa	NULL
species	NULL
,	NULL
since	NULL
its	NULL
relative	NULL
proportion	NULL
varied	NULL
from	NULL
preparation	NULL
to	NULL
preparation	NULL
and	NULL
increased	NULL
with	NULL
handling	NULL
of	NULL
the	NULL
sample	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
cf	NULL
.	NULL

lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
IBR	NULL
is	NULL
structurally	NULL
related	NULL
to	NULL
IBF	NULL
(	NULL
HD3	NULL
)	NULL
and	NULL
that	NULL
HeLa	NULL
cells	NULL
contain	NULL
a	NULL
protein	NULL
which	NULL
is	NULL
probably	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
IBF	NULL
.	NULL

Cloning	NULL
and	NULL
analysis	NULL
of	NULL
IBR	NULL
cDNA	NULL
.	NULL

To	NULL
characterize	NULL
IBR	NULL
and	NULL
to	NULL
determine	NULL
its	NULL
structural	NULL
relationship	NULL
with	NULL
IBF	NULL
,	NULL
we	NULL
undertook	NULL
the	NULL
cloning	NULL
of	NULL
IBR	NULL
cDNA	NULL
.	NULL

Purified	NULL
IBR	NULL
from	NULL
mature	NULL
erythrocytes	NULL
was	NULL
cleaved	NULL
with	NULL
CNBr	NULL
and	NULL
trypsin	NULL
,	NULL
and	NULL
four	NULL
peptides	NULL
separated	NULL
by	NULL
HPLC	NULL
were	NULL
sequenced	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
com-puter-assisted	NULL
search	NULL
of	NULL
the	NULL
GenBank	NULL
and	NULL
SwissProt	NULL
databases	NULL
revealed	NULL
that	NULL
P3A2	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
isolated	NULL
from	NULL
sea	NULL
urchin	NULL
embryos	NULL
(	NULL
11	NULL
)	NULL
,	NULL
contained	NULL
almost	NULL
identical	NULL
sequences	NULL
.	NULL

To	NULL
obtain	NULL
a	NULL
probe	NULL
for	NULL
IBR	NULL
cDNA	NULL
cloning	NULL
,	NULL
double-stranded	NULL
cDNA	NULL
from	NULL
immature	NULL
erythrocytes	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
degenerate	NULL
oligonucleotide	NULL
primers	NULL
corresponding	NULL
to	NULL
the	NULL
outer	NULL
PHVFE	NULL
and	NULL
WTQAL	NULL
peptides	NULL
of	NULL
IBR	NULL
according	NULL
to	NULL
the	NULL
P3A2	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
A	NULL
__	NULL
ME	NULL
HD3	NULL
Hela	NULL
|	NULL
wT	NULL
_	NULL
MT	NULL
_	NULL
WT	NULL
MT	NULL
WT	NULL
-	NULL
MT	NULL
-	NULL
util	NULL
_..	NULL
atthe	NULL
_._	NULL
IBR/IBF	NULL
t	NULL
»	NULL
-	NULL
@	NULL
0	NULL
is	NULL
want	NULL
wes	NULL
agp	NULL
we	NULL
an	NULL
-	NULL
-o	NULL
--	NULL
B	NULL
,	NULL
_	NULL
_	NULL
ME	NULL
_	NULL
;	NULL
HD3	NULL
_	NULL
;	NULL
|	NULL
Hela	NULL
_	NULL
Ab	NULL
Ab	NULL
Ab	NULL
_-	NULL
D|	NULL
_	NULL
.	NULL

11	NULL
_.	NULL
P	NULL
|	NULL
--	NULL
m	NULL
--	NULL
--	NULL
..	NULL
--	NULL
cts	NULL
«	NULL
xtra	NULL
SS	NULL
m	NULL
l	NULL
tng	NULL
H6	NULL
IBR/IBF	NULL
a	NULL
»	NULL
(	NULL
Whig	NULL
)	NULL
coud	NULL
duh	NULL
bu	NULL
but	NULL
-	NULL
bub	NULL
-	NULL
(	NULL
@	NULL
(	NULL
t	NULL
wt	NULL
jut	NULL
#	NULL
4	NULL
44	NULL
49	NULL
14	NULL
ao	NULL
sme	NULL
os	NULL
a	NULL
»	NULL
WB	NULL
--	NULL
as	NULL
»	NULL
-=	NULL
#	NULL
ase	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Specific	NULL
binding	NULL
of	NULL
IBR	NULL
from	NULL
mature	NULL
erythrocytes	NULL
(	NULL
ME	NULL
)	NULL
and	NULL
IBF	NULL
from	NULL
HD3	NULL
and	NULL
HeLa	NULL
cells	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
region	NULL
of	NULL
the	NULL
A5	NULL
gene	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Gel	NULL
retardation	NULL
assays	NULL
of	NULL
a	NULL
°P-labeled	NULL
A5	NULL
probe	NULL
(	NULL
-20	NULL
to	NULL
+14	NULL
)	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
nuclear	NULL
extracts	NULL
.	NULL

Leftmost	NULL
lane	NULL
,	NULL
no	NULL
protein	NULL
;	NULL
lanes	NULL
-	NULL
,	NULL
no	NULL
competitor	NULL
oligonucleotide	NULL
;	NULL
lanes	NULL
WT	NULL
and	NULL
MT	NULL
,	NULL
competition	NULL
with	NULL
a	NULL
20-fold	NULL
and	NULL
80-fold	NULL
molar	NULL
excess	NULL
of	NULL
nonlabeled	NULL
wild-type	NULL
or	NULL
mutant	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Antibodies	NULL
against	NULL
IBR	NULL
recognize	NULL
the	NULL
specific	NULL
A5-binding	NULL
factors	NULL
of	NULL
HD3	NULL
and	NULL
HeLa	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
of	NULL
the	NULL
A5	NULL
probe	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
nuclear	NULL
extracts	NULL
pretreated	NULL
with	NULL
anti-IBR	NULL
IgG	NULL
.	NULL

Lanes	NULL
-	NULL
,	NULL
no	NULL
antibody	NULL
;	NULL
lanes	NULL
Ab	NULL
,	NULL
preincubation	NULL
for	NULL
2	NULL
h	NULL
with	NULL
50	NULL
,	NULL
125	NULL
,	NULL
and	NULL
250	NULL
pg	NULL
of	NULL
anti-IBR	NULL
IgG	NULL
;	NULL
lanes	NULL
PI	NULL
,	NULL
preincubation	NULL
for	NULL
2	NULL
h	NULL
with	NULL
250	NULL
ug	NULL
of	NULL
preimmune	NULL
IgG	NULL
;	NULL
last	NULL
lane	NULL
of	NULL
the	NULL
HD3	NULL
set	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

The	NULL
specific	NULL
IBR/F	NULL
and	NULL
supershifted	NULL
(	NULL
SS	NULL
)	NULL
complexes	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Antibodies	NULL
against	NULL
IBR	NULL
recognize	NULL
IBF	NULL
.	NULL

IBR	NULL
from	NULL
mature	NULL
erythrocytes	NULL
and	NULL
IBF	NULL
from	NULL
HD3	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
purified	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
anti-IBR	NULL
antibodies	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
,	NULL
IBF	NULL
(	NULL
HD3	NULL
)	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
IBR	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
IBF	NULL
(	NULL
HeLa	NULL
)	NULL
.	NULL

MOLECULAR	NULL
CHARACTERIZATION	NULL
OF	NULL
IBR/F	NULL
(	NULL
GRF-1	NULL
)	NULL
6673	NULL
sequence	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
amplified	NULL
DNA	NULL
product	NULL
encompassed	NULL
a	NULL
reading	NULL
frame	NULL
coding	NULL
for	NULL
the	NULL
two	NULL
internal	NULL
pep-tides	NULL
,	NULL
while	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
sequence	NULL
confirmed	NULL
the	NULL
strong	NULL
homology	NULL
of	NULL
IBR	NULL
with	NULL
P3AZ	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
erythrocyte	NULL
PCR	NULL
product	NULL
and	NULL
a	NULL
456-bp	NULL
PCR	NULL
product	NULL
of	NULL
chicken	NULL
liver	NULL
cDNA	NULL
amplified	NULL
with	NULL
different	NULL
P3A2-specific	NULL
primers	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
F.	NULL
Calzone	NULL
)	NULL
had	NULL
identical	NULL
overlapping	NULL
sequences	NULL
.	NULL

This	NULL
result	NULL
further	NULL
indicated	NULL
that	NULL
IBR	NULL
is	NULL
the	NULL
chicken	NULL
homolog	NULL
of	NULL
P3A2	NULL
.	NULL

Since	NULL
the	NULL
size	NULL
of	NULL
IBR	NULL
mRNA	NULL
was	NULL
estimated	NULL
to	NULL
be	NULL
3.6	NULL
X	NULL
10°	NULL
nucleotides	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
a	NULL
partial	NULL
cDNA	NULL
library	NULL
was	NULL
constructed	NULL
with	NULL
size-fractionated	NULL
double-stranded	NULL
cDNA	NULL
of	NULL
>	NULL
1.5	NULL
kbp	NULL
to	NULL
enrich	NULL
the	NULL
IBR	NULL
cDNA	NULL
.	NULL

Screening	NULL
of	NULL
6	NULL
X	NULL
10°	NULL
recombinant	NULL
phages	NULL
of	NULL
the	NULL
nonamplified	NULL
library	NULL
with	NULL
the	NULL
PCR	NULL
probe	NULL
resulted	NULL
in	NULL
the	NULL
isolation	NULL
of	NULL
two	NULL
overlapping	NULL
IBR	NULL
cDNA	NULL
clones	NULL
,	NULL
peIBR1	NULL
and	NULL
pceIBR2	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
which	NULL
contained	NULL
incomplete	NULL
ORFs	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
without	NULL
the	NULL
initiator	NULL
methionine	NULL
)	NULL
and	NULL
different	NULL
lengths	NULL
of	NULL
3	NULL
'	NULL
untranslated	NULL
(	NULL
UTR	NULL
)	NULL
sequences	NULL
.	NULL

Because	NULL
further	NULL
screening	NULL
of	NULL
the	NULL
library	NULL
yielded	NULL
no	NULL
additional	NULL
positive	NULL
clones	NULL
,	NULL
the	NULL
missing	NULL
5	NULL
'	NULL
sequences	NULL
were	NULL
obtained	NULL
by	NULL
LMPCR	NULL
of	NULL
erythrocyte	NULL
cDNA	NULL
with	NULL
nested	NULL
reverse	NULL
primers	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
unique	NULL
MiuI	NULL
site	NULL
of	NULL
peIBR1	NULL
.	NULL

The	NULL
major	NULL
amplified	NULL
DNA	NULL
product	NULL
(	NULL
pcIBR3	NULL
[	NULL
Fig	NULL
.	NULL

2	NULL
]	NULL
)	NULL
contained	NULL
the	NULL
expected	NULL
pelBR1	NULL
overlapping	NULL
fragment	NULL
and	NULL
additional	NULL
5°	NULL
sequences	NULL
that	NULL
included	NULL
a	NULL
putative	NULL
initiator	NULL
ATG	NULL
.	NULL

Although	NULL
the	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
AUG	NULL
codon	NULL
could	NULL
code	NULL
for	NULL
additional	NULL
N-terminal	NULL
amino	NULL
acids	NULL
,	NULL
we	NULL
considered	NULL
this	NULL
unlikely	NULL
because	NULL
no	NULL
PCR	NULL
products	NULL
longer	NULL
than	NULL
pcIBR3	NULL
were	NULL
detected	NULL
by	NULL
hybridization	NULL
with	NULL
peIBR1	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
cDNA	NULL
containing	NULL
the	NULL
complete	NULL
ORF	NULL
of	NULL
IBR	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
pelBR	NULL
,	NULL
was	NULL
constructed	NULL
by	NULL
swapping	NULL
the	NULL
5	NULL
'	NULL
fragment	NULL
of	NULL
peIBR3	NULL
and	NULL
the	NULL
3	NULL
'	NULL
fragment	NULL
of	NULL
pelBR1	NULL
at	NULL
the	NULL
unique	NULL
M/uI	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Although	NULL
peIBR2	NULL
ends	NULL
with	NULL
a	NULL
stretch	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
,	NULL
this	NULL
sequence	NULL
is	NULL
likely	NULL
to	NULL
represent	NULL
not	NULL
the	NULL
true	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
mRNA	NULL
but	NULL
the	NULL
product	NULL
of	NULL
internal	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
priming	NULL
at	NULL
this	NULL
tract	NULL
,	NULL
since	NULL
erythrocyte	NULL
IBR	NULL
mRNA	NULL
is	NULL
3.6	NULL
kb	NULL
long	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
interpretation	NULL
,	NULL
Southern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
erythrocyte	NULL
double-stranded	NULL
cDNA	NULL
indicated	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
major	NULL
species	NULL
(	NULL
>	NULL
95	NULL
%	NULL
)	NULL
of	NULL
about	NULL
2	NULL
kbp	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
concluded	NULL
that	NULL
approximately	NULL
1.6	NULL
kb	NULL
of	NULL
3	NULL
'	NULL
UTR	NULL
were	NULL
missing	NULL
from	NULL
the	NULL
cloned	NULL
cDNA	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
peIBR	NULL
predicts	NULL
an	NULL
acidic	NULL
protein	NULL
(	NULL
pK	NULL
,	NULL
=	NULL
4.8	NULL
)	NULL
of	NULL
503	NULL
amino	NULL
acids	NULL
(	NULL
53.6	NULL
kDa	NULL
)	NULL
with	NULL
strong	NULL
local	NULL
homology	NULL
to	NULL
P3A2	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
calculated	NULL
mass	NULL
of	NULL
IBR	NULL
is	NULL
27	NULL
%	NULL
smaller	NULL
than	NULL
that	NULL
estimated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

This	NULL
discrepancy	NULL
is	NULL
mainly	NULL
due	NULL
to	NULL
an	NULL
anomalous	NULL
electrophoretic	NULL
behavior	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
as	NULL
already	NULL
noted	NULL
for	NULL
P3A2	NULL
(	NULL
11	NULL
)	NULL
and	NULL
other	NULL
related	NULL
factors	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
since	NULL
the	NULL
recombinant	NULL
protein	NULL
(	NULL
rIBR	NULL
)	NULL
made	NULL
in	NULL
£	NULL
.	NULL

coli	NULL
had	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
natural	NULL
IBR	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Figure	NULL
2	NULL
also	NULL
shows	NULL
a	NULL
schematic	NULL
map	NULL
of	NULL
IBR	NULL
based	NULL
on	NULL
its	NULL
amino	NULL
acid	NULL
composition	NULL
,	NULL
the	NULL
DNA-binding/dimerization	NULL
domain	NULL
,	NULL
several	NULL
putative	NULL
CK-II	NULL
sites	NULL
,	NULL
and	NULL
the	NULL
NLS	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
36	NULL
N-terminal	NULL
residues	NULL
,	NULL
relatively	NULL
glutamine-rich	NULL
(	NULL
14	NULL
%	NULL
)	NULL
,	NULL
are	NULL
followed	NULL
by	NULL
an	NULL
acidic	NULL
region	NULL
(	NULL
pK	NULL
,	NULL
=	NULL
2.9	NULL
)	NULL
,	NULL
comprising	NULL
residues	NULL
37	NULL
to	NULL
67	NULL
,	NULL
that	NULL
contains	NULL
several	NULL
putative	NULL
sites	NULL
for	NULL
CK-II	NULL
,	NULL
at	NULL
least	NULL
one	NULL
of	NULL
which	NULL
is	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
the	NULL
purified	NULL
kinase	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

This	NULL
region	NULL
is	NULL
separated	NULL
by	NULL
an	NULL
alanine-rich	NULL
(	NULL
48	NULL
%	NULL
)	NULL
motif	NULL
,	NULL
encompassing	NULL
residues	NULL
68	NULL
to	NULL
88	NULL
,	NULL
from	NULL
a	NULL
basic	NULL
segment	NULL
,	NULL
residues	NULL
89	NULL
to	NULL
127	NULL
(	NULL
pK	NULL
,	NULL
=	NULL
12.3	NULL
)	NULL
,	NULL
which	NULL
harbors	NULL
a	NULL
putative	NULL
bipartite	NULL
NLS	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

13	NULL
)	NULL
.	NULL

The	NULL
region	NULL
from	NULL
residues	NULL
127	NULL
to	NULL
285	NULL
is	NULL
neutral	NULL
and	NULL
relatively	NULL
proline-rich	NULL
,	NULL
whereas	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
molecule	NULL
is	NULL
acidic	NULL
(	NULL
pK	NULL
,	NULL
=	NULL
3.6	NULL
)	NULL
and	NULL
relatively	NULL
glu-tamine-rich	NULL
.	NULL

DNA-binding	NULL
specificity	NULL
of	NULL
recombinant	NULL
IBR	NULL
.	NULL

To	NULL
ascertain	NULL
that	NULL
IBR	NULL
and	NULL
rIBR	NULL
recognized	NULL
identical	NULL
DNA	NULL
sequences	NULL
,	NULL
their	NULL
footprints	NULL
on	NULL
the	NULL
A5	NULL
promoter	NULL
were	NULL
analyzed	NULL
.	NULL

The	NULL
A5	NULL
gene	NULL
6674	NULL
GOMEZ-CUADRADO	NULL
ET	NULL
AL	NULL
.	NULL

-	NULL
peIBR3	NULL
CACGGCGCAGGCCCGCCGCAGCGCAGCCCTCTGACTACCTATTGATGGAAGAACACGGCG	NULL
K	NULL
B	NULL
BE	NULL
H	NULL
G	NULL
v	NULL
TGACTCAAACAGAACACATGGCCACCATCGAGGCCCACGCAGTGGCCCAGCAGGTGcaGc	NULL
T	NULL
Q	NULL
T	NULL
BE	NULL
H	NULL
M	NULL
A	NULL
T	NULL
I	NULL
BR	NULL
A	NULL
H	NULL
A	NULL
v	NULL
A	NULL
q	NULL
Q	NULL
v	NULL
g	NULL
o	NULL
AGGTCCACGTGGCCACCTACACGGAGCACAGCATGCTGAGTGCCGACGAGGACTCACCTT	NULL
v	NULL
H	NULL
V	NULL
A	NULL
T	NULL
v	NULL
T	NULL
B	NULL
H	NULL
S	NULL
M	NULL
L	NULL
8	NULL
A	NULL
D	NULL
B	NULL
D	NULL
Ss	NULL
P	NULL
$	NULL
CCTCACCCGAGGACACGTCCTATGATGACTCTGACATCCTCAACTCCACAGCTGCCGATG	NULL
8	NULL
P	NULL
E	NULL
D	NULL
T	NULL
Ss	NULL
Y	NULL
D	NULL
D	NULL
Ss	NULL
D	NULL
I	NULL
L	NULL
N	NULL
S	NULL
T	NULL
A	NULL
A	NULL
D	NULL
E	NULL
peIBRL	NULL
AGGTGACGGCCCACCTGGCTGCAGCAGCCCCTGTGGGGATGGCAGCAGCTECTGCTeTGG	NULL
v	NULL
T	NULL
A	NULL
HOL	NULL
A	NULL
A	NULL
A	NULL
G	NULL
PoV	NULL
G	NULL
M	NULL
A	NULL
A	NULL
A	NULL
A	NULL
A	NULL
V	NULL
A	NULL
CAACGGGTAAGAAACGGAAGCGACCACACGTTTTTGAATCCAACCCATCCATCCGTAAGA	NULL
T	NULL
G	NULL
k	NULL
K	NULL
R	NULL
K	NULL
R	NULL
P	NULL
H	NULL
V	NULL
F	NULL
B	NULL
S	NULL
N	NULL
P	NULL
S	NULL
I	NULL
R	NULL
K	NULL
R	NULL
peIBR3	NULL
GGCAGCAGACGCGTTTGCTACGGAAGCTCCGTGCCACGCTGGATGAGTACACCACCAGAG	NULL
Q	NULL
Q	NULL
T	NULL
R	NULL
L	NULL
L	NULL
R	NULL
K	NULL
L	NULL
R	NULL
A	NULL
T	NULL
L	NULL
DoE	NULL
¥	NULL
T	NULL
T	NULL
R	NULL
Y	NULL
TGGGGCAGCAAGCCATCGTCCTGTGCATCTCACCCTCCAAACCCAACCCTGTCTTCAAAG	NULL
8	NULL
Q	NULL
Q	NULL
A	NULL
I	NULL
V	NULL
L	NULL
C	NULL
I	NULL
$	NULL
P	NULL
S	NULL
K	NULL
P	NULL
N	NULL
P	NULL
V	NULL
P	NULL
K	NULL
v	NULL
TTTTTCGAGCTGCACCCTTGGAGAATGTGGTACGCAAGTACAAGAGCATGATTCTGGAAG	NULL
FG	NULL
A	NULL
A	NULL
P	NULL
L	NULL
B	NULL
N	NULL
V	NULL
V	NULL
R	NULL
K	NULL
Y	NULL
K	NULL
s	NULL
KM	NULL
I	NULL
L	NULL
&	NULL
D	NULL
ACCTGGAGTCGGCGCTGGCAGAACACGCTCCTGCACCTCAGGAGCTTAACTCAGAGTTAC	NULL
L	NULL
B	NULL
S	NULL
A	NULL
L	NULL
A	NULL
B	NULL
H	NULL
A	NULL
B	NULL
A	NULL
PB	NULL
Q	NULL
B	NULL
Vv	NULL
N	NULL
S	NULL
BR	NULL
L	NULL
P	NULL
CACCCCTCACCATTGATGGCATTCCAGTCTCAGTGGACAAGATGACCCAGGCACAGCTGC	NULL
POL	NULL
T	NULL
I	NULL
D	NULL
G	NULL
I	NULL
P	NULL
V	NULL
Ss	NULL
v	NULL
D	NULL
K	NULL
M	NULL
T	NULL
Q	NULL
A	NULL
Q	NULL
L	NULL
R	NULL
GAGCGTTCATCCCGGAGATGCTGAAGTATTCCACGGGTCGTGGGAAGCCAGGCTGGGGCA	NULL
A	NULL
F	NULL
I	NULL
B	NULL
R	NULL
M	NULL
L	NULL
K	NULL
Y	NULL
Ss	NULL
T	NULL
G	NULL
R	NULL
OG	NULL
K	NULL
Pog	NULL
W	NULL
G	NULL
kK	NULL
|-	NULL
peIBR2	NULL
AGGAGAGCTGCAAGCCCATTTGGTGGCCTGAGGACATTCCCTGGGCCAACGTCCGAAGTG	NULL
E	NULL
_s	NULL
C	NULL
K	NULL
Pp	NULL
I	NULL
Ww	NULL
W	NULL
PB	NULL
B	NULL
D	NULL
I	NULL
B	NULL
W	NULL
A	NULL
N	NULL
V	NULL
R	NULL
s	NULL
b	NULL
ATGTGCGCACAGAGGAGCAGAAGCAGCGGGTGTCATGGACCCAAGCATTGAGGACTATCG	NULL
v	NULL
R	NULL
T	NULL
E	NULL
E	NULL
Q	NULL
K	NULL
Q	NULL
R	NULL
V	NULL
§	NULL
W	NULL
T	NULL
Q	NULL
A	NULL
L	NULL
R	NULL
T	NULL
I	NULL
v	NULL
TGAAGAACTGCTACAAGCAGCATGGGCGCGAGGACCTGCTCTACGCATTTGAGGATCAGC	NULL
K	NULL
N	NULL
C	NULL
Y	NULL
K	NULL
Q	NULL
H	NULL
G	NULL
R	NULL
E	NULL
D	NULL
L	NULL
L	NULL
Y	NULL
A	NULL
F	NULL
E	NULL
D	NULL
Q	NULL
Q	NULL
AGACACAGCAACAGACCACAACCACACACAGTATAGCACACCTGGTGCCCTCACAGACAG	NULL
T	NULL
g	NULL
Q	NULL
Q	NULL
To	NULL
T	NULL
T	NULL
T	NULL
H	NULL
Ss	NULL
I	NULL
A	NULL
H	NULL
L	NULL
v	NULL
P	NULL
Ss	NULL
Q	NULL
T	NULL
v	NULL
TGGTACAAACCTTCAGTAACCCTGATGGCACTGTGTCCCTCATCCAGGTTGGCACTGGTG	NULL
v	NULL
q	NULL
T	NULL
F	NULL
s	NULL
N	NULL
P	NULL
D	NULL
G	NULL
T	NULL
v	NULL
$	NULL
s	NULL
L	NULL
I	NULL
Q	NULL
v	NULL
a	NULL
T	NULL
G	NULL
aA	NULL
CCACAGTTGCCACACTGGCCGACGCCTCCGAGCTGCCTACCACAGTTACTSTTGCACAAG	NULL
T	NULL
V	NULL
A	NULL
T	NULL
L	NULL
A	NULL
D	NULL
A	NULL
S	NULL
BR	NULL
L	NULL
BoT	NULL
T	NULL
V	NULL
T	NULL
v	NULL
A	NULL
Q	NULL
v	NULL
TCAATTATTCTGCAGTGGCTGATGGAGAGGTGGAGCAGAACTGGCCAACGCTACAGGGGG	NULL
NO	NULL
Y	NULL
s	NULL
A	NULL
v	NULL
A	NULL
D	NULL
G	NULL
B	NULL
v	NULL
E	NULL
Qq	NULL
N	NULL
W	NULL
A	NULL
T	NULL
L	NULL
q	NULL
G	NULL
G	NULL
GTGAGATGACCATCCAGACAACGCAGGCGTCGGAGGCCACCCAGGCGGTAGCATCGTTAG	NULL
E	NULL
M	NULL
T	NULL
I	NULL
Q	NULL
T	NULL
T	NULL
Q	NULL
A	NULL
S	NULL
Ro	NULL
A	NULL
T	NULL
Q	NULL
A	NULL
V	NULL
A	NULL
S	NULL
L	NULL
A	NULL
CAGAAGCAGCAGTGCCAGCATCTCAGGACATGCAGCAAGGAGCAACTGTTACCATGGCAC	NULL
E	NULL
A	NULL
A	NULL
V	NULL
A	NULL
A	NULL
S	NULL
Q	NULL
B	NULL
M	NULL
Q	NULL
Q	NULL
G	NULL
A	NULL
T	NULL
V	NULL
T	NULL
K	NULL
A	NULL
L	NULL
TTAACAGTGAAGCAGCTGCCCACGCCGTAGCCACGCTGGCTGAAGCCACTCTTCAGGGTG	NULL
N	NULL
S	NULL
B	NULL
A	NULL
A	NULL
A	NULL
H	NULL
A	NULL
V	NULL
A	NULL
T	NULL
L	NULL
A	NULL
B	NULL
A	NULL
T	NULL
L	NULL
Qq	NULL
G	NULL
c	NULL
GAGGACAGATCGTCCTATCTGGTGAAACCGCAGCAGCAGTGGGAGCACTCACTGGAGTCC	NULL
G	NULL
Q	NULL
I	NULL
V	NULL
L	NULL
S	NULL
@	NULL
B	NULL
T	NULL
A	NULL
A	NULL
A	NULL
v	NULL
G	NULL
A	NULL
L	NULL
T	NULL
c	NULL
v	NULL
o	NULL
AAGATGCCAATGGCCTCGTGCAGATCCCTGTCAGCATGTACCAGACCGTGSTCACCAGCC	NULL
D	NULL
A	NULL
N	NULL
G	NULL
L	NULL
Vv	NULL
q	NULL
I	NULL
PoV	NULL
s	NULL
M	NULL
Y	NULL
q	NULL
T	NULL
v	NULL
v	NULL
T	NULL
s	NULL
L	NULL
TGGCCCAGGGCAACGGCCCAGTGCAGGTGGCGATEGCACCGGTCACCACGCGGATAGCGG	NULL
A	NULL
Q	NULL
G	NULL
N	NULL
G	NULL
P	NULL
v	NULL
Q	NULL
v	NULL
A	NULL
M	NULL
A	NULL
Pov	NULL
T	NULL
TP	NULL
R	NULL
I	NULL
A	NULL
D	NULL
ACAGTGCCGTCACCGTGGACGGGCAGGCGGTGGAAGTCGGTAACTTTGGAACAGTGACCAT	NULL
§	NULL
A	NULL
v	NULL
T	NULL
v	NULL
Dp	NULL
G	NULL
q	NULL
A	NULL
v	NULL
BR	NULL
v	NULL
v	NULL
T	NULL
L	NULL
B	NULL
Q	NULL
AACCCACAGCAGGATCACGATGATTTATTTTTATTTTTTTGATETTTTCTTTMTTCTUTTT	NULL
TTTTECTTTTTTTTTECTTTTTTITTTTEECTCCTCGTCTCTTATGCGAATAAATTTTTTT	NULL
peIBR1	NULL
ACGCCTATCCRGAGATGCAATCAGGTGGCATTGAGTCTCTCTCCGCTTCGGAAGCAAAAG	NULL
AGTTTTGCTGACCATTTTTAATGAAAAAAATAACGAAGGATGCGTGTGTTAAGTGCGTCT	NULL
TTGTAGCACCACCTTGGAGCAAGAAGCCCAGCACAGACGGGACTTCCATTCTGAAGAGAT	NULL
TAGAAAGGAGAAAAAAAAAATACACACACACAAAAATACAACTCCTTGGGCCCCTTTCCT	NULL
CCCACAGTGGATCAGAGCAGGGGAACGCGGATGCTCCCATGTGGGGTGAATTAGGTTTCA	NULL
AAGATTTTAACATGGACTTTTATATTAAAAAAGTTT	NULL
peIBR2	NULL
J	NULL
36	NULL
818	NULL
127	NULL
285	NULL
120	NULL
26	NULL
180	NULL
46	NULL
240	NULL
66	NULL
300	NULL
86	NULL
360	NULL
106	NULL
420	NULL
126	NULL
480	NULL
146	NULL
540	NULL
166	NULL
600	NULL
186	NULL
660	NULL
206	NULL
720	NULL
226	NULL
780	NULL
246	NULL
840	NULL
266	NULL
900	NULL
286	NULL
960	NULL
306	NULL
1020	NULL
326	NULL
1080	NULL
346	NULL
1140	NULL
366	NULL
1200	NULL
386	NULL
1260	NULL
406	NULL
1320	NULL
426	NULL
1380	NULL
446	NULL
1440	NULL
466	NULL
1500	NULL
486	NULL
1560	NULL
503	NULL
1620	NULL
1680	NULL
1740	NULL
1800	NULL
1860	NULL
1920	NULL
1980	NULL
2029	NULL
503	NULL
a	NULL
|of	NULL
o	NULL
p	NULL
o	NULL
a	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
MOLECULAR	NULL
CHARACTERIZATION	NULL
OF	NULL
IBR/F	NULL
(	NULL
GRF-1	NULL
)	NULL
6675	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
a	NULL
partial	NULL
IBR	NULL
cDNA	NULL
(	NULL
peIBR	NULL
;	NULL
EMBL	NULL
database	NULL
accession	NULL
number	NULL
X86013	NULL
)	NULL
and	NULL
deduced	NULL
protein	NULL
sequence	NULL
of	NULL
IBR	NULL
.	NULL

peIBR	NULL
was	NULL
reconstructed	NULL
from	NULL
the	NULL
cDNA	NULL
clones	NULL
pe	NULL
[	NULL
BR1	NULL
to	NULL
peIBR3	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Nucleotides	NULL
present	NULL
in	NULL
pcIBR1	NULL
and	NULL
not	NULL
in	NULL
peIBR2	NULL
are	NULL
shown	NULL
in	NULL
lowercase	NULL
letters	NULL
.	NULL

Underscored	NULL
amino	NULL
acids	NULL
correspond	NULL
to	NULL
the	NULL
peptide	NULL
sequences	NULL
determined	NULL
from	NULL
purified	NULL
IBR	NULL
.	NULL

A	NULL
schematic	NULL
representation	NULL
of	NULL
IBR	NULL
subregions	NULL
is	NULL
given	NULL
below	NULL
the	NULL
sequence	NULL
.	NULL

Q	NULL
,	NULL
glutamine-rich	NULL
regions	NULL
(	NULL
12	NULL
to	NULL
14	NULL
%	NULL
)	NULL
;	NULL
P	NULL
,	NULL
proline-rich	NULL
region	NULL
(	NULL
9	NULL
%	NULL
)	NULL
;	NULL
-	NULL
,	NULL
acidic	NULL
regions	NULL
(	NULL
pK	NULL
,	NULL
2.9	NULL
to	NULL
3.6	NULL
)	NULL
;	NULL
+	NULL
,	NULL
a	NULL
highly	NULL
basic	NULL
region	NULL
(	NULL
pK	NULL
,	NULL
,	NULL
12.3	NULL
)	NULL
.	NULL

Vertical	NULL
broken	NULL
lines	NULL
correspond	NULL
to	NULL
putative	NULL
CK-II	NULL
sites	NULL
.	NULL

The	NULL
solid	NULL
box	NULL
shows	NULL
the	NULL
bipartite	NULL
nuclear	NULL
localization	NULL
signal	NULL
,	NULL
and	NULL
the	NULL
hatched	NULL
box	NULL
shows	NULL
an	NULL
alanine-rich	NULL
region	NULL
(	NULL
48	NULL
%	NULL
)	NULL
.	NULL

contains	NULL
several	NULL
IBR/IBF	NULL
binding	NULL
motifs	NULL
,	NULL
including	NULL
a	NULL
series	NULL
of	NULL
6-bp	NULL
overlapping	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
boxes	NULL
B	NULL
to	NULL
E	NULL
)	NULL
,	NULL
the	NULL
-7	NULL
to	NULL
+5	NULL
site	NULL
(	NULL
box	NULL
C	NULL
)	NULL
having	NULL
the	NULL
highest	NULL
affinity	NULL
and	NULL
strongest	NULL
methylation	NULL
interference	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
DNase	NULL
I	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
indicated	NULL
that	NULL
rIBR	NULL
protected	NULL
the	NULL
same	NULL
regions	NULL
as	NULL
IBR	NULL
and	NULL
IBF	NULL
,	NULL
including	NULL
sequences	NULL
upstream	NULL
and	NULL
downstream	NULL
of	NULL
the	NULL
A5	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

At	NULL
the	NULL
lower	NULL
protein	NULL
concentrations	NULL
,	NULL
the	NULL
three	NULL
proteins	NULL
first	NULL
protected	NULL
sites	NULL
B	NULL
to	NULL
E	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
half-site	NULL
A	NULL
.	NULL

At	NULL
the	NULL
higher	NULL
rIBR	NULL
concentration	NULL
used	NULL
,	NULL
a	NULL
protection	NULL
of	NULL
the	NULL
lowest-affinity	NULL
site	NULL
F	NULL
was	NULL
also	NULL
observed	NULL
.	NULL

The	NULL
additional	NULL
footprint	NULL
upstream	NULL
of	NULL
A	NULL
,	NULL
observed	NULL
with	NULL
the	NULL
three	NULL
proteins	NULL
,	NULL
corresponds	NULL
to	NULL
an	NULL
FspI	NULL
site	NULL
of	NULL
the	NULL
pBR322	NULL
vector	NULL
that	NULL
has	NULL
the	NULL
sequence	NULL
TGCGCA	NULL
,	NULL
corresponding	NULL
to	NULL
half	NULL
of	NULL
the	NULL
IBR	NULL
optimal	NULL
recognition	NULL
site	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
IBR	NULL
and	NULL
rIBR	NULL
to	NULL
form	NULL
complexes	NULL
with	NULL
£5	NULL
probes	NULL
that	NULL
have	NULL
the	NULL
same	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
further	NULL
indicated	NULL
that	NULL
pcIBR	NULL
encodes	NULL
bona	NULL
fide	NULL
IBR	NULL
.	NULL

Homology	NULL
of	NULL
IBR	NULL
to	NULL
related	NULL
nuclear	NULL
factors	NULL
.	NULL

During	NULL
the	NULL
course	NULL
of	NULL
this	NULL
work	NULL
,	NULL
the	NULL
sequences	NULL
of	NULL
two	NULL
proteins	NULL
highly	NULL
related	NULL
to	NULL
IBR	NULL
,	NULL
Drosophila	NULL
EWG	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
human	NULL
NRF-1	NULL
(	NULL
88	NULL
)	NULL
,	NULL
became	NULL
available	NULL
.	NULL

EWG	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
and	NULL
flight	NULL
muscles	NULL
.	NULL

Although	NULL
the	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
effects	NULL
of	NULL
EWG	NULL
were	NULL
not	NULL
investi-gated	NULL
,	NULL
this	NULL
protein	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
a	NULL
transcription	NULL
factor	NULL
by	NULL
analogy	NULL
to	NULL
the	NULL
other	NULL
proteins	NULL
of	NULL
this	NULL
family	NULL
.	NULL

NRF-1	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
nuclear	NULL
genes	NULL
involved	NULL
in	NULL
mitochondrial	NULL
energy	NULL
transduction	NULL
(	NULL
88	NULL
)	NULL
and	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
recently	NULL
reported	NULL
human	NULL
«	NULL
-Pal	NULL
factor	NULL
(	NULL
18	NULL
)	NULL
,	NULL
which	NULL
activates	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
eif-2	NULL
«	NULL
)	NULL
coding	NULL
for	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
translation	NULL
initiation	NULL
factor	NULL
IF-2	NULL
.	NULL

In	NULL
common	NULL
with	NULL
IBR	NULL
and	NULL
P3A2	NULL
,	NULL
these	NULL
proteins	NULL
behaved	NULL
in	NULL
SDS-PAGE	NULL
as	NULL
having	NULL
apparent	NULL
molecular	NULL
masses	NULL
30	NULL
to	NULL
50	NULL
%	NULL
larger	NULL
than	NULL
those	NULL
predicted	NULL
from	NULL
their	NULL
respective	NULL
cDNAs	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
structurally	NULL
related	NULL
factors	NULL
showed	NULL
that	NULL
IBR	NULL
has	NULL
the	NULL
same	NULL
size	NULL
as	NULL
and	NULL
99	NULL
%	NULL
overall	NULL
identity	NULL
with	NULL
NRF-1/	NULL
«	NULL
-Pal	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
clearly	NULL
indicating	NULL
that	NULL
it	NULL
is	NULL
the	NULL
chicken	NULL
homolog	NULL
of	NULL
the	NULL
human	NULL
factor	NULL
.	NULL

The	NULL
five	NULL
changes	NULL
between	NULL
the	NULL
sequences	NULL
of	NULL
IBR	NULL
and	NULL
NRF-1/	NULL
«	NULL
-Pal	NULL
occur	NULL
in	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
the	NULL
proteins	NULL
at	NULL
residues	NULL
289	NULL
(	NULL
Q-T	NULL
)	NULL
,	NULL
291	NULL
(	NULL
T-A¥	NULL
)	NULL
,	NULL
293	NULL
(	NULL
T-A	NULL
)	NULL
,	NULL
485	NULL
(	NULL
A-S	NULL
)	NULL
,	NULL
and	NULL
491	NULL
(	NULL
V-M	NULL
)	NULL
.	NULL

The	NULL
homology	NULL
between	NULL
_	NULL
IBR	NULL
_	NULL
IBE	NULL
_	NULL
eIBR	NULL
A	NULL
mmca	NULL
scueam	NULL
core	NULL
uke	NULL
a	NULL
!	NULL

a	NULL
'	NULL
8	NULL
d	NULL
g	NULL
:	NULL
fnlled	NULL
+	NULL
#	NULL
&	NULL
``	NULL
e®	NULL
|	NULL
-	NULL
as	NULL
as	NULL
@	NULL
7	NULL
a	NULL
+99	NULL
j	NULL
:	NULL
g3	NULL
'	NULL
!	NULL

n	NULL
in	NULL
ta	NULL
sess	NULL
-=-	NULL
<	NULL
z8	NULL
#	NULL
80	NULL
<	NULL
~-	NULL
«	NULL
o	NULL
w	NULL
»	NULL
«	NULL
s	NULL
do	NULL
a	NULL
>	NULL
-	NULL
--	NULL
«	NULL
-	NULL
«	NULL
»	NULL
ap	NULL
an	NULL
as	NULL
Sf	NULL
!	NULL

``	NULL
*	NULL
28°	NULL
``	NULL
ja	NULL
_14	NULL
,	NULL
>	NULL
«	NULL
s	NULL
an	NULL
-	NULL
as	NULL
s-Eﬁ	NULL
JA	NULL
ss	NULL
am	NULL
am	NULL
--	NULL
--	NULL
J	NULL
+1	NULL
=	NULL
B-E	NULL
a	NULL
B-E	NULL
C	NULL
B-E	NULL
+1	NULL
(	NULL
0+	NULL
%	NULL
-	NULL
a	NULL
a-se	NULL
-	NULL
as	NULL
as	NULL
as	NULL
as	NULL
..	NULL
&	NULL
as	NULL
as	NULL
as	NULL
an	NULL
an	NULL
+19	NULL
=	NULL
°	NULL
T	NULL
e	NULL
=	NULL
z	NULL
&	NULL
z	NULL
=	NULL
=	NULL
E	NULL
l	NULL
s	NULL
eg	NULL
:	NULL
f	NULL
$	NULL
5	NULL
.	NULL

2	NULL
=-	NULL
F	NULL
@	NULL
*	NULL
&	NULL
-	NULL
%	NULL
%	NULL
%	NULL
;	NULL
o	NULL
&	NULL
4	NULL
a	NULL
&	NULL
-	NULL
-	NULL
$	NULL
%	NULL
;	NULL
#	NULL
o	NULL
o	NULL
-	NULL
~	NULL
»	NULL
B	NULL
p	NULL
E	NULL
A	NULL
B	NULL
F	NULL
CO	NULL
RA	NULL
[	NULL
1	NULL
TTAAATGCGTGCTGGTGGC	NULL
NGACGCAGCGGCGGCGGCAGCAGGAGCAGCCCCACATCCG	NULL
AATTTACGCACGACCACCG	NULL
f	NULL
7	NULL
E	NULL
AA	NULL
AA	NULL
&	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Footprint	NULL
of	NULL
IBR	NULL
,	NULL
IBF	NULL
,	NULL
and	NULL
rIBR	NULL
on	NULL
the	NULL
transcription	NULL
initiation	NULL
region	NULL
of	NULL
the	NULL
A5	NULL
gene	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
*°P-labeled	NULL
probe	NULL
of	NULL
the	NULL
A5	NULL
gene	NULL
(	NULL
-388	NULL
to	NULL
+72	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
the	NULL
purified	NULL
proteins	NULL
before	NULL
digestion	NULL
with	NULL
DNase	NULL
I	NULL
:	NULL
IBR	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
15	NULL
,	NULL
and	NULL
20	NULL
ng	NULL
;	NULL
IBF	NULL
,	NULL
3	NULL
,	NULL
6	NULL
,	NULL
12	NULL
,	NULL
25	NULL
,	NULL
and	NULL
50	NULL
ng	NULL
;	NULL
and	NULL
rIBR	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
16	NULL
,	NULL
32	NULL
,	NULL
64	NULL
,	NULL
and	NULL
128	NULL
ng	NULL
.	NULL

Lanes	NULL
-	NULL
,	NULL
no	NULL
protein	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
footprints	NULL
was	NULL
determined	NULL
from	NULL
G+A	NULL
sequence	NULL
ladders	NULL
run	NULL
in	NULL
parallel	NULL
lanes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
footprints	NULL
at	NULL
moderate	NULL
and	NULL
higher	NULL
concentrations	NULL
of	NULL
protein	NULL
(	NULL
upper	NULL
and	NULL
lower	NULL
lines	NULL
underneath	NULL
the	NULL
sequence	NULL
,	NULL
respectively	NULL
)	NULL
and	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
(	NULL
arrowheads	NULL
)	NULL
.	NULL

The	NULL
solid	NULL
box	NULL
and	NULL
the	NULL
dots	NULL
indicate	NULL
nucleotides	NULL
showing	NULL
maximal	NULL
and	NULL
partial	NULL
methylation	NULL
interference	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
6-bp-overlapping	NULL
12-bp	NULL
IBR/F	NULL
binding	NULL
sites	NULL
(	NULL
A	NULL
to	NULL
F	NULL
)	NULL
are	NULL
marked	NULL
by	NULL
brackets	NULL
.	NULL

The	NULL
bent	NULL
arrow	NULL
indicates	NULL
the	NULL
major	NULL
A5	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
+1	NULL
)	NULL
.	NULL

6676	NULL
GOMEZ-CUADRADO	NULL
ET	NULL
AL	NULL
.	NULL

Conserved	NULL
Non-conserved	NULL
36	NULL
285	NULL
503	NULL
CH	NULL
--	NULL
-H®=40	NULL
``	NULL
A	NULL
4	NULL
#	NULL
D	NULL
]	NULL
}	NULL
1	NULL
.	NULL

Ca	NULL
J	NULL
459	NULL
[	NULL
H	NULL
_	NULL
«	NULL
s	NULL
__	NULL
[	NULL
J|	NULL
]	NULL
»	NULL
«	NULL
I_	NULL
]	NULL
pae	NULL
A	NULL
£	NULL
sl	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Homology	NULL
of	NULL
IBR	NULL
to	NULL
related	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
sequences	NULL
compared	NULL
with	NULL
IBR	NULL
are	NULL
NRF-1/	NULL
«	NULL
-Pal	NULL
(	NULL
18	NULL
,	NULL
88	NULL
)	NULL
,	NULL
sea	NULL
urchin	NULL
P3A2	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
Drosophila	NULL
EWG	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
amino	NULL
acid	NULL
identity	NULL
between	NULL
the	NULL
evolutionarily	NULL
conserved	NULL
and	NULL
nonconserved	NULL
regions	NULL
is	NULL
indicated	NULL
inside	NULL
the	NULL
boxes	NULL
.	NULL

Patches	NULL
of	NULL
homology	NULL
in	NULL
the	NULL
C-terminal	NULL
halves	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
open	NULL
boxes	NULL
.	NULL

Other	NULL
symbols	NULL
are	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2.	NULL
the	NULL
vertebrate	NULL
and	NULL
invertebrate	NULL
factors	NULL
is	NULL
only	NULL
segmental	NULL
,	NULL
EWG	NULL
having	NULL
longer	NULL
N-	NULL
and	NULL
C-terminal	NULL
sequences	NULL
,	NULL
whereas	NULL
P3A2	NULL
has	NULL
a	NULL
shorter	NULL
N-terminal	NULL
sequence	NULL
.	NULL

However	NULL
,	NULL
residues	NULL
36	NULL
to	NULL
285	NULL
of	NULL
IBR	NULL
have	NULL
been	NULL
evolutionarily	NULL
conserved	NULL
with	NULL
respect	NULL
to	NULL
residues	NULL
1	NULL
to	NULL
250	NULL
of	NULL
P3A2	NULL
(	NULL
67.5	NULL
%	NULL
identity	NULL
)	NULL
and	NULL
residues	NULL
94	NULL
to	NULL
343	NULL
of	NULL
EWG	NULL
(	NULL
59.7	NULL
%	NULL
identity	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
these	NULL
regions	NULL
encompass	NULL
the	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
domains	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
NLS	NULL
and	NULL
some	NULL
of	NULL
the	NULL
potential	NULL
CK-II	NULL
sites	NULL
(	NULL
see	NULL
below	NULL
,	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
12	NULL
,	NULL
and	NULL
13	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
C-terminal	NULL
halves	NULL
have	NULL
low	NULL
general	NULL
sequence	NULL
conservation	NULL
(	NULL
26.8	NULL
%	NULL
and	NULL
21.2	NULL
%	NULL
identity	NULL
for	NULL
P3AZ	NULL
and	NULL
EWG	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
although	NULL
they	NULL
have	NULL
patches	NULL
of	NULL
significant	NULL
homology	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
IBR	NULL
312	NULL
to	NULL
334	NULL
with	NULL
P3A2	NULL
285	NULL
to	NULL
302	NULL
and	NULL
EWG	NULL
552	NULL
to	NULL
562	NULL
,	NULL
IBR	NULL
377	NULL
to	NULL
392	NULL
and	NULL
P3A2	NULL
339	NULL
to	NULL
354	NULL
,	NULL
IBR	NULL
454	NULL
to	NULL
464	NULL
with	NULL
P3AZ	NULL
396	NULL
to	NULL
406	NULL
and	NULL
EWG	NULL
639	NULL
to	NULL
649	NULL
[	NULL
Fig	NULL
.	NULL

4	NULL
]	NULL
)	NULL
.	NULL

CJ	NULL
A	NULL
ees	NULL
E	NULL
=	NULL
Z	NULL
i=	NULL
m	NULL
ID	NULL
C	NULL
(	NULL
E	NULL
8—	NULL
“	NULL
5:1	NULL
:	NULL
i	NULL
A	NULL
m	NULL
A	NULL
me	NULL
c	NULL
4	NULL
4	NULL
5	NULL
}	NULL
it	NULL
we	NULL
``	NULL
-s	NULL
11	NULL
Lad	NULL
w	NULL
»	NULL
am	NULL
an	NULL
``	NULL
``	NULL
=	NULL
,	NULL
U-	NULL
-	NULL
#	NULL
4	NULL
cue	NULL
ae	NULL
:	NULL
Lea	NULL
's	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Northern	NULL
and	NULL
(	NULL
B	NULL
)	NULL
Southern	NULL
blot	NULL
analyses	NULL
of	NULL
nucleic	NULL
acids	NULL
from	NULL
chicken	NULL
erythroid	NULL
cells	NULL
hybridized	NULL
with	NULL
``	NULL
P-labeled	NULL
peIBR1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Lanes	NULL
HD3ni	NULL
and	NULL
HD3i	NULL
,	NULL
16	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
nondifferentiated	NULL
and	NULL
differentiated	NULL
HD3	NULL
cells	NULL
,	NULL
respectively	NULL
;	NULL
lane	NULL
IE	NULL
,	NULL
4	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
immature	NULL
adult	NULL
erythrocytes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Hen	NULL
erythrocyte	NULL
DNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
(	NULL
ERI	NULL
)	NULL
,	NULL
BamHI	NULL
(	NULL
BHI	NULL
)	NULL
,	NULL
HindIII	NULL
(	NULL
HIIT	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
them	NULL
.	NULL

Lanes	NULL
St	NULL
contained	NULL
an	NULL
amount	NULL
of	NULL
pcIBR1	NULL
DNA	NULL
equivalent	NULL
to	NULL
one	NULL
copy	NULL
per	NULL
haploid	NULL
chicken	NULL
genome	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
the	NULL
fragments	NULL
(	NULL
in	NULL
kilobases	NULL
)	NULL
were	NULL
estimated	NULL
from	NULL
RNA	NULL
and	NULL
DNA	NULL
markers	NULL
run	NULL
in	NULL
parallel	NULL
lanes	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
IBF	NULL
IBR	NULL
rIBR	NULL
Teen	NULL
MMT	NULL
t	NULL
4	NULL
a-	NULL
==	NULL
SRI	NULL
aB	NULL
§	NULL
)	NULL
J	NULL
|	NULL
b	NULL
--	NULL
(	NULL
dh	NULL
M	NULL
=	NULL
]	NULL
E	NULL
\	NULL
a	NULL
b	NULL
b	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Peptide	NULL
maps	NULL
of	NULL
IBR	NULL
,	NULL
IBF	NULL
,	NULL
and	NULL
rIBR	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
purified	NULL
proteins	NULL
were	NULL
partially	NULL
cleaved	NULL
at	NULL
tryptophan	NULL
residues	NULL
with	NULL
BNPS-skatole	NULL
,	NULL
and	NULL
the	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
anti-r	NULL
[	NULL
BR	NULL
antibodies	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
positions	NULL
of	NULL
tryptophan	NULL
residues	NULL
in	NULL
IBR	NULL
and	NULL
the	NULL
origin	NULL
of	NULL
the	NULL
cleaved	NULL
peptides	NULL
.	NULL

IBR	NULL
and	NULL
IBF	NULL
are	NULL
the	NULL
products	NULL
of	NULL
the	NULL
same	NULL
gene	NULL
.	NULL

RNA	NULL
from	NULL
immature	NULL
erythrocytes	NULL
and	NULL
undifferentiated	NULL
or	NULL
differentiated	NULL
HD3	NULL
cells	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
unique	NULL
species	NULL
of	NULL
about	NULL
3.6	NULL
kb	NULL
when	NULL
hybridized	NULL
to	NULL
a	NULL
peIBR1	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Amplification	NULL
by	NULL
LMPCR	NULL
of	NULL
double-stranded	NULL
cDNA	NULL
from	NULL
immature	NULL
erythrocyte	NULL
and	NULL
HD3	NULL
cells	NULL
with	NULL
specific	NULL
IBR	NULL
cDNA	NULL
primers	NULL
yielded	NULL
fragments	NULL
similar	NULL
in	NULL
length	NULL
and	NULL
identical	NULL
in	NULL
DNA	NULL
sequence	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
the	NULL
other	NULL
properties	NULL
common	NULL
to	NULL
IBR	NULL
and	NULL
IBF	NULL
,	NULL
such	NULL
as	NULL
epitopes	NULL
,	NULL
DNA-binding	NULL
specificity	NULL
,	NULL
footprints	NULL
,	NULL
and	NULL
mobility	NULL
of	NULL
the	NULL
DNA	NULL
com-plexes	NULL
,	NULL
suggested	NULL
that	NULL
the	NULL
two	NULL
proteins	NULL
are	NULL
probably	NULL
coded	NULL
by	NULL
the	NULL
same	NULL
gene	NULL
.	NULL

Southern	NULL
analysis	NULL
of	NULL
genomic	NULL
chicken	NULL
DNA	NULL
hybridized	NULL
with	NULL
peIBR1	NULL
indicated	NULL
that	NULL
the	NULL
ibr	NULL
gene	NULL
is	NULL
unique	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
and	NULL
hybridization	NULL
under	NULL
less	NULL
stringent	NULL
conditions	NULL
failed	NULL
to	NULL
detect	NULL
other	NULL
genomic	NULL
DNA	NULL
fragments	NULL
having	NULL
about	NULL
80	NULL
%	NULL
identity	NULL
to	NULL
the	NULL
probe	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
further	NULL
supported	NULL
the	NULL
view	NULL
that	NULL
IBR	NULL
and	NULL
IBF	NULL
have	NULL
the	NULL
same	NULL
sequence	NULL
,	NULL
although	NULL
the	NULL
possibility	NULL
that	NULL
IBR	NULL
and	NULL
IBF	NULL
were	NULL
the	NULL
products	NULL
of	NULL
alternative	NULL
splicing	NULL
was	NULL
not	NULL
ruled	NULL
out	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
,	NULL
purified	NULL
IBR	NULL
,	NULL
IBF	NULL
,	NULL
and	NULL
rIBR	NULL
were	NULL
reacted	NULL
with	NULL
BNPS-skatole	NULL
,	NULL
a	NULL
reagent	NULL
that	NULL
specifically	NULL
cleaves	NULL
at	NULL
tryptophan	NULL
residues	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
the	NULL
products	NULL
of	NULL
cleavage	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

Figure	NULL
6	NULL
shows	NULL
that	NULL
the	NULL
affinity-purified	NULL
anti-rIBR	NULL
antibody	NULL
recognized	NULL
the	NULL
same	NULL
partial	NULL
digestion	NULL
products	NULL
of	NULL
the	NULL
three	NULL
proteins	NULL
,	NULL
further	NULL
indicating	NULL
that	NULL
IBR	NULL
and	NULL
IBF	NULL
have	NULL
identical	NULL
amino	NULL
acid	NULL
sequences	NULL
.	NULL

Although	NULL
we	NULL
can	NULL
not	NULL
completely	NULL
exclude	NULL
that	NULL
IBR	NULL
and	NULL
IBF	NULL
differ	NULL
by	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a	NULL
short	NULL
peptide	NULL
sequence	NULL
,	NULL
the	NULL
almost	NULL
identical	NULL
sequences	NULL
of	NULL
IBR	NULL
and	NULL
NRF-1/	NULL
«	NULL
-Pal	NULL
and	NULL
the	NULL
identical	NULL
electrophoretic	NULL
mobilities	NULL
of	NULL
IBF	NULL
and	NULL
NRF-1/a-Pal	NULL
make	NULL
this	NULL
possibility	NULL
remote	NULL
.	NULL

IBR	NULL
and	NULL
IBF	NULL
differ	NULL
in	NULL
extent	NULL
of	NULL
glycosylation	NULL
.	NULL

If	NULL
IBR	NULL
and	NULL
IBF	NULL
have	NULL
the	NULL
same	NULL
primary	NULL
structure	NULL
,	NULL
it	NULL
follows	NULL
that	NULL
their	NULL
different	NULL
electrophoretic	NULL
behaviors	NULL
should	NULL
reflect	NULL
differential	NULL
posttranslational	NULL
modifications	NULL
.	NULL

Since	NULL
previous	NULL
results	NULL
have	NULL
suggested	NULL
that	NULL
IBR	NULL
contains	NULL
N-acetylglucosamine	NULL
residues	NULL
(	NULL
25	NULL
)	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
IBR	NULL
and	NULL
IBF	NULL
had	NULL
different	NULL
degrees	NULL
of	NULL
glycosylation	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
erythrocytes	NULL
and	NULL
HD3	NULL
cells	NULL
were	NULL
fractionated	NULL
into	NULL
succinylated	NULL
WGA-binding	NULL
and	NULL
non	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
A	NULL
;	NULL
WGA-Sepharose	NULL
h	NULL
B1	NULL
FT	NULL
¥	NULL
¥	NULL
¥	NULL
¥	NULL
WGA-Sepharose	NULL
xa	NULL
-	NULL
iN	NULL
FT2	NULL
B2	NULL
FT2	NULL
B2	NULL
NE	NULL
IBF	NULL
IBR	NULL
ME	NULL
__	NULL
,	NULL
;	NULL
_	NULL
HD3	NULL
,	NULL
,	NULL
_FT1	NULL
,	NULL
;	NULL
B1	NULL
_	NULL
,	NULL
,	NULL
B1	NULL
--	NULL
+-	NULL
+-	NULL
-	NULL
r-	NULL
qd	NULL
Ot	NULL
4	NULL
C	NULL
>	NULL
EE	NULL
elt	NULL
s	NULL
be	NULL
ts	NULL
abe	NULL
80	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Glycosylation	NULL
of	NULL
IBR	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
(	NULL
NE	NULL
)	NULL
from	NULL
mature	NULL
erythrocytes	NULL
(	NULL
ME	NULL
)	NULL
and	NULL
HD3	NULL
cells	NULL
were	NULL
fractionated	NULL
into	NULL
WGA-binding	NULL
(	NULL
B1	NULL
)	NULL
and	NULL
nonbinding	NULL
(	NULL
FT1	NULL
)	NULL
proteins	NULL
.	NULL

IBR	NULL
and	NULL
IBF	NULL
from	NULL
each	NULL
of	NULL
the	NULL
fractions	NULL
were	NULL
purified	NULL
by	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
and	NULL
separated	NULL
again	NULL
into	NULL
WGA-binding	NULL
(	NULL
B2	NULL
)	NULL
and	NULL
nonbinding	NULL
(	NULL
FT2	NULL
)	NULL
fractions	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Gel	NULL
retardation	NULL
assays	NULL
of	NULL
a	NULL
°°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
of	NULL
the	NULL
A5	NULL
gene	NULL
(	NULL
-20	NULL
to	NULL
+14	NULL
)	NULL
incubated	NULL
with	NULL
proteins	NULL
from	NULL
the	NULL
fractions	NULL
described	NULL
for	NULL
panel	NULL
A	NULL
.	NULL

Lanes	NULL
W	NULL
contained	NULL
wash	NULL
fractions	NULL
between	NULL
the	NULL
flowthrough	NULL
and	NULL
0.3	NULL
M	NULL
N-acetylglucosamine	NULL
elution	NULL
.	NULL

binding	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
,	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
factors	NULL
in	NULL
the	NULL
various	NULL
fractions	NULL
was	NULL
detected	NULL
by	NULL
gel	NULL
retardation	NULL
assays	NULL
with	NULL
the	NULL
25	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
IBR	NULL
from	NULL
the	NULL
erythrocyte	NULL
extract	NULL
was	NULL
retained	NULL
by	NULL
the	NULL
WGA	NULL
column	NULL
,	NULL
and	NULL
it	NULL
was	NULL
subsequently	NULL
eluted	NULL
with	NULL
N-acetylglucosamine	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
IBF	NULL
from	NULL
the	NULL
HD3	NULL
extract	NULL
was	NULL
only	NULL
partially	NULL
retained	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
suggested	NULL
that	NULL
IBF	NULL
was	NULL
partially	NULL
glycosylated	NULL
,	NULL
as	NULL
reported	NULL
for	NULL
other	NULL
transcription	NULL
factors	NULL
that	NULL
behaved	NULL
in	NULL
this	NULL
way	NULL
in	NULL
a	NULL
similar	NULL
assay	NULL
(	NULL
38	NULL
)	NULL
,	NULL
the	NULL
possibility	NULL
existed	NULL
that	NULL
the	NULL
proteins	NULL
were	NULL
indirectly	NULL
retained	NULL
by	NULL
WGA	NULL
through	NULL
specific	NULL
or	NULL
nonspecific	NULL
interactions	NULL
with	NULL
other	NULL
glycosylated	NULL
proteins	NULL
.	NULL

Therefore	NULL
,	NULL
IBR	NULL
and	NULL
IBF	NULL
from	NULL
the	NULL
WGA-bound	NULL
and	NULL
nonbound	NULL
fractions	NULL
were	NULL
purified	NULL
by	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
,	NULL
and	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
WGA	NULL
as	NULL
purified	NULL
proteins	NULL
was	NULL
reassessed	NULL
.	NULL

Clearly	NULL
,	NULL
while	NULL
purified	NULL
IBR	NULL
was	NULL
quantitatively	NULL
retained	NULL
by	NULL
the	NULL
second	NULL
WGA	NULL
column	NULL
and	NULL
was	NULL
eluted	NULL
with	NULL
N-acetylglucosamine	NULL
,	NULL
IBF	NULL
was	NULL
not	NULL
retained	NULL
whether	NULL
or	NULL
not	NULL
it	NULL
belonged	NULL
to	NULL
the	NULL
original	NULL
WGA-bound	NULL
or	NULL
unbound	NULL
fraction	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
behavior	NULL
of	NULL
IBF	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
action	NULL
of	NULL
deglycosylases	NULL
that	NULL
could	NULL
be	NULL
present	NULL
in	NULL
the	NULL
extract	NULL
,	NULL
as	NULL
judged	NULL
from	NULL
the	NULL
mobility	NULL
of	NULL
IBF	NULL
in	NULL
the	NULL
original	NULL
extract	NULL
and	NULL
purified	NULL
fraction	NULL
,	NULL
the	NULL
results	NULL
demonstrated	NULL
that	NULL
IBF	NULL
is	NULL
either	NULL
not	NULL
glycosylated	NULL
or	NULL
glycosylated	NULL
to	NULL
a	NULL
much	NULL
lesser	NULL
MOLECULAR	NULL
CHARACTERIZATION	NULL
OF	NULL
IBR/F	NULL
(	NULL
GRF-1	NULL
)	NULL
6677	NULL
extent	NULL
than	NULL
IBR	NULL
.	NULL

Other	NULL
experiments	NULL
also	NULL
indicated	NULL
that	NULL
IBF	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
NRF-1/	NULL
«	NULL
-Pal	NULL
)	NULL
,	NULL
rat	NULL
liver	NULL
,	NULL
and	NULL
chicken	NULL
brain	NULL
was	NULL
not	NULL
detectably	NULL
glycosylated	NULL
,	NULL
whereas	NULL
IBR	NULL
from	NULL
5-day	NULL
embryonic	NULL
erythrocytes	NULL
was	NULL
partially	NULL
glycosylated	NULL
.	NULL

We	NULL
concluded	NULL
that	NULL
IBR	NULL
is	NULL
a	NULL
glycosylated	NULL
form	NULL
of	NULL
IBF	NULL
and	NULL
that	NULL
,	NULL
within	NULL
the	NULL
limits	NULL
of	NULL
detection	NULL
,	NULL
IBR	NULL
glycosylation	NULL
is	NULL
an	NULL
erythrocyte-specific	NULL
modification	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
differential	NULL
glycosylation	NULL
of	NULL
IBR	NULL
is	NULL
probably	NULL
responsible	NULL
for	NULL
its	NULL
slower	NULL
electrophoretic	NULL
mobility	NULL
,	NULL
since	NULL
treatment	NULL
of	NULL
purified	NULL
IBR	NULL
and	NULL
IBF	NULL
with	NULL
acid	NULL
or	NULL
alkaline	NULL
phosphatases	NULL
did	NULL
not	NULL
change	NULL
their	NULL
electrophoretic	NULL
mobilities	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
IBR/F	NULL
.	NULL

Despite	NULL
the	NULL
negative	NULL
phosphatase	NULL
results	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
IBR/F	NULL
is	NULL
phosphorylated	NULL
in	NULL
vivo	NULL
because	NULL
phosphorylation	NULL
mediates	NULL
a	NULL
variety	NULL
of	NULL
biological	NULL
responses	NULL
(	NULL
36	NULL
)	NULL
and	NULL
details	NULL
about	NULL
the	NULL
responsible	NULL
kinases	NULL
may	NULL
give	NULL
information	NULL
on	NULL
the	NULL
regulatory	NULL
pathways	NULL
in	NULL
which	NULL
the	NULL
factor	NULL
is	NULL
involved	NULL
.	NULL

Immature	NULL
erythrocytes	NULL
were	NULL
incubated	NULL
with	NULL
and	NULL
IBR/F	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
the	NULL
nuclear	NULL
extract	NULL
with	NULL
affinity-purified	NULL
anti-rIBR	NULL
antibodies	NULL
.	NULL

Autoradiog-raphy	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
proteins	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
revealed	NULL
a	NULL
doublet	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lane	NULL
a	NULL
)	NULL
corresponding	NULL
to	NULL
IBR	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
treatment	NULL
of	NULL
the	NULL
same	NULL
membrane	NULL
with	NULL
anti-rIBR	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
b	NULL
to	NULL
d	NULL
)	NULL
.	NULL

A	NULL
survey	NULL
of	NULL
the	NULL
IBR/F	NULL
sequence	NULL
for	NULL
possible	NULL
kinase	NULL
consensus	NULL
sites	NULL
indicated	NULL
that	NULL
the	NULL
region	NULL
extending	NULL
from	NULL
38	NULL
to	NULL
70	NULL
contained	NULL
a	NULL
cluster	NULL
of	NULL
four	NULL
CK-II	NULL
and	NULL
one	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
consensus	NULL
sites	NULL
.	NULL

The	NULL
clustering	NULL
of	NULL
sites	NULL
and	NULL
their	NULL
evolutionary	NULL
conservation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
4	NULL
)	NULL
hinted	NULL
that	NULL
they	NULL
could	NULL
be	NULL
actual	NULL
phosphorylation	NULL
sites	NULL
.	NULL

This	NULL
was	NULL
tested	NULL
by	NULL
incubation	NULL
of	NULL
rIBR	NULL
with	NULL
purified	NULL
CK-II	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
JATP	NULL
.	NULL

Figure	NULL
8B	NULL
shows	NULL
that	NULL
rIBR	NULL
was	NULL
indeed	NULL
phosphorylated	NULL
and	NULL
that	NULL
phosphorylation	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
CK-II	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
deletion	NULL
mutant	NULL
AN79	NULL
,	NULL
A	NULL
_	NULL
a	NULL
buec.d	NULL
B	NULL
rIBR	NULL
__	NULL
,	NULL
AN79	NULL
-CKII	NULL
_	NULL
+CKII	NULL
+CKII	NULL
#	NULL
4	NULL
wis	NULL
QN—	NULL
-a-	NULL
IBR	NULL
rIBR	NULL
--	NULL
»	NULL
<	NULL
p	NULL
C_	NULL
Trans	NULL
|	NULL
Mock	NULL
:	NULL
#	NULL
00~	NULL
00	NULL
-	NULL
+	NULL
IBR	NULL
cuase	NULL
quae	NULL
cone	NULL
r	NULL
y	NULL
AN79	NULL
*~	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

IBR/F	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoprecipitated	NULL
proteins	NULL
from	NULL
immature	NULL
adult	NULL
erythrocytes	NULL
incubated	NULL
with	NULL
*°P	NULL
;	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

Lane	NULL
a	NULL
,	NULL
autoradiog-raphy	NULL
;	NULL
lanes	NULL
b	NULL
to	NULL
d	NULL
,	NULL
Western	NULL
blot	NULL
with	NULL
anti-r	NULL
[	NULL
BR	NULL
antibodies	NULL
.	NULL

Lane	NULL
b	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
a	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
IBR	NULL
purified	NULL
from	NULL
mature	NULL
erythrocytes	NULL
;	NULL
lane	NULL
d	NULL
,	NULL
r	NULL
[	NULL
BR	NULL
.	NULL

(	NULL
B	NULL
)	NULL
rIBR	NULL
and	NULL
the	NULL
AN79	NULL
deletion	NULL
mutant	NULL
were	NULL
incubated	NULL
with	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
JATP	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
purified	NULL
CK-II	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
upper	NULL
part	NULL
of	NULL
the	NULL
figure	NULL
shows	NULL
an	NULL
autoradiograph	NULL
of	NULL
the	NULL
proteins	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
the	NULL
lower	NULL
part	NULL
shows	NULL
the	NULL
stained	NULL
gel	NULL
.	NULL

(	NULL
C	NULL
)	NULL
IBR	NULL
was	NULL
incubated	NULL
with	NULL
[	NULL
y-*°P	NULL
]	NULL
|ATP	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
immunoprecipitated	NULL
p42*	NULL
``	NULL
*	NULL
from	NULL
quiescent	NULL
(	NULL
-	NULL
)	NULL
or	NULL
serum	NULL
stimulated	NULL
(	NULL
+	NULL
)	NULL
CCL39	NULL
cells	NULL
transfected	NULL
(	NULL
Trans	NULL
)	NULL
with	NULL
an	NULL
epitope-tagged	NULL
p42*	NULL
``	NULL
~	NULL
expression	NULL
vector	NULL
or	NULL
a	NULL
nonspecific	NULL
immunoprecipitate	NULL
from	NULL
mock-transfected	NULL
cells	NULL
(	NULL
Mock	NULL
)	NULL
.	NULL

6678	NULL
GOMEZ-CUADRADO	NULL
ET	NULL
AL	NULL
.	NULL

lacking	NULL
the	NULL
79	NULL
N-terminal	NULL
amino	NULL
acids	NULL
,	NULL
was	NULL
not	NULL
phosphorylated	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
at	NULL
least	NULL
one	NULL
of	NULL
the	NULL
putative	NULL
CK-II	NULL
sites	NULL
was	NULL
recognized	NULL
by	NULL
the	NULL
kinase	NULL
.	NULL

Similar	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
activated	NULL
p42	NULL
MAP	NULL
kinase	NULL
from	NULL
mitogen-stimulated	NULL
p42*	NULL
``	NULL
~-transfected	NULL
CCL39	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
indicated	NULL
that	NULL
this	NULL
particular	NULL
MAP	NULL
kinase	NULL
was	NULL
not	NULL
able	NULL
to	NULL
phosphorylate	NULL
rIBR	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
)	NULL
,	NULL
even	NULL
though	NULL
parallel	NULL
control	NULL
experiments	NULL
with	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
a	NULL
substrate	NULL
of	NULL
MAP	NULL
kinases	NULL
)	NULL
indicated	NULL
that	NULL
was	NULL
active	NULL
.	NULL

The	NULL
labeling	NULL
of	NULL
rIBR	NULL
that	NULL
was	NULL
observed	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
due	NULL
to	NULL
a	NULL
contaminating	NULL
constitutive	NULL
protein	NULL
ki-nase	NULL
(	NULL
s	NULL
)	NULL
,	NULL
since	NULL
it	NULL
was	NULL
independent	NULL
of	NULL
p42*	NULL
``	NULL
``	NULL
*	NULL
expression	NULL
or	NULL
mitogen	NULL
activation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

The	NULL
above	NULL
results	NULL
indicate	NULL
that	NULL
CK-II	NULL
is	NULL
potentially	NULL
one	NULL
of	NULL
the	NULL
kinases	NULL
that	NULL
phosphorylate	NULL
IBR/F	NULL
in	NULL
vivo	NULL
,	NULL
but	NULL
they	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
action	NULL
of	NULL
other	NULL
kinases	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
same	NULL
N-terminal	NULL
region	NULL
contains	NULL
two	NULL
CK-I	NULL
consensus	NULL
sites	NULL
,	NULL
and	NULL
the	NULL
DNA-binding/dimerization	NULL
domain	NULL
contains	NULL
a	NULL
possible	NULL
p34	NULL
``	NULL
``	NULL
and	NULL
several	NULL
possible	NULL
DNA-dependent	NULL
kinase	NULL
sites	NULL
.	NULL

Selection	NULL
of	NULL
binding	NULL
sites	NULL
from	NULL
random	NULL
oligonucleotides	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
IBR	NULL
is	NULL
the	NULL
chicken	NULL
homolog	NULL
of	NULL
human	NULL
NRF-1/a-Pal	NULL
was	NULL
surprising	NULL
because	NULL
their	NULL
DNA	NULL
recognition	NULL
sequences	NULL
appeared	NULL
to	NULL
be	NULL
rather	NULL
different	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
NRF-1	NULL
,	NULL
a	NULL
consensus	NULL
motif	NULL
,	NULL
YGCGCAYGCGCR	NULL
(	NULL
where	NULL
Y	NULL
is	NULL
C	NULL
or	NULL
T	NULL
and	NULL
R	NULL
is	NULL
G	NULL
or	NULL
A	NULL
)	NULL
,	NULL
was	NULL
derived	NULL
from	NULL
comparison	NULL
of	NULL
the	NULL
sequences	NULL
recognized	NULL
by	NULL
the	NULL
factor	NULL
in	NULL
a	NULL
few	NULL
promoters	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
«	NULL
-Pal	NULL
,	NULL
the	NULL
palindrome	NULL
TGCGCATGCGCA	NULL
was	NULL
derived	NULL
from	NULL
a	NULL
statistical	NULL
analysis	NULL
of	NULL
67	NULL
sequences	NULL
bound	NULL
by	NULL
the	NULL
factor	NULL
after	NULL
only	NULL
a	NULL
single	NULL
cycle	NULL
of	NULL
selection	NULL
with	NULL
a	NULL
probe	NULL
containing	NULL
randomized	NULL
(	NULL
N	NULL
)	NULL
,	NULL
,	NULL
tracts	NULL
(	NULL
18	NULL
)	NULL
.	NULL

As	NULL
in	NULL
the	NULL
case	NULL
of	NULL
NRF-1	NULL
,	NULL
the	NULL
optimal	NULL
sequence	NULL
did	NULL
not	NULL
differ	NULL
significantly	NULL
from	NULL
that	NULL
present	NULL
in	NULL
the	NULL
eif-2a	NULL
promoter	NULL
used	NULL
to	NULL
identify	NULL
the	NULL
factor	NULL
.	NULL

Because	NULL
the	NULL
con-sensus/optimal	NULL
NRF-1/a	NULL
«	NULL
-Pal	NULL
DNA-binding	NULL
sequences	NULL
did	NULL
not	NULL
readily	NULL
conform	NULL
to	NULL
the	NULL
A5	NULL
binding	NULL
sequence	NULL
(	NULL
25	NULL
)	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
and	NULL
because	NULL
a	NULL
14-bp	NULL
randomized	NULL
stretch	NULL
could	NULL
impose	NULL
constraints	NULL
on	NULL
a	NULL
12-bp	NULL
binding	NULL
factor	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
independently	NULL
determine	NULL
the	NULL
optimal	NULL
sequences	NULL
recognized	NULL
by	NULL
IBR	NULL
.	NULL

A	NULL
large	NULL
molar	NULL
excess	NULL
of	NULL
a	NULL
pool	NULL
of	NULL
oligonucleotides	NULL
containing	NULL
centrally	NULL
located	NULL
(	NULL
N	NULL
)	NULL
;	NULL
,	NULL
random	NULL
tracts	NULL
was	NULL
incubated	NULL
with	NULL
purified	NULL
IBR	NULL
,	NULL
and	NULL
the	NULL
complexes	NULL
were	NULL
enriched	NULL
by	NULL
WGA	NULL
affinity	NULL
chromatography	NULL
,	NULL
taking	NULL
advantage	NULL
of	NULL
IBR	NULL
glycosylation	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

After	NULL
the	NULL
resin	NULL
was	NULL
washed	NULL
under	NULL
more	NULL
stringent	NULL
salt	NULL
conditions	NULL
,	NULL
the	NULL
bound	NULL
complexes	NULL
were	NULL
eluted	NULL
with	NULL
N-acetylglucosamine	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
moiety	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
and	NULL
used	NULL
in	NULL
a	NULL
subsequent	NULL
selection	NULL
cycle	NULL
.	NULL

Figure	NULL
9A	NULL
shows	NULL
a	NULL
summary	NULL
of	NULL
54	NULL
independent	NULL
sequences	NULL
selected	NULL
by	NULL
IBR	NULL
after	NULL
five	NULL
consecutive	NULL
cycles	NULL
.	NULL

The	NULL
palindromic	NULL
direct	NULL
repeat	NULL
sequence	NULL
TGCGCATGCGCA	NULL
,	NULL
identical	NULL
to	NULL
that	NULL
reported	NULL
for	NULL
«	NULL
-Pal	NULL
(	NULL
18	NULL
)	NULL
,	NULL
was	NULL
derived	NULL
.	NULL

However	NULL
,	NULL
we	NULL
noticed	NULL
that	NULL
the	NULL
perfect	NULL
palindrome	NULL
and	NULL
half-palindrome	NULL
sequences	NULL
represented	NULL
1.8	NULL
and	NULL
66	NULL
%	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
,	NULL
respectively	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
factor	NULL
could	NULL
bind	NULL
modified	NULL
versions	NULL
of	NULL
the	NULL
palindrome	NULL
with	NULL
high	NULL
affinity	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
central	NULL
8-bp	NULL
palindrome	NULL
CGCATGCG	NULL
was	NULL
present	NULL
in	NULL
54	NULL
%	NULL
of	NULL
the	NULL
sequences	NULL
,	NULL
and	NULL
this	NULL
number	NULL
increased	NULL
to	NULL
81	NULL
%	NULL
if	NULL
allowance	NULL
was	NULL
made	NULL
for	NULL
one	NULL
mismatch	NULL
that	NULL
conserved	NULL
the	NULL
alternating	NULL
purine-pyrimidine	NULL
motif	NULL
of	NULL
the	NULL
sequence	NULL
.	NULL

To	NULL
further	NULL
test	NULL
the	NULL
significance	NULL
of	NULL
the	NULL
palindrome	NULL
,	NULL
three	NULL
supplementary	NULL
selection	NULL
cycles	NULL
were	NULL
performed	NULL
,	NULL
and	NULL
the	NULL
sequence	NULL
of	NULL
24	NULL
additional	NULL
binding	NULL
sites	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
strengthened	NULL
the	NULL
statistical	NULL
significance	NULL
of	NULL
the	NULL
perfect	NULL
palindrome	NULL
,	NULL
the	NULL
frequency	NULL
of	NULL
which	NULL
increased	NULL
to	NULL
8.3	NULL
%	NULL
,	NULL
but	NULL
also	NULL
revealed	NULL
that	NULL
the	NULL
8-bp	NULL
palindrome	NULL
CGCATGCG	NULL
was	NULL
present	NULL
in	NULL
83	NULL
%	NULL
of	NULL
the	NULL
clones	NULL
.	NULL

Again	NULL
,	NULL
this	NULL
number	NULL
raised	NULL
to	NULL
96	NULL
%	NULL
if	NULL
one	NULL
transition	NULL
change	NULL
was	NULL
allowed	NULL
in	NULL
the	NULL
alternating	NULL
purine-pyrimidine	NULL
sequence	NULL
.	NULL

We	NULL
note	NULL
that	NULL
despite	NULL
the	NULL
AT	NULL
bias	NULL
at	NULL
the	NULL
dyad	NULL
of	NULL
the	NULL
palindrome	NULL
,	NULL
a	NULL
sequence	NULL
containing	NULL
GC	NULL
at	NULL
this	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

H	NULL
T	NULL
G	NULL
C	NULL
G	NULL
C	NULL
A	NULL
T	NULL
G	NULL
C	NULL
G	NULL
C	NULL
A	NULL
H	NULL
68	NULL
65	NULL
95	NULL
89	NULL
98	NULL
95	NULL
89	NULL
98	NULL
87	NULL
85	NULL
70	NULL
67	NULL
T	NULL
37	NULL
0	NULL
1	NULL
1	NULL
1	NULL
0	NULL
48	NULL
0	NULL
4	NULL
3	NULL
13	NULL
3	NULL
C	NULL
7	NULL
1	NULL
51	NULL
1	NULL
53	NULL
1	NULL
5	NULL
0	NULL
47	NULL
1	NULL
38	NULL
11	NULL
G	NULL
8	NULL
35	NULL
0	NULL
48	NULL
0	NULL
2	NULL
1	NULL
53	NULL
1	NULL
46	NULL
0	NULL
4	NULL
A	NULL
2	NULL
18	NULL
2	NULL
4	NULL
0	NULL
51	NULL
0	NULL
1	NULL
2	NULL
4	NULL
3	NULL
36	NULL
CctgTACAATGCGCATGCGCACCTAGAGccta	NULL
CctgCGCATGCG	NULL
@	NULL
TAATACTTCTCGTTACecta	NULL
cctgGCCAAGCTTGTGCGCATGCTCATTccta	NULL
cctgCGCATGCGTACATACTTTCCATIGecta	NULL
cctgTACCCTTGAATGCGCATGCGCTGTecta	NULL
taggGACGCAAGCGCATGCGececTeccccagy	NULL
CctgACAGGAATACGCATGCGCTCTCGAccta	NULL
CctgTACACCATTGCGCATGCGTCCGTAccta	NULL
CCtgGCAAGATGTCAATTCGCGCATGCGecta	NULL
taygTACGGAAATGGCGCATGCGTATTGcagy	NULL
cctgCGCATGCeTecTecTGTTTCCaTAccta	NULL
cctgATTACACGCAGTATTGCGCATGCGéecta	NULL
taggTACGCAGCGTCTTATGCGCATGCGeaqgq	NULL
taggATAAACAGCGCATGCGCATCAGCCcagy	NULL
cctgTAACGACTGGCGCATGCGéCATCTToecta	NULL
taggTCGGTACATGTTTTGATGCGCGCGeaqgq	NULL
CctgCGCATGCGTGAACCATTCTAACGTecta	NULL
taggTACGCATGCGCAGCACTTACTTCGcaqgqy	NULL
CctgCACGCATGCGCAGAGGTGTCTCTccta	NULL
taggGATACTACGCGTGCGCTGGAACAAcaqgq	NULL
taggCGCATGCGCAATATTATGCGACTAcagq	NULL
cctgTGAAACTGAATGCGCATGCGCTAAccta	NULL
taggTATATGCGCACGCACTCATTCGCcaqgq	NULL
taggCGCATGC6TécACTTGCGATAGATcagqy	NULL
H	NULL
T	NULL
G	NULL
C	NULL
G	NULL
C	NULL
A	NULL
T	NULL
G	NULL
C	NULL
G	NULL
C	NULL
A	NULL
H	NULL
62	NULL
79	NULL
96	NULL
100	NULL
100	NULL
92	NULL
92	NULL
100	NULL
100	NULL
92	NULL
71	NULL
50	NULL
T	NULL
15	NULL
0	NULL
1	NULL
0	NULL
0	NULL
0	NULL
22	NULL
y	NULL
0	NULL
1	NULL
7	NULL
5	NULL
C	NULL
2	NULL
0	NULL
23	NULL
0	NULL
24	NULL
0	NULL
2	NULL
0	NULL
24	NULL
0	NULL
17	NULL
3	NULL
G	NULL
5	NULL
19	NULL
0	NULL
24	NULL
0	NULL
2	NULL
0	NULL
24	NULL
0	NULL
22	NULL
0	NULL
4	NULL
A	NULL
2	NULL
5	NULL
0	NULL
0	NULL
0	NULL
22	NULL
0	NULL
0	NULL
0	NULL
1	NULL
0	NULL
12	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

IBR	NULL
binding	NULL
site	NULL
selection	NULL
.	NULL

Purified	NULL
IBR	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
pool	NULL
of	NULL
53-mer	NULL
oligonucleotides	NULL
containing	NULL
random	NULL
(	NULL
N	NULL
)	NULL
;	NULL
,	NULL
stretches	NULL
in	NULL
the	NULL
middle	NULL
of	NULL
the	NULL
sequence	NULL
.	NULL

Complexes	NULL
were	NULL
purified	NULL
by	NULL
WGA-Sepharose	NULL
chromatography	NULL
,	NULL
and	NULL
the	NULL
oligonucleotide	NULL
moieties	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
and	NULL
used	NULL
in	NULL
a	NULL
subsequent	NULL
cycle	NULL
of	NULL
selection	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
IBR	NULL
binding	NULL
sequences	NULL
from	NULL
54	NULL
independent	NULL
clones	NULL
after	NULL
five	NULL
consecutive	NULL
cycles	NULL
of	NULL
selection	NULL
.	NULL

The	NULL
projected	NULL
optimal	NULL
sequence	NULL
is	NULL
boxed	NULL
,	NULL
and	NULL
the	NULL
frequency	NULL
of	NULL
each	NULL
nucleotide	NULL
is	NULL
given	NULL
as	NULL
a	NULL
percentage	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sequences	NULL
of	NULL
24	NULL
binding	NULL
sites	NULL
after	NULL
eight	NULL
cycles	NULL
of	NULL
selection	NULL
and	NULL
sequence	NULL
summary	NULL
.	NULL

Nucleotides	NULL
in	NULL
lowercase	NULL
letters	NULL
correspond	NULL
to	NULL
the	NULL
constant	NULL
sequence	NULL
of	NULL
the	NULL
53-mer	NULL
flanking	NULL
the	NULL
random	NULL
(	NULL
N	NULL
)	NULL
;	NULL
,	NULL
tracts	NULL
.	NULL

position	NULL
was	NULL
obtained	NULL
even	NULL
after	NULL
eight	NULL
cycles	NULL
of	NULL
selection	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
although	NULL
the	NULL
perfect	NULL
12-bp	NULL
palindrome	NULL
is	NULL
probably	NULL
the	NULL
highest	NULL
affinity	NULL
site	NULL
for	NULL
IBR	NULL
,	NULL
the	NULL
more	NULL
general	NULL
consensus	NULL
sequence	NULL
RCGCRYGCGY	NULL
is	NULL
more	NULL
appropriate	NULL
as	NULL
a	NULL
representative	NULL
of	NULL
potential	NULL
high-affinity	NULL
sites	NULL
(	NULL
see	NULL
Discussion	NULL
)	NULL
.	NULL

IBR	NULL
might	NULL
thus	NULL
recognize	NULL
structural	NULL
characteristics	NULL
of	NULL
DNA	NULL
other	NULL
than	NULL
sequence	NULL
,	NULL
since	NULL
alternate	NULL
purine-pyrimidine	NULL
sequences	NULL
have	NULL
the	NULL
potential	NULL
to	NULL
adopt	NULL
a	NULL
z-DNA	NULL
conformation	NULL
(	NULL
91	NULL
)	NULL
.	NULL

IBR	NULL
and	NULL
IBF	NULL
associate	NULL
as	NULL
stable	NULL
homodimers	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
recognition	NULL
site	NULL
of	NULL
IBR	NULL
is	NULL
a	NULL
palindrome	NULL
insinuated	NULL
that	NULL
the	NULL
factor	NULL
binds	NULL
to	NULL
DNA	NULL
as	NULL
a	NULL
dimer	NULL
,	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
Stokes	NULL
'	NULL
radius	NULL
determined	NULL
by	NULL
molecular	NULL
filtration	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
because	NULL
the	NULL
optimal	NULL
recognition	NULL
sequence	NULL
is	NULL
also	NULL
a	NULL
direct	NULL
repeat	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
IBR	NULL
binds	NULL
to	NULL
DNA	NULL
as	NULL
two	NULL
independent	NULL
monomers	NULL
could	NULL
not	NULL
be	NULL
dismissed	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
type	NULL
of	NULL
complex	NULL
made	NULL
in	NULL
solution	NULL
,	NULL
IBR	NULL
and	NULL
IBF	NULL
were	NULL
reacted	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
glutaraldehyde	NULL
,	NULL
and	NULL
the	NULL
products	NULL
of	NULL
the	NULL
reaction	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blot	NULL
with	NULL
affinity-purified	NULL
anti-r	NULL
[	NULL
BR	NULL
antibodies	NULL
.	NULL

Figure	NULL
10A	NULL
shows	NULL
that	NULL
the	NULL
monomer	NULL
species	NULL
were	NULL
cross-linked	NULL
into	NULL
dimers	NULL
,	NULL
by	NULL
comparison	NULL
with	NULL
the	NULL
mobility	NULL
of	NULL
standard	NULL
proteins	NULL
,	NULL
and	NULL
that	NULL
no	NULL
higher-order	NULL
oligomers	NULL
were	NULL
produced	NULL
.	NULL

The	NULL
higher	NULL
concentration	NULL
of	NULL
glutaraldehyde	NULL
needed	NULL
to	NULL
cross-link	NULL
IBF	NULL
was	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
A	NULL
Glutaraldehyde	NULL
]	NULL
_	NULL
[	NULL
Glutaraldehyde	NULL
]	NULL
_	NULL
[	NULL
y	NULL
Dimers	NULL
Dimer	NULL
»	NULL
C	NULL
Monome	NULL
r	NULL
_	NULL
...	NULL
.	NULL

@	NULL
w	NULL
.	NULL

@	NULL
@	NULL
@	NULL
.	NULL

mos	NULL
Monomers	NULL
.	NULL

==	NULL
=	NULL
=	NULL
IBR	NULL
IBF	NULL
h5	NULL
C/D	NULL
[	NULL
eSHICGCGCGGCCGCL	NULL
eptesen	NULL
tent	NULL
}	NULL
PAL	NULL
CTA	NULL
ca	NULL
1/2-	NULL
PAL	NULL
-	NULL
cateracacie	NULL
@	NULL
eertreroratec	NULL
h5	NULL
PAL	NULL
___	NULL
cae	NULL
_	NULL
.	NULL

._	NULL
___	NULL
_	NULL
—-_M	NULL
__.-m	NULL
1/2-	NULL
PAL	NULL
-*~gri	NULL
#	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

(	NULL
A	NULL
)	NULL
IBR	NULL
and	NULL
IBF	NULL
associate	NULL
and	NULL
bind	NULL
to	NULL
DNA	NULL
as	NULL
homodimers	NULL
.	NULL

Approximately	NULL
50	NULL
ng	NULL
of	NULL
IBR	NULL
or	NULL
partially	NULL
purified	NULL
IBF	NULL
was	NULL
reacted	NULL
with	NULL
glutaraldehyde	NULL
(	NULL
final	NULL
concentrations	NULL
:	NULL
0.005	NULL
,	NULL
0.01	NULL
,	NULL
0.025	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
products	NULL
of	NULL
the	NULL
reactions	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
purified	NULL
anti-IBR	NULL
(	NULL
IBR	NULL
)	NULL
or	NULL
anti-r	NULL
[	NULL
BR	NULL
(	NULL
IBF	NULL
)	NULL
IgG	NULL
.	NULL

The	NULL
apparent	NULL
molecular	NULL
masses	NULL
of	NULL
the	NULL
monomer	NULL
and	NULL
dimer	NULL
species	NULL
were	NULL
determined	NULL
by	NULL
comparison	NULL
with	NULL
that	NULL
of	NULL
standard	NULL
proteins	NULL
run	NULL
in	NULL
a	NULL
parallel	NULL
lane	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Gel	NULL
retardation	NULL
assays	NULL
of	NULL
°°P-labeled	NULL
24-mer	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
either	NULL
the	NULL
-10	NULL
to	NULL
+14	NULL
sequences	NULL
of	NULL
A5	NULL
(	NULL
A5	NULL
)	NULL
,	NULL
a	NULL
perfect	NULL
palindrome	NULL
(	NULL
PAL	NULL
)	NULL
,	NULL
or	NULL
a	NULL
perfect	NULL
half	NULL
palindrome	NULL
(	NULL
1/2	NULL
PAL	NULL
)	NULL
,	NULL
incubated	NULL
without	NULL
protein	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
0.7	NULL
,	NULL
4	NULL
,	NULL
3	NULL
,	NULL
or	NULL
6	NULL
ng	NULL
of	NULL
affinity-purified	NULL
IBR	NULL
.	NULL

probably	NULL
related	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
proteins	NULL
in	NULL
the	NULL
partially	NULL
purified	NULL
sample	NULL
.	NULL

Under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
the	NULL
mono-meric	NULL
histone	NULL
HS	NULL
was	NULL
cross-linked	NULL
into	NULL
higher-order	NULL
oligomers	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
homodimer	NULL
is	NULL
the	NULL
main	NULL
molecular	NULL
form	NULL
of	NULL
IBR	NULL
and	NULL
IBF	NULL
at	NULL
the	NULL
concentration	NULL
of	NULL
protein	NULL
used	NULL
.	NULL

We	NULL
next	NULL
determined	NULL
if	NULL
the	NULL
dimer	NULL
was	NULL
the	NULL
active	NULL
DNA-binding	NULL
species	NULL
by	NULL
characterizing	NULL
the	NULL
complexes	NULL
formed	NULL
by	NULL
IBR	NULL
with	NULL
probes	NULL
containing	NULL
the	NULL
12-bp	NULL
palindrome	NULL
(	NULL
PAL	NULL
)	NULL
,	NULL
the	NULL
6-bp	NULL
half-palindrome	NULL
(	NULL
1/2	NULL
PAL	NULL
)	NULL
,	NULL
and	NULL
the	NULL
A5	NULL
sequences	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
indicated	NULL
that	NULL
at	NULL
the	NULL
IBR	NULL
concentrations	NULL
tested	NULL
,	NULL
the	NULL
complexes	NULL
had	NULL
identical	NULL
electrophoretic	NULL
mobilities	NULL
(	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
,	NULL
implying	NULL
that	NULL
IBR	NULL
recognized	NULL
the	NULL
probes	NULL
as	NULL
an	NULL
identical	NULL
molecular	NULL
species	NULL
whether	NULL
or	NULL
not	NULL
the	NULL
site	NULL
contained	NULL
the	NULL
full	NULL
or	NULL
the	NULL
half	NULL
recognition	NULL
sequence	NULL
.	NULL

Because	NULL
no	NULL
faster-mobility	NULL
complex	NULL
could	NULL
be	NULL
detected	NULL
even	NULL
at	NULL
the	NULL
lowest	NULL
protein	NULL
concentrations	NULL
used	NULL
,	NULL
it	NULL
follows	NULL
that	NULL
the	NULL
monomer	NULL
can	NULL
not	NULL
stably	NULL
interact	NULL
with	NULL
DNA	NULL
and	NULL
that	NULL
the	NULL
homodimer	NULL
is	NULL
the	NULL
relevant	NULL
DNA-binding	NULL
species	NULL
.	NULL

We	NULL
designed	NULL
experiments	NULL
to	NULL
estimate	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
dimers	NULL
according	NULL
to	NULL
the	NULL
reaction	NULL
P2P	NULL
,	NULL
K	NULL
where	NULL
P	NULL
represents	NULL
the	NULL
concentration	NULL
of	NULL
monomers	NULL
and	NULL
P	NULL
;	NULL
is	NULL
the	NULL
concentration	NULL
of	NULL
dimers	NULL
.	NULL

At	NULL
equilibrium	NULL
,	NULL
K	NULL
=	NULL
[	NULL
P	NULL
,	NULL
]	NULL
/	NULL
[	NULL
P	NULL
]	NULL
is	NULL
the	NULL
dissociation	NULL
constant	NULL
of	NULL
dimers	NULL
.	NULL

For	NULL
the	NULL
experiments	NULL
,	NULL
increasing	NULL
concentrations	NULL
of	NULL
rIBR	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
a	NULL
constant	NULL
excess	NULL
of	NULL
the	NULL
PAL	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
protein-DNA	NULL
complex	NULL
formed	NULL
at	NULL
equilibrium	NULL
was	NULL
measured	NULL
by	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

Since	NULL
the	NULL
DNA	NULL
was	NULL
in	NULL
MOLECULAR	NULL
CHARACTERIZATION	NULL
OF	NULL
IBR/F	NULL
(	NULL
GRF-1	NULL
)	NULL
6679	NULL
excess	NULL
,	NULL
the	NULL
concentration	NULL
of	NULL
dimers	NULL
at	NULL
each	NULL
protein	NULL
input	NULL
was	NULL
estimated	NULL
to	NULL
be	NULL
equal	NULL
to	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
DNA	NULL
complex	NULL
[	NULL
P	NULL
,	NULL
D	NULL
]	NULL
,	NULL
and	NULL
the	NULL
monomer	NULL
concentration	NULL
was	NULL
calculated	NULL
by	NULL
subtracting	NULL
the	NULL
dimer	NULL
concentration	NULL
from	NULL
the	NULL
total	NULL
protein	NULL
concentration	NULL
.	NULL

The	NULL
apparent	NULL
dissociation	NULL
constant	NULL
,	NULL
calculated	NULL
from	NULL
the	NULL
slope	NULL
of	NULL
the	NULL
plot	NULL
of	NULL
P	NULL
,	NULL
D	NULL
versus	NULL
[	NULL
P	NULL
]	NULL
(	NULL
Fig	NULL
.	NULL

11A	NULL
)	NULL
,	NULL
varied	NULL
between	NULL
4.3	NULL
X	NULL
10~®	NULL
and	NULL
7.6	NULL
x	NULL
10~®	NULL
M	NULL
in	NULL
different	NULL
experiments	NULL
.	NULL

Since	NULL
our	NULL
approach	NULL
underestimates	NULL
the	NULL
dimer	NULL
concentration	NULL
,	NULL
the	NULL
actual	NULL
dissociation	NULL
constant	NULL
should	NULL
be	NULL
even	NULL
lower	NULL
than	NULL
that	NULL
calculated	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
the	NULL
result	NULL
indicates	NULL
that	NULL
the	NULL
dimer	NULL
is	NULL
very	NULL
stable	NULL
and	NULL
suggests	NULL
that	NULL
,	NULL
unless	NULL
properly	NULL
destabilized	NULL
,	NULL
the	NULL
IBR/F	NULL
dimer	NULL
may	NULL
not	NULL
easily	NULL
exchange	NULL
subunits	NULL
with	NULL
other	NULL
as	NULL
yet	NULL
unknown	NULL
factors	NULL
(	NULL
see	NULL
Discussion	NULL
)	NULL
.	NULL

Kinetics	NULL
of	NULL
DNA	NULL
binding	NULL
by	NULL
IBR	NULL
.	NULL

The	NULL
equilibrium	NULL
dissociation	NULL
constant	NULL
for	NULL
the	NULL
optimal	NULL
palindrome	NULL
TGCGCATGCGCA	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
for	NULL
«	NULL
-Pal	NULL
as	NULL
6.5	NULL
x	NULL
10~*	NULL
'	NULL
M	NULL
(	NULL
18	NULL
)	NULL
,	NULL
a	NULL
value	NULL
which	NULL
is	NULL
of	NULL
the	NULL
same	NULL
order	NULL
of	NULL
magnitude	NULL
as	NULL
the	NULL
one	NULL
that	NULL
we	NULL
determined	NULL
for	NULL
IBR	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
indicated	NULL
that	NULL
the	NULL
affinity	NULL
of	NULL
IBR	NULL
for	NULL
site	NULL
C/D	NULL
of	NULL
A5	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
and	NULL
the	NULL
half-palindrome	NULL
TGCGCA	NULL
was	NULL
10-fold	NULL
lower	NULL
than	NULL
for	NULL
the	NULL
12-bp	NULL
palindrome	NULL
(	NULL
not	NULL
shown	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
the	NULL
contacts	NULL
determining	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
IBR-DNA	NULL
complex	NULL
probably	NULL
occur	NULL
between	NULL
each	NULL
monomer	NULL
and	NULL
the	NULL
CGC/	NULL
GCG	NULL
sequences	NULL
surrounding	NULL
the	NULL
central	NULL
RY	NULL
dyad	NULL
,	NULL
the	NULL
results	NULL
indicate	NULL
that	NULL
insofar	NULL
as	NULL
one	NULL
of	NULL
the	NULL
subunits	NULL
establishes	NULL
specific	NULL
contacts	NULL
with	NULL
DNA	NULL
,	NULL
the	NULL
other	NULL
subunit	NULL
can	NULL
accommodate	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
sequences	NULL
at	NULL
a	NULL
relatively	NULL
low	NULL
thermodynamic	NULL
cost	NULL
for	NULL
the	NULL
complex	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
kinetics	NULL
of	NULL
IBR	NULL
interaction	NULL
with	NULL
those	NULL
sequences	NULL
,	NULL
the	NULL
apparent	NULL
association	NULL
and	NULL
dissociation	NULL
rates	NULL
of	NULL
the	NULL
DNA	NULL
complexes	NULL
were	NULL
determined	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
apparent	NULL
association	NULL
rate	NULL
to	NULL
the	NULL
palindrome	NULL
was	NULL
between	NULL
1.6	NULL
and	NULL
1.8	NULL
times	NULL
slower	NULL
than	NULL
that	NULL
to	NULL
the	NULL
A5	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

11C	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
effect	NULL
was	NULL
reproducible	NULL
,	NULL
the	NULL
result	NULL
may	NULL
indicate	NULL
that	NULL
stable	NULL
binding	NULL
of	NULL
IBR	NULL
to	NULL
the	NULL
palindrome	NULL
requires	NULL
a	NULL
structural	NULL
transition	NULL
to	NULL
occur	NULL
in	NULL
the	NULL
complex	NULL
,	NULL
a	NULL
transition	NULL
which	NULL
may	NULL
not	NULL
occur	NULL
in	NULL
the	NULL
imperfect	NULL
A5	NULL
sequence	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
half-life	NULL
of	NULL
the	NULL
£5	NULL
complex	NULL
was	NULL
15	NULL
times	NULL
shorter	NULL
than	NULL
that	NULL
of	NULL
the	NULL
palindrome	NULL
complex	NULL
,	NULL
the	NULL
t	NULL
,	NULL
,	NULL
,	NULL
of	NULL
the	NULL
palindrome	NULL
and	NULL
A5	NULL
complex	NULL
being	NULL
38	NULL
and	NULL
2.5	NULL
min	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

11B	NULL
)	NULL
.	NULL

The	NULL
high	NULL
off-rate	NULL
of	NULL
the	NULL
A5	NULL
complex	NULL
suggests	NULL
that	NULL
the	NULL
transcriptional	NULL
effect	NULL
of	NULL
IBR	NULL
on	NULL
the	NULL
A5	NULL
promoter	NULL
should	NULL
be	NULL
highly	NULL
sensitive	NULL
to	NULL
the	NULL
intracellular	NULL
concentration	NULL
of	NULL
the	NULL
factor	NULL
.	NULL

DNA-binding	NULL
and	NULL
dimerization	NULL
domains	NULL
of	NULL
IBR	NULL
.	NULL

To	NULL
dissect	NULL
the	NULL
functional	NULL
domains	NULL
of	NULL
IBR	NULL
,	NULL
a	NULL
series	NULL
of	NULL
N-	NULL
and	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
(	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

12A	NULL
)	NULL
were	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
.	NULL

The	NULL
recombinant	NULL
proteins	NULL
were	NULL
efficiently	NULL
synthesized	NULL
in	NULL
bacteria	NULL
(	NULL
Fig	NULL
.	NULL

12B	NULL
)	NULL
and	NULL
soluble	NULL
under	NULL
nondenaturing	NULL
con-ditions	NULL
.	NULL

The	NULL
DNA-binding	NULL
activity	NULL
of	NULL
the	NULL
purified	NULL
proteins	NULL
was	NULL
analyzed	NULL
by	NULL
gel	NULL
retardation	NULL
assays	NULL
with	NULL
the	NULL
PAL	NULL
probe	NULL
,	NULL
whereas	NULL
their	NULL
ability	NULL
to	NULL
form	NULL
dimers	NULL
was	NULL
assessed	NULL
in	NULL
parallel	NULL
experiments	NULL
by	NULL
glutaraldehyde	NULL
cross-linking	NULL
.	NULL

Mutant	NULL
AN110	NULL
was	NULL
not	NULL
included	NULL
in	NULL
this	NULL
study	NULL
because	NULL
the	NULL
majority	NULL
of	NULL
molecules	NULL
were	NULL
cleaved	NULL
at	NULL
an	NULL
internal	NULL
site	NULL
in	NULL
£	NULL
.	NULL

coli	NULL
(	NULL
Fig	NULL
.	NULL

12B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
gel	NULL
retardation	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

12C	NULL
)	NULL
indicated	NULL
that	NULL
all	NULL
mutants	NULL
except	NULL
AN172	NULL
and	NULL
AC247	NULL
were	NULL
able	NULL
to	NULL
form	NULL
complexes	NULL
AN79	NULL
,	NULL
which	NULL
is	NULL
not	NULL
shown	NULL
in	NULL
the	NULL
figure	NULL
,	NULL
was	NULL
also	NULL
able	NULL
to	NULL
form	NULL
a	NULL
complex	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
outer	NULL
limits	NULL
of	NULL
the	NULL
DNA-binding/dimerization	NULL
domain	NULL
,	NULL
which	NULL
comprises	NULL
most	NULL
of	NULL
the	NULL
evolutionarily	NULL
conserved	NULL
region	NULL
,	NULL
is	NULL
defined	NULL
by	NULL
deletions	NULL
AN127	NULL
and	NULL
AC283	NULL
(	NULL
Fig	NULL
.	NULL

12A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Glutaraldehyde	NULL
cross-linking	NULL
indicated	NULL
that	NULL
all	NULL
the	NULL
mutants	NULL
except	NULL
AN172	NULL
efficiently	NULL
formed	NULL
dimers	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
AN172	NULL
monomer	NULL
was	NULL
cross-linked	NULL
into	NULL
higher-order	NULL
oligomers	NULL
with	NULL
no	NULL
pause	NULL
at	NULL
the	NULL
dimeric	NULL
form	NULL
,	NULL
indicating	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
definite	NULL
complex	NULL
.	NULL

These	NULL
results	NULL
,	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

12A	NULL
,	NULL
locate	NULL
the	NULL
dimerization	NULL
domain	NULL
towards	NULL
6680	NULL
GOMEZ-CUADRADO	NULL
ET	NULL
AL	NULL
.	NULL

0	NULL
0	NULL
O	NULL
,	NULL
.1	NULL
0,2	NULL
0,3	NULL
04	NULL
0,5	NULL
0,6	NULL
0.7	NULL
0,8	NULL
B	NULL
107	NULL
``	NULL
M	NULL
100	NULL
%	NULL
DNA	NULL
bound	NULL
3	NULL
on	NULL
1	NULL
Ro	NULL
Ur	NULL
L	NULL
o-	NULL
m	NULL
0	NULL
50	NULL
100	NULL
-	NULL
150	NULL
-	NULL
200	NULL
-	NULL
350	NULL
-	NULL
400	NULL
-	NULL
450	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
p3	NULL
s	NULL
I	NULL
<	NULL
<	NULL
3	NULL
g	NULL
8	NULL
.8	NULL
6	NULL
e	NULL
A	NULL
,	NULL
7	NULL
0	NULL
-or-	NULL
e	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
70	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
FIG	NULL
.	NULL

11	NULL
.	NULL

Kinetic	NULL
measurements	NULL
of	NULL
IBR	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Determination	NULL
of	NULL
the	NULL
dissociation	NULL
constant	NULL
of	NULL
rIBR	NULL
dimers	NULL
into	NULL
monomers	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Dissociation	NULL
rates	NULL
of	NULL
the	NULL
IBR-PAL	NULL
(	NULL
&	NULL
)	NULL
and	NULL
IBR-A5	NULL
(	NULL
I	NULL
)	NULL
complexes	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Association	NULL
rates	NULL
of	NULL
IBR	NULL
to	NULL
PAL	NULL
(	NULL
&	NULL
)	NULL
and	NULL
A5	NULL
probes	NULL
(	NULL
MR	NULL
)	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
DNA-	NULL
|	NULL
.	NULL

.	NULL

427	NULL
283	NULL
503	NULL
Binding	NULL
-	NULL
Dimerization	NULL
[	NULL
Te	NULL
Terr	NULL
e	NULL
___	NULL
]	NULL
``	NULL
BR	NULL
+	NULL
+	NULL
AN49	NULL
+	NULL
+	NULL
AN7Z3	NULL
+	NULL
+	NULL
AN127Z	NULL
+	NULL
+	NULL
AN172	NULL
-	NULL
AC424	NULL
+	NULL
+	NULL
AC333	NULL
+	NULL
+	NULL
-	NULL
AC3O0	NULL
+	NULL
+	NULL
AC283	NULL
+	NULL
+	NULL
AC247	NULL
-	NULL
+	NULL
o	NULL
D	NULL
Ad	NULL
B	NULL
$	NULL
f	NULL
§	NULL
§	NULL
1g	NULL
g	NULL
g	NULL
8	NULL
&	NULL
&	NULL
3	NULL
8	NULL
8	NULL
0	NULL
8	NULL
2	NULL
z	NULL
z	NULL
z	NULL
z	NULL
-	NULL
2	NULL
a	NULL
a	NULL
4	NULL
4	NULL
4	NULL
4	NULL
4	NULL
s	NULL
4	NULL
<	NULL
hand	NULL
-==	NULL
_-	NULL
~	NULL
-	NULL
``	NULL
*	NULL
-am	NULL
.	NULL

’	NULL
..	NULL
cap	NULL
Go	NULL
m	NULL
3	NULL
§	NULL
§	NULL
§	NULL
&	NULL
f	NULL
8	NULL
9	NULL
C	NULL
&	NULL
3	NULL
8	NULL
8	NULL
8	NULL
8	NULL
z	NULL
>	NULL
z	NULL
2	NULL
4	NULL
4	NULL
4	NULL
4	NULL
4	NULL
4	NULL
<	NULL
<	NULL
.	NULL

|	NULL
°	NULL
a	NULL
+	NULL
FIG	NULL
.	NULL

12	NULL
.	NULL

Deletion	NULL
mapping	NULL
of	NULL
IBR	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Diagram	NULL
of	NULL
the	NULL
deletion	NULL
mutants	NULL
of	NULL
IBR	NULL
tested	NULL
for	NULL
dimerization	NULL
and	NULL
DNA	NULL
binding	NULL
.	NULL

The	NULL
127	NULL
to	NULL
283	NULL
box	NULL
indicates	NULL
the	NULL
outer	NULL
limits	NULL
of	NULL
the	NULL
DNA-binding/dimerization	NULL
domain	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
of	NULL
whole	NULL
E.	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
expressing	NULL
the	NULL
indicated	NULL
IBR	NULL
mutants	NULL
reacted	NULL
with	NULL
anti-rIBR	NULL
antibodies	NULL
.	NULL

Lane	NULL
-	NULL
,	NULL
nontransformed	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
DNA-binding	NULL
activity	NULL
of	NULL
IBR	NULL
deletion	NULL
mutants	NULL
.	NULL

The	NULL
*°P-labeled	NULL
PAL	NULL
probe	NULL
was	NULL
used	NULL
for	NULL
the	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

Only	NULL
the	NULL
region	NULL
containing	NULL
the	NULL
complexes	NULL
is	NULL
shown	NULL
.	NULL

the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
composite	NULL
DNA-binding/dimerization	NULL
domain	NULL
.	NULL

The	NULL
DNA-binding	NULL
domain	NULL
of	NULL
IBR	NULL
,	NULL
which	NULL
is	NULL
relatively	NULL
proline-rich	NULL
and	NULL
neutral	NULL
in	NULL
charge	NULL
,	NULL
shows	NULL
none	NULL
of	NULL
the	NULL
typical	NULL
motifs	NULL
found	NULL
in	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
zinc	NULL
fingers	NULL
,	NULL
b-ZIP	NULL
,	NULL
basic	NULL
helix-loop-helix	NULL
,	NULL
and	NULL
helix-turn-helix	NULL
.	NULL

The	NULL
region	NULL
encompassing	NULL
residues	NULL
232	NULL
to	NULL
255	NULL
has	NULL
the	NULL
loose	NULL
consensus	NULL
of	NULL
a	NULL
homeobox	NULL
domain	NULL
signature	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
a	NULL
typical	NULL
helix-turn-helix	NULL
can	NULL
be	NULL
formed	NULL
because	NULL
the	NULL
region	NULL
that	NULL
should	NULL
correspond	NULL
to	NULL
helix	NULL
II	NULL
(	NULL
24	NULL
)	NULL
is	NULL
punctuated	NULL
with	NULL
proline	NULL
residues	NULL
and	NULL
therefore	NULL
can	NULL
not	NULL
adopt	NULL
an	NULL
«	NULL
-helix	NULL
conformation	NULL
.	NULL

Nuclear	NULL
targeting	NULL
of	NULL
IBR	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
the	NULL
evolutionarily	NULL
conserved	NULL
bipartite	NULL
NLS	NULL
which	NULL
lies	NULL
at	NULL
the	NULL
N-terminal	NULL
side	NULL
of	NULL
the	NULL
dimerization/DNA-binding	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
4	NULL
)	NULL
was	NULL
functional	NULL
.	NULL

Transformed	NULL
H32	NULL
quail	NULL
fibroblasts	NULL
were	NULL
transfected	NULL
with	NULL
RSV	NULL
vectors	NULL
expressing	NULL
the	NULL
collection	NULL
of	NULL
IBR	NULL
deletion	NULL
mutants	NULL
described	NULL
above	NULL
,	NULL
and	NULL
the	NULL
cellular	NULL
compartmentaliza-tion	NULL
of	NULL
the	NULL
proteins	NULL
was	NULL
determined	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
and	NULL
confocal	NULL
microscopy	NULL
.	NULL

The	NULL
primary	NULL
antibody	NULL
used	NULL
for	NULL
detection	NULL
of	NULL
the	NULL
N-terminal	NULL
deletion	NULL
mutants	NULL
was	NULL
directed	NULL
against	NULL
an	NULL
SV40	NULL
T	NULL
antigen	NULL
epitope	NULL
tag	NULL
(	NULL
49	NULL
)	NULL
introduced	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IBR	NULL
.	NULL

To	NULL
detect	NULL
the	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
,	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
MOLECULAR	NULL
CHARACTERIZATION	NULL
OF	NULL
IBR/F	NULL
(	NULL
GRF-1	NULL
)	NULL
6681	NULL
FIG	NULL
.	NULL

13	NULL
.	NULL

Cellular	NULL
localization	NULL
of	NULL
IBR	NULL
and	NULL
IBR	NULL
deletion	NULL
mutants	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
.	NULL

H32	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
IBR	NULL
expression	NULL
vectors	NULL
were	NULL
reacted	NULL
with	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
kt3	NULL
(	NULL
A	NULL
to	NULL
C	NULL
)	NULL
or	NULL
affinity-purified	NULL
rabbit	NULL
anti-r	NULL
[	NULL
BR	NULL
antibodies	NULL
(	NULL
A	NULL
and	NULL
D	NULL
to	NULL
H	NULL
)	NULL
and	NULL
postreacted	NULL
with	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
anti-mouse	NULL
IgG	NULL
or	NULL
Texas	NULL
red-conjugated	NULL
anti-rabbit	NULL
IgG	NULL
antibodies	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
A	NULL
)	NULL
RSV-IBR	NULL
;	NULL
the	NULL
field	NULL
shows	NULL
the	NULL
same	NULL
cell	NULL
reacted	NULL
with	NULL
kt3	NULL
(	NULL
arrowhead	NULL
)	NULL
and	NULL
anti-rIBR	NULL
(	NULL
arrow	NULL
)	NULL
antibodies	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RSV-AN49	NULL
;	NULL
(	NULL
C	NULL
)	NULL
RSV-AN79	NULL
;	NULL
(	NULL
D	NULL
)	NULL
RSV-AC434	NULL
;	NULL
(	NULL
E	NULL
)	NULL
RSV-AC333	NULL
;	NULL
(	NULL
F	NULL
)	NULL
RSV-AC300	NULL
;	NULL
(	NULL
G	NULL
)	NULL
RSV-AC283	NULL
;	NULL
(	NULL
H	NULL
)	NULL
RSV-AC247	NULL
.	NULL

See	NULL
Fig	NULL
.	NULL

12A	NULL
for	NULL
maps	NULL
of	NULL
the	NULL
deletion	NULL
mutants	NULL
.	NULL

diluted	NULL
anti-rIBR	NULL
was	NULL
used	NULL
as	NULL
the	NULL
primary	NULL
antibody	NULL
because	NULL
a	NULL
short	NULL
FLAG	NULL
epitope	NULL
tag	NULL
(	NULL
6	NULL
)	NULL
,	NULL
introduced	NULL
at	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
IBR	NULL
,	NULL
was	NULL
not	NULL
recognized	NULL
by	NULL
the	NULL
commercial	NULL
antibodies	NULL
.	NULL

The	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
antibodies	NULL
specifically	NULL
recognized	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
transgenic	NULL
IBR	NULL
and	NULL
that	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
anti-rIBR	NULL
,	NULL
the	NULL
endogenous	NULL
factor	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
analysis	NULL
because	NULL
of	NULL
its	NULL
lower	NULL
relative	NULL
concentration	NULL
with	NULL
respect	NULL
to	NULL
that	NULL
of	NULL
the	NULL
transgenic	NULL
proteins	NULL
(	NULL
however	NULL
,	NULL
when	NULL
the	NULL
concentration	NULL
of	NULL
anti-rIBR	NULL
antibodies	NULL
was	NULL
increased	NULL
20-fold	NULL
,	NULL
the	NULL
nontransfected	NULL
cells	NULL
showed	NULL
the	NULL
same	NULL
type	NULL
of	NULL
nuclear	NULL
fluorescence	NULL
as	NULL
the	NULL
transfected	NULL
cells	NULL
,	NULL
and	NULL
no	NULL
fluorescence	NULL
was	NULL
detected	NULL
if	NULL
the	NULL
antibodies	NULL
were	NULL
preincubated	NULL
with	NULL
rIBR	NULL
)	NULL
.	NULL

Figure	NULL
13A	NULL
shows	NULL
a	NULL
transfected	NULL
cell	NULL
expressing	NULL
transgenic	NULL
IBR	NULL
reacted	NULL
either	NULL
with	NULL
the	NULL
monoclonal	NULL
antibody	NULL
against	NULL
the	NULL
T	NULL
antigen	NULL
epitope	NULL
(	NULL
arrow-head	NULL
,	NULL
green	NULL
fluorescence	NULL
in	NULL
the	NULL
original	NULL
)	NULL
or	NULL
with	NULL
diluted	NULL
affinity-purified	NULL
anti-rIBR	NULL
(	NULL
arrow	NULL
,	NULL
red	NULL
fluorescence	NULL
in	NULL
the	NULL
original	NULL
)	NULL
.	NULL

The	NULL
two	NULL
antibodies	NULL
gave	NULL
intense	NULL
granular	NULL
nuclear	NULL
fluorescence	NULL
and	NULL
the	NULL
nucleoli	NULL
were	NULL
negative	NULL
,	NULL
whereas	NULL
the	NULL
nontransfected	NULL
cells	NULL
present	NULL
in	NULL
the	NULL
preparation	NULL
showed	NULL
no	NULL
nuclear	NULL
fluorescence	NULL
(	NULL
see	NULL
,	NULL
for	NULL
example	NULL
,	NULL
Fig	NULL
.	NULL

13B	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
residues	NULL
1	NULL
to	NULL
49	NULL
(	NULL
Fig	NULL
.	NULL

13B	NULL
)	NULL
and	NULL
1	NULL
to	NULL
79	NULL
(	NULL
Fig	NULL
.	NULL

13C	NULL
)	NULL
at	NULL
the	NULL
N	NULL
terminus	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
the	NULL
proteins	NULL
,	NULL
whereas	NULL
mutations	NULL
removing	NULL
sequences	NULL
1	NULL
to	NULL
127	NULL
and	NULL
1	NULL
to	NULL
172	NULL
resulted	NULL
in	NULL
lack	NULL
of	NULL
nuclear	NULL
fluorescence	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
even	NULL
though	NULL
control	NULL
experiments	NULL
indicated	NULL
that	NULL
the	NULL
cells	NULL
had	NULL
been	NULL
transfected	NULL
.	NULL

Since	NULL
the	NULL
AN127	NULL
and	NULL
AN172	NULL
mutants	NULL
also	NULL
failed	NULL
to	NULL
accumulate	NULL
in	NULL
the	NULL
6682	NULL
GOMEZ-CUADRADO	NULL
ET	NULL
AL	NULL
.	NULL

cytoplasm	NULL
,	NULL
the	NULL
results	NULL
indicate	NULL
that	NULL
deletion	NULL
of	NULL
residues	NULL
79	NULL
to	NULL
127	NULL
removed	NULL
the	NULL
nuclear	NULL
targeting	NULL
sequence	NULL
and/or	NULL
destabi-lized	NULL
the	NULL
proteins	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
removal	NULL
of	NULL
C-terminal	NULL
sequences	NULL
from	NULL
503	NULL
to	NULL
424	NULL
,	NULL
333	NULL
,	NULL
300	NULL
,	NULL
283	NULL
,	NULL
and	NULL
247	NULL
produced	NULL
proteins	NULL
that	NULL
localized	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

13D	NULL
to	NULL
H	NULL
)	NULL
.	NULL

These	NULL
results	NULL
argue	NULL
that	NULL
the	NULL
bipartite	NULL
NLS	NULL
,	NULL
encompassing	NULL
residues	NULL
89	NULL
to	NULL
106	NULL
,	NULL
is	NULL
necessary	NULL
for	NULL
nuclear	NULL
targeting	NULL
of	NULL
IBR	NULL
.	NULL

DISCUSSION	NULL
Cloning	NULL
of	NULL
IBR	NULL
eDNA	NULL
.	NULL

To	NULL
characterize	NULL
IBR	NULL
,	NULL
we	NULL
have	NULL
isolated	NULL
its	NULL
cDNA	NULL
from	NULL
a	NULL
chicken	NULL
erythrocyte	NULL
library	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
peIBR	NULL
encodes	NULL
IBR	NULL
.	NULL

(	NULL
i	NULL
)	NULL
The	NULL
ORF	NULL
included	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
four	NULL
peptides	NULL
obtained	NULL
from	NULL
purified	NULL
IBR	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
The	NULL
recombinant	NULL
protein	NULL
had	NULL
the	NULL
expected	NULL
size	NULL
,	NULL
gave	NULL
identical	NULL
footprints	NULL
to	NULL
IBR	NULL
on	NULL
the	NULL
A5	NULL
promoter	NULL
,	NULL
and	NULL
formed	NULL
complexes	NULL
with	NULL
DNA	NULL
having	NULL
the	NULL
same	NULL
electrophoretic	NULL
mobility	NULL
as	NULL
IBR	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
Anti-IBR	NULL
IgG	NULL
recognized	NULL
the	NULL
recombinant	NULL
protein	NULL
and	NULL
vice	NULL
versa	NULL
.	NULL

(	NULL
iv	NULL
)	NULL
The	NULL
peptides	NULL
produced	NULL
from	NULL
IBR	NULL
and	NULL
rIBR	NULL
by	NULL
cleavage	NULL
at	NULL
tryptophan	NULL
residues	NULL
had	NULL
identical	NULL
electrophoretic	NULL
mobilities	NULL
.	NULL

The	NULL
predicted	NULL
sequence	NULL
of	NULL
IBR	NULL
indicated	NULL
that	NULL
the	NULL
factor	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
family	NULL
of	NULL
evolutionarily	NULL
related	NULL
factors	NULL
that	NULL
includes	NULL
sea	NULL
urchin	NULL
P3A2	NULL
(	NULL
11	NULL
)	NULL
,	NULL
Drosophila	NULL
EWG	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
human	NULL
NRF-1/	NULL
«	NULL
a-Pal	NULL
(	NULL
18	NULL
,	NULL
88	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
IBR/F	NULL
and	NULL
NRF-1/	NULL
«	NULL
-Pal	NULL
are	NULL
99	NULL
%	NULL
identical	NULL
in	NULL
sequence	NULL
.	NULL

Relationship	NULL
of	NULL
IBR	NULL
with	NULL
IBF	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
IBR	NULL
from	NULL
erythrocytes	NULL
and	NULL
IBF	NULL
from	NULL
HD3	NULL
cells	NULL
are	NULL
products	NULL
of	NULL
the	NULL
same	NULL
gene	NULL
that	NULL
most	NULL
likely	NULL
have	NULL
the	NULL
same	NULL
amino	NULL
acid	NULL
sequence	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Partial	NULL
IBF	NULL
cDNAs	NULL
had	NULL
sequences	NULL
identical	NULL
to	NULL
IBR	NULL
cDNA	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
The	NULL
IBR	NULL
gene	NULL
is	NULL
single	NULL
copy	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
The	NULL
IBR	NULL
cDNA	NULL
hybridized	NULL
to	NULL
a	NULL
3.6	NULL
X	NULL
10°	NULL
nucleotide-long	NULL
RNA	NULL
from	NULL
erythrocytes	NULL
(	NULL
containing	NULL
IBR	NULL
but	NULL
not	NULL
IBF	NULL
)	NULL
and	NULL
HD3	NULL
cells	NULL
(	NULL
containing	NULL
IBF	NULL
but	NULL
not	NULL
IBR	NULL
)	NULL
.	NULL

(	NULL
iv	NULL
)	NULL
IBR	NULL
and	NULL
IBF	NULL
gave	NULL
identical	NULL
footprints	NULL
on	NULL
the	NULL
25	NULL
promoter	NULL
and	NULL
formed	NULL
complexes	NULL
with	NULL
DNA	NULL
having	NULL
the	NULL
same	NULL
electrophoretic	NULL
mobilities	NULL
.	NULL

(	NULL
v	NULL
)	NULL
IBF	NULL
and	NULL
NRF-1	NULL
had	NULL
the	NULL
same	NULL
electrophoretic	NULL
mobility	NULL
and	NULL
were	NULL
recognized	NULL
by	NULL
anti-IBR	NULL
and	NULL
anti-rIBR	NULL
IgG	NULL
.	NULL

(	NULL
vi	NULL
)	NULL
The	NULL
peptides	NULL
produced	NULL
by	NULL
cleavage	NULL
of	NULL
IBR	NULL
and	NULL
IBF	NULL
at	NULL
tryptophan	NULL
residues	NULL
had	NULL
the	NULL
same	NULL
electrophoretic	NULL
mobilities	NULL
.	NULL

Although	NULL
we	NULL
can	NULL
not	NULL
completely	NULL
rule	NULL
out	NULL
that	NULL
IBR	NULL
and	NULL
IBF	NULL
are	NULL
the	NULL
products	NULL
of	NULL
alternative	NULL
splicing	NULL
differing	NULL
by	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a	NULL
short	NULL
peptide	NULL
sequence	NULL
,	NULL
our	NULL
evidence	NULL
and	NULL
the	NULL
independent	NULL
cloning	NULL
of	NULL
the	NULL
human	NULL
cDNAs	NULL
for	NULL
NRF-1	NULL
(	NULL
88	NULL
)	NULL
and	NULL
«	NULL
-Pal	NULL
(	NULL
18	NULL
)	NULL
,	NULL
which	NULL
predicts	NULL
a	NULL
protein	NULL
of	NULL
the	NULL
same	NULL
size	NULL
and	NULL
essentially	NULL
the	NULL
same	NULL
sequence	NULL
as	NULL
IBR	NULL
,	NULL
do	NULL
not	NULL
support	NULL
this	NULL
possibility	NULL
.	NULL

Posttranslational	NULL
modifications	NULL
of	NULL
IBR	NULL
and	NULL
IBF	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
difference	NULL
in	NULL
apparent	NULL
molecular	NULL
mass	NULL
between	NULL
IBR	NULL
and	NULL
IBF	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
differential	NULL
glycosylation	NULL
of	NULL
these	NULL
factors	NULL
.	NULL

Purified	NULL
IBR	NULL
but	NULL
not	NULL
IBF	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
succinylated	NULL
WGA	NULL
,	NULL
which	NULL
is	NULL
specific	NULL
for	NULL
N-acetylglucosamine	NULL
(	NULL
G1-cNAc	NULL
)	NULL
residues	NULL
.	NULL

Although	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
glycosidic	NULL
linkage	NULL
was	NULL
not	NULL
determined	NULL
,	NULL
we	NULL
presume	NULL
,	NULL
by	NULL
analogy	NULL
to	NULL
other	NULL
glycosylated	NULL
intracellular	NULL
proteins	NULL
(	NULL
30	NULL
)	NULL
,	NULL
that	NULL
several	NULL
monosaccharide	NULL
moieties	NULL
are	NULL
linked	NULL
to	NULL
hydroxyl	NULL
groups	NULL
of	NULL
serine	NULL
or	NULL
threonine	NULL
residues	NULL
(	NULL
O-GlcNAc	NULL
)	NULL
.	NULL

The	NULL
IBR	NULL
glycosylated	NULL
form	NULL
appears	NULL
to	NULL
specifically	NULL
occur	NULL
in	NULL
maturing	NULL
and	NULL
mature	NULL
adult	NULL
erythrocytes	NULL
,	NULL
whereas	NULL
the	NULL
apparently	NULL
nonglycosylated	NULL
IBF	NULL
form	NULL
was	NULL
found	NULL
in	NULL
earlier	NULL
erythroid	NULL
precursors	NULL
and	NULL
other	NULL
types	NULL
of	NULL
cells	NULL
(	NULL
liver	NULL
,	NULL
brain	NULL
,	NULL
MSB-1	NULL
,	NULL
HeLa	NULL
,	NULL
NIH	NULL
3T3	NULL
,	NULL
and	NULL
L	NULL
cells	NULL
)	NULL
from	NULL
several	NULL
vertebrates	NULL
(	NULL
human	NULL
,	NULL
mouse	NULL
,	NULL
rat	NULL
,	NULL
and	NULL
chicken	NULL
)	NULL
.	NULL

O-GlcNAc	NULL
glycosylation	NULL
of	NULL
transcription	NULL
factors	NULL
has	NULL
been	NULL
extensively	NULL
documented	NULL
in	NULL
the	NULL
cases	NULL
of	NULL
Sp1	NULL
(	NULL
38	NULL
)	NULL
and	NULL
serum	NULL
response	NULL
transcription	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
(	NULL
68	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
assays	NULL
indicated	NULL
that	NULL
SRF	NULL
glycosylation	NULL
plays	NULL
no	NULL
major	NULL
role	NULL
in	NULL
DNA	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

binding	NULL
(	NULL
50	NULL
,	NULL
53	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
Sp1	NULL
,	NULL
the	NULL
nonglycosylated	NULL
recombinant	NULL
protein	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
but	NULL
showed	NULL
reduced	NULL
ability	NULL
to	NULL
transactivate	NULL
(	NULL
38	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
this	NULL
was	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
glycosylation	NULL
,	NULL
lack	NULL
of	NULL
phos-phorylation	NULL
,	NULL
or	NULL
to	NULL
an	NULL
anomalous	NULL
structure	NULL
of	NULL
the	NULL
bacterial	NULL
protein	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
IBR/F	NULL
,	NULL
glycosylation	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
alter	NULL
its	NULL
ability	NULL
to	NULL
dimerize	NULL
and	NULL
bind	NULL
to	NULL
DNA	NULL
(	NULL
this	NULL
work	NULL
)	NULL
or	NULL
to	NULL
detectably	NULL
influence	NULL
its	NULL
transcriptional	NULL
effect	NULL
on	NULL
the	NULL
A5	NULL
and	NULL
model	NULL
promoters	NULL
in	NULL
vitro	NULL
(	NULL
24a	NULL
)	NULL
.	NULL

These	NULL
results	NULL
notwithstanding	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
that	NULL
IBR	NULL
glycosylation	NULL
affects	NULL
its	NULL
transcriptional	NULL
properties	NULL
in	NULL
other	NULL
promoter	NULL
contexts	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
steric	NULL
effects	NULL
of	NULL
the	NULL
sugar	NULL
moieties	NULL
or	NULL
inhibition	NULL
of	NULL
phosphorylation	NULL
at	NULL
the	NULL
glycosylated	NULL
sites	NULL
(	NULL
41	NULL
)	NULL
could	NULL
modulate	NULL
its	NULL
interactions	NULL
with	NULL
certain	NULL
ancillary	NULL
transcription	NULL
factors	NULL
.	NULL

We	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
IBR/F	NULL
is	NULL
phosphorylated	NULL
in	NULL
vivo	NULL
and	NULL
that	NULL
CK-II	NULL
phosphorylates	NULL
in	NULL
vitro	NULL
at	NULL
least	NULL
one	NULL
of	NULL
four	NULL
putative	NULL
sites	NULL
in	NULL
the	NULL
region	NULL
extending	NULL
from	NULL
residues	NULL
37	NULL
to	NULL
67	NULL
.	NULL

With	NULL
the	NULL
caveat	NULL
that	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
could	NULL
be	NULL
unrelated	NULL
(	NULL
37	NULL
)	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
sites	NULL
occur	NULL
in	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
region	NULL
suggests	NULL
that	NULL
this	NULL
modification	NULL
may	NULL
have	NULL
a	NULL
functional	NULL
role	NULL
.	NULL

CK-II	NULL
is	NULL
an	NULL
essential	NULL
Ser/Thr	NULL
protein	NULL
kinase	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
which	NULL
is	NULL
higher	NULL
in	NULL
tissues	NULL
of	NULL
elevated	NULL
metabolic	NULL
activity	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Because	NULL
no	NULL
second	NULL
messengers	NULL
for	NULL
CK-II	NULL
are	NULL
known	NULL
(	NULL
37	NULL
)	NULL
,	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
relate	NULL
its	NULL
action	NULL
to	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Phosphorylation	NULL
by	NULL
CK-II	NULL
may	NULL
alter	NULL
the	NULL
DNA-binding	NULL
turnover	NULL
of	NULL
IBR/F	NULL
,	NULL
as	NULL
in	NULL
the	NULL
case	NULL
of	NULL
SRF	NULL
(	NULL
53	NULL
)	NULL
,	NULL
Max/Myc	NULL
,	NULL
and	NULL
Max/Max	NULL
(	NULL
8	NULL
)	NULL
,	NULL
or	NULL
modulate	NULL
its	NULL
transcriptional	NULL
activity	NULL
,	NULL
as	NULL
in	NULL
the	NULL
cases	NULL
of	NULL
vesicular	NULL
stomatitis	NULL
virus	NULL
phospho-protein	NULL
P	NULL
(	NULL
4	NULL
)	NULL
and	NULL
the	NULL
coactivator	NULL
PC4	NULL
(	NULL
23	NULL
)	NULL
.	NULL

CK-II	NULL
phosphorylation	NULL
of	NULL
sites	NULL
close	NULL
to	NULL
the	NULL
NLS	NULL
sequence	NULL
of	NULL
the	NULL
SV40	NULL
T	NULL
antigen	NULL
increase	NULL
the	NULL
rate	NULL
of	NULL
its	NULL
nuclear	NULL
translocation	NULL
(	NULL
70	NULL
)	NULL
,	NULL
and	NULL
it	NULL
is	NULL
perhaps	NULL
relevant	NULL
that	NULL
the	NULL
NLS	NULL
of	NULL
IBR/F	NULL
lies	NULL
close	NULL
to	NULL
the	NULL
CK-II	NULL
sites	NULL
.	NULL

Molecular	NULL
properties	NULL
of	NULL
IBR/F	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
IBR/F	NULL
with	NULL
the	NULL
related	NULL
factors	NULL
indicates	NULL
that	NULL
the	NULL
half	NULL
N-terminal	NULL
region	NULL
has	NULL
been	NULL
evolutionarily	NULL
conserved	NULL
between	NULL
the	NULL
vertebrate	NULL
and	NULL
invertebrate	NULL
members	NULL
of	NULL
the	NULL
family	NULL
.	NULL

This	NULL
region	NULL
harbors	NULL
a	NULL
CK-II	NULL
site	NULL
(	NULL
s	NULL
)	NULL
,	NULL
the	NULL
putative	NULL
NLS	NULL
,	NULL
and	NULL
the	NULL
DNA-binding/dimerization	NULL
domain	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
C-terminal	NULL
halves	NULL
have	NULL
only	NULL
conserved	NULL
short	NULL
patches	NULL
of	NULL
homology	NULL
.	NULL

We	NULL
have	NULL
presented	NULL
direct	NULL
evidence	NULL
that	NULL
IBR/F	NULL
associates	NULL
as	NULL
stable	NULL
dimers	NULL
in	NULL
solution	NULL
and	NULL
that	NULL
the	NULL
dimer	NULL
is	NULL
the	NULL
active	NULL
DNA-binding	NULL
species	NULL
.	NULL

Although	NULL
this	NULL
result	NULL
appears	NULL
to	NULL
be	NULL
at	NULL
variance	NULL
with	NULL
the	NULL
report	NULL
that	NULL
NRF-1	NULL
binds	NULL
to	NULL
DNA	NULL
as	NULL
a	NULL
monomer	NULL
(	NULL
88	NULL
)	NULL
,	NULL
that	NULL
conclusion	NULL
was	NULL
reached	NULL
from	NULL
the	NULL
inability	NULL
of	NULL
DNA-binding	NULL
NRF-1	NULL
deletion	NULL
mutants	NULL
to	NULL
form	NULL
heterodimers	NULL
,	NULL
an	NULL
observation	NULL
which	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
own	NULL
results	NULL
from	NULL
similar	NULL
experiments	NULL
with	NULL
IBR/F	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
failure	NULL
to	NULL
heterodimerize	NULL
under	NULL
the	NULL
conditions	NULL
assayed	NULL
is	NULL
an	NULL
expected	NULL
consequence	NULL
of	NULL
the	NULL
low	NULL
equilibrium	NULL
dissociation	NULL
constant	NULL
of	NULL
the	NULL
homodimers	NULL
.	NULL

We	NULL
have	NULL
delimited	NULL
the	NULL
outer	NULL
borders	NULL
of	NULL
the	NULL
DNA-binding/	NULL
dimerization	NULL
domain	NULL
to	NULL
the	NULL
region	NULL
extending	NULL
from	NULL
residues	NULL
127	NULL
to	NULL
283	NULL
and	NULL
shown	NULL
that	NULL
the	NULL
dimerization	NULL
domain	NULL
is	NULL
located	NULL
at	NULL
the	NULL
N-terminal	NULL
side	NULL
of	NULL
the	NULL
composite	NULL
domain	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
deletion	NULL
analysis	NULL
of	NULL
NRF-1	NULL
(	NULL
88	NULL
)	NULL
,	NULL
which	NULL
delimited	NULL
the	NULL
outer	NULL
borders	NULL
of	NULL
the	NULL
DNA-binding	NULL
domain	NULL
to	NULL
the	NULL
region	NULL
extending	NULL
from	NULL
105	NULL
to	NULL
305	NULL
,	NULL
since	NULL
mutants	NULL
lacking	NULL
residues	NULL
1	NULL
to	NULL
144	NULL
or	NULL
503	NULL
to	NULL
264	NULL
were	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
.	NULL

Taking	NULL
together	NULL
the	NULL
IBR/F	NULL
and	NULL
NRF-1	NULL
deletion	NULL
data	NULL
,	NULL
it	NULL
can	NULL
be	NULL
concluded	NULL
that	NULL
the	NULL
dimerization	NULL
domain	NULL
of	NULL
these	NULL
factors	NULL
starts	NULL
somewhere	NULL
between	NULL
residues	NULL
127	NULL
and	NULL
144	NULL
and	NULL
that	NULL
the	NULL
DNA-binding	NULL
domain	NULL
ends	NULL
somewhere	NULL
between	NULL
residues	NULL
264	NULL
and	NULL
283	NULL
.	NULL

The	NULL
DNA-binding/dimerization	NULL
domain	NULL
of	NULL
IBR/F	NULL
shows	NULL
none	NULL
of	NULL
the	NULL
typical	NULL
motifs	NULL
found	NULL
in	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
as	NULL
zinc	NULL
fingers	NULL
,	NULL
b-ZIP	NULL
,	NULL
or	NULL
bHLH	NULL
,	NULL
since	NULL
the	NULL
atypical	NULL
b-ZIP	NULL
region	NULL
proposed	NULL
for	NULL
«	NULL
-Pal	NULL
(	NULL
18	NULL
)	NULL
was	NULL
dispensable	NULL
for	NULL
both	NULL
dimerization	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
AN127	NULL
IBR	NULL
mutant	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
the	NULL
domain	NULL
with	NULL
algorithms	NULL
for	NULL
prediction	NULL
of	NULL
secondary	NULL
structure	NULL
hints	NULL
that	NULL
the	NULL
regions	NULL
most	NULL
likely	NULL
to	NULL
adopt	NULL
an	NULL
«	NULL
-helix	NULL
conformation	NULL
are	NULL
confined	NULL
to	NULL
residues	NULL
160	NULL
to	NULL
175	NULL
and	NULL
240	NULL
to	NULL
283	NULL
,	NULL
the	NULL
latter	NULL
having	NULL
some	NULL
resemblance	NULL
to	NULL
the	NULL
DNA-binding	NULL
helix	NULL
III	NULL
of	NULL
the	NULL
homeodomain	NULL
(	NULL
24	NULL
)	NULL
.	NULL

At	NULL
this	NULL
stage	NULL
,	NULL
we	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
the	NULL
homology	NULL
is	NULL
relevant	NULL
,	NULL
and	NULL
structural	NULL
work	NULL
will	NULL
be	NULL
needed	NULL
to	NULL
clarify	NULL
this	NULL
issue	NULL
.	NULL

Transcription	NULL
factors	NULL
very	NULL
often	NULL
exist	NULL
as	NULL
families	NULL
of	NULL
related	NULL
members	NULL
that	NULL
recognize	NULL
identical	NULL
or	NULL
similar	NULL
DNA	NULL
sequences	NULL
.	NULL

The	NULL
families	NULL
may	NULL
originate	NULL
from	NULL
the	NULL
same	NULL
gene	NULL
by	NULL
alternative	NULL
splicing	NULL
or	NULL
alternative	NULL
polyadenylation	NULL
,	NULL
for	NULL
example	NULL
,	NULL
ATF/CREB	NULL
(	NULL
28	NULL
)	NULL
and	NULL
E12/E47	NULL
(	NULL
83	NULL
)	NULL
,	NULL
and/or	NULL
from	NULL
related	NULL
genes	NULL
coding	NULL
for	NULL
partially	NULL
homologous	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
NF-1	NULL
(	NULL
76	NULL
)	NULL
,	NULL
GATA	NULL
(	NULL
93	NULL
)	NULL
,	NULL
and	NULL
Sp1	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Family	NULL
members	NULL
can	NULL
usually	NULL
be	NULL
distinguished	NULL
by	NULL
their	NULL
different	NULL
mRNA	NULL
sizes	NULL
or	NULL
by	NULL
the	NULL
distinct	NULL
electrophoretic	NULL
mobilities	NULL
of	NULL
their	NULL
complexes	NULL
with	NULL
DNA	NULL
.	NULL

Using	NULL
a	NULL
variety	NULL
of	NULL
nuclear	NULL
extracts	NULL
,	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
detect	NULL
specific	NULL
DNA	NULL
complexes	NULL
other	NULL
than	NULL
those	NULL
made	NULL
by	NULL
IBR/F	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
other	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
work	NULL
and	NULL
the	NULL
lethal	NULL
phenotype	NULL
of	NULL
the	NULL
ewg	NULL
null	NULL
mutants	NULL
(	NULL
17	NULL
)	NULL
,	NULL
raise	NULL
the	NULL
interesting	NULL
possibility	NULL
that	NULL
,	NULL
in	NULL
a	NULL
given	NULL
species	NULL
,	NULL
there	NULL
might	NULL
be	NULL
no	NULL
other	NULL
highly	NULL
related	NULL
family	NULL
members	NULL
acting	NULL
at	NULL
the	NULL
same	NULL
sequences	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
high	NULL
stability	NULL
of	NULL
the	NULL
IBR/F	NULL
homodimer	NULL
makes	NULL
the	NULL
likelihood	NULL
of	NULL
subunit	NULL
exchange	NULL
with	NULL
possible	NULL
partners	NULL
somehow	NULL
remote	NULL
,	NULL
thus	NULL
further	NULL
restricting	NULL
,	NULL
although	NULL
not	NULL
eliminating	NULL
,	NULL
another	NULL
potential	NULL
source	NULL
of	NULL
functional	NULL
diversity	NULL
.	NULL

Possible	NULL
roles	NULL
of	NULL
IBR/F	NULL
.	NULL

To	NULL
gain	NULL
wider	NULL
insight	NULL
into	NULL
the	NULL
genes	NULL
that	NULL
might	NULL
be	NULL
regulated	NULL
by	NULL
IBR/F	NULL
,	NULL
a	NULL
homology	NULL
search	NULL
of	NULL
the	NULL
GenBank	NULL
database	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
alternating	NULL
purine-pyrimidine	NULL
IBR/F	NULL
consensus	NULL
and	NULL
the	NULL
restrictive	NULL
proviso	NULL
that	NULL
the	NULL
sequence	NULL
should	NULL
appear	NULL
no	NULL
farther	NULL
than	NULL
300	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

Although	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
IBR/F	NULL
cognate	NULL
sequence	NULL
is	NULL
not	NULL
a	NULL
proof	NULL
of	NULL
its	NULL
activity	NULL
,	NULL
we	NULL
noticed	NULL
in	NULL
a	NULL
significant	NULL
number	NULL
of	NULL
cases	NULL
that	NULL
the	NULL
sequence	NULL
and	NULL
its	NULL
location	NULL
have	NULL
been	NULL
evolutionarily	NULL
conserved	NULL
,	NULL
arguing	NULL
for	NULL
its	NULL
functionality	NULL
.	NULL

This	NULL
analysis	NULL
revealed	NULL
a	NULL
set	NULL
of	NULL
88	NULL
genes	NULL
(	NULL
the	NULL
list	NULL
of	NULL
which	NULL
,	NULL
with	NULL
the	NULL
locations	NULL
of	NULL
the	NULL
putative	NULL
IBR/F	NULL
sites	NULL
,	NULL
is	NULL
available	NULL
upon	NULL
request	NULL
)	NULL
,	NULL
some	NULL
of	NULL
which	NULL
are	NULL
known	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
IBR/NRF-1/	NULL
«	NULL
-Pal	NULL
(	NULL
9	NULL
,	NULL
13	NULL
,	NULL
19	NULL
,	NULL
22	NULL
,	NULL
35	NULL
,	NULL
39	NULL
,	NULL
75	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
palindrome	NULL
TGCGCATGCGCA	NULL
was	NULL
present	NULL
in	NULL
only	NULL
two	NULL
of	NULL
the	NULL
scored	NULL
genes	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
whereas	NULL
it	NULL
did	NULL
not	NULL
occur	NULL
in	NULL
the	NULL
genes	NULL
known	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
this	NULL
family	NULL
of	NULL
factors	NULL
(	NULL
9	NULL
,	NULL
13	NULL
,	NULL
19	NULL
,	NULL
22	NULL
,	NULL
25	NULL
,	NULL
35	NULL
,	NULL
39	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
high-affinity	NULL
sites	NULL
do	NULL
depart	NULL
from	NULL
the	NULL
perfect	NULL
palindrome	NULL
,	NULL
in	NULL
accordance	NULL
with	NULL
our	NULL
binding-site	NULL
selection	NULL
data	NULL
.	NULL

With	NULL
a	NULL
few	NULL
exceptions	NULL
,	NULL
the	NULL
overwhelming	NULL
majority	NULL
of	NULL
scored	NULL
genes	NULL
were	NULL
TATA-less	NULL
genes	NULL
coding	NULL
for	NULL
housekeeping	NULL
enzymatic	NULL
activities	NULL
expressed	NULL
in	NULL
most	NULL
tissues	NULL
,	NULL
although	NULL
at	NULL
various	NULL
levels	NULL
.	NULL

Examples	NULL
include	NULL
genes	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
(	NULL
insulin-like	NULL
growth	NULL
factor	NULL
receptor	NULL
I	NULL
[	NULL
14	NULL
]	NULL
,	NULL
c-Ha-ras	NULL
[	NULL
48	NULL
]	NULL
,	NULL
Ga	NULL
,	NULL
[	NULL
47	NULL
]	NULL
,	NULL
Ca**	NULL
-binding	NULL
proteins	NULL
[	NULL
3	NULL
,	NULL
29	NULL
,	NULL
43	NULL
]	NULL
,	NULL
the	NULL
regulatory	NULL
subunit	NULL
of	NULL
phosphatase	NULL
2A	NULL
[	NULL
55	NULL
]	NULL
,	NULL
and	NULL
cyclic	NULL
nucleotide	NULL
phosphodiesterase	NULL
[	NULL
46	NULL
]	NULL
)	NULL
,	NULL
mitochondrial	NULL
energy	NULL
transduction	NULL
(	NULL
cytochrome	NULL
¢	NULL
and	NULL
several	NULL
subunits	NULL
of	NULL
cyto-chrome	NULL
c	NULL
oxidase	NULL
[	NULL
13	NULL
,	NULL
19	NULL
,	NULL
88	NULL
]	NULL
,	NULL
5-aminolevulinate	NULL
synthase	NULL
[	NULL
5-ALAS	NULL
]	NULL
[	NULL
9	NULL
]	NULL
,	NULL
and	NULL
subunit	NULL
y	NULL
of	NULL
ATPase/synthase	NULL
[	NULL
13	NULL
,	NULL
54	NULL
]	NULL
)	NULL
,	NULL
protein	NULL
metabolism	NULL
(	NULL
subunits	NULL
«	NULL
and	NULL
B	NULL
of	NULL
the	NULL
translation	NULL
initiation	NULL
factor	NULL
eIF-2	NULL
[	NULL
13	NULL
,	NULL
18	NULL
,	NULL
39	NULL
]	NULL
,	NULL
the	NULL
$	NULL
16	NULL
ribosomal	NULL
protein	NULL
[	NULL
89	NULL
]	NULL
,	NULL
disulfide	NULL
isomerase	NULL
[	NULL
86	NULL
]	NULL
,	NULL
and	NULL
proteases	NULL
specific	NULL
for	NULL
short-lived	NULL
or	NULL
defective	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
the	NULL
proteasome	NULL
HC3	NULL
[	NULL
84	NULL
]	NULL
and	NULL
the	NULL
calcium-activated	NULL
neutral	NULL
protease	NULL
[	NULL
31	NULL
]	NULL
)	NULL
,	NULL
lipid	NULL
metabolism	NULL
(	NULL
subunit	NULL
Ela	NULL
of	NULL
the	NULL
mitochondrial	NULL
pyruvate	NULL
dehydrogenase	NULL
[	NULL
52	NULL
]	NULL
,	NULL
sterol	NULL
and	NULL
androgen	NULL
carrier	NULL
proteins	NULL
[	NULL
65	NULL
,	NULL
80	NULL
]	NULL
,	NULL
lipoprotein	NULL
receptor	NULL
[	NULL
22	NULL
]	NULL
,	NULL
acetyl	NULL
coenzyme	NULL
A	NULL
binding	NULL
protein	NULL
[	NULL
51	NULL
]	NULL
,	NULL
carbonyl	NULL
MOLECULAR	NULL
CHARACTERIZATION	NULL
OF	NULL
IBR/F	NULL
(	NULL
GRF-1	NULL
)	NULL
6683	NULL
reductase	NULL
[	NULL
20	NULL
]	NULL
,	NULL
and	NULL
alcohol	NULL
dehydrogenase	NULL
[	NULL
7	NULL
]	NULL
)	NULL
,	NULL
and	NULL
nucleic	NULL
acid	NULL
metabolism	NULL
(	NULL
DNA	NULL
polymerase	NULL
a	NULL
[	NULL
63	NULL
]	NULL
,	NULL
the	NULL
14.5-kDa	NULL
subunit	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
[	NULL
1	NULL
]	NULL
,	NULL
topoisomerase	NULL
I	NULL
[	NULL
45	NULL
]	NULL
,	NULL
mitochondrial	NULL
transcription	NULL
factor	NULL
A	NULL
[	NULL
mTFA	NULL
]	NULL
[	NULL
61	NULL
]	NULL
,	NULL
inosine-5'-monophosphate	NULL
dehydrogenase	NULL
type	NULL
II	NULL
[	NULL
94	NULL
]	NULL
,	NULL
hypoxanthine	NULL
phosphoribosyltransferase	NULL
[	NULL
56	NULL
]	NULL
,	NULL
glutamine	NULL
phosphoribosylpy-rophosphate	NULL
amidotransferase	NULL
[	NULL
GPAT	NULL
]	NULL
and	NULL
5'-phosphoribo-sylaminoimidazole	NULL
carboxylase	NULL
[	NULL
AIRC	NULL
]	NULL
[	NULL
10	NULL
]	NULL
,	NULL
GADD1S3	NULL
[	NULL
62	NULL
]	NULL
,	NULL
ERCC2	NULL
[	NULL
90	NULL
]	NULL
,	NULL
RNase	NULL
MRP	NULL
[	NULL
12	NULL
,	NULL
58	NULL
]	NULL
,	NULL
UZaf-binding	NULL
protein	NULL
[	NULL
32	NULL
]	NULL
,	NULL
retinoblastoma	NULL
[	NULL
85	NULL
]	NULL
,	NULL
prohibitin	NULL
[	NULL
60	NULL
]	NULL
,	NULL
cyclin	NULL
B1	NULL
[	NULL
66	NULL
]	NULL
,	NULL
and	NULL
RCCI	NULL
[	NULL
21	NULL
]	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
housekeeping	NULL
functions	NULL
,	NULL
IBR/F	NULL
may	NULL
also	NULL
regulate	NULL
tissue-specific	NULL
genes	NULL
in	NULL
certain	NULL
types	NULL
of	NULL
cells	NULL
,	NULL
including	NULL
h5	NULL
(	NULL
25	NULL
)	NULL
,	NULL
e-myb	NULL
(	NULL
26	NULL
,	NULL
40	NULL
)	NULL
,	NULL
preproenkephalin	NULL
A	NULL
(	NULL
87	NULL
)	NULL
,	NULL
synapsin	NULL
I	NULL
(	NULL
77	NULL
)	NULL
,	NULL
acetylcholine	NULL
receptor	NULL
(	NULL
33	NULL
)	NULL
,	NULL
and	NULL
slow	NULL
sarcoplasmic	NULL
reticulum	NULL
Ca-dependent	NULL
ATPase	NULL
(	NULL
71	NULL
)	NULL
.	NULL

Although	NULL
more	NULL
functional	NULL
data	NULL
are	NULL
needed	NULL
,	NULL
it	NULL
appears	NULL
possible	NULL
that	NULL
IBR/F	NULL
and	NULL
related	NULL
factors	NULL
are	NULL
primarily	NULL
involved	NULL
in	NULL
the	NULL
coregulation	NULL
of	NULL
networks	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
growth-related	NULL
functions	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
unify	NULL
the	NULL
present	NULL
nomencla-tures	NULL
,	NULL
we	NULL
would	NULL
like	NULL
to	NULL
propose	NULL
the	NULL
more	NULL
general	NULL
term	NULL
GRF-1	NULL
(	NULL
growth	NULL
regulatory	NULL
factor	NULL
1	NULL
)	NULL
to	NULL
describe	NULL
IBR/F	NULL
and	NULL
related	NULL
factors	NULL
because	NULL
it	NULL
appears	NULL
to	NULL
portray	NULL
their	NULL
functions	NULL
more	NULL
appropriately	NULL
than	NULL
the	NULL
current	NULL
particular	NULL
definitions	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
K.	NULL
Stone	NULL
and	NULL
K.	NULL
Williams	NULL
for	NULL
peptide	NULL
sequence	NULL
determination	NULL
,	NULL
F.	NULL
Calzone	NULL
for	NULL
kindly	NULL
providing	NULL
a	NULL
chicken	NULL
P3AZ	NULL
PCR	NULL
probe	NULL
,	NULL
J.	NULL
Guay	NULL
for	NULL
the	NULL
MAP	NULL
kinase	NULL
tests	NULL
,	NULL
J.	NULL
Renaud	NULL
for	NULL
supershift	NULL
analysis	NULL
,	NULL
C.	NULL
Chamberlain	NULL
for	NULL
confocal	NULL
microscopy	NULL
,	NULL
and	NULL
M.	NULL
Lambert	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
.	NULL

A.G.-C.	NULL
is	NULL
a	NULL
graduate	NULL
student	NULL
of	NULL
the	NULL
C.LD	NULL
.	NULL

(	NULL
C.S.L.C	NULL
.	NULL

of	NULL
Barcelona	NULL
)	NULL
and	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
predoctoral	NULL
studentship	NULL
from	NULL
the	NULL
Generalitat	NULL
de	NULL
Catalunya	NULL
(	NULL
Formacid	NULL
d'Investigadors	NULL
)	NULL
.	NULL

M.M	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
studentship	NULL
of	NULL
the	NULL
Government	NULL
of	NULL
Quebec	NULL
(	NULL
Programme	NULL
de	NULL
Bourses	NULL
d'Excellence	NULL
)	NULL
.	NULL

The	NULL
research	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Acker	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Wintzerith	NULL
,	NULL
M.	NULL
Vigneron	NULL
,	NULL
and	NULL
C.	NULL
Kedinger	NULL
.	NULL

1993	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
14.5	NULL
kDa	NULL
subunit	NULL
of	NULL
human	NULL
RNA	NULL
polymerase	NULL
II	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5345-5350	NULL
.	NULL

2	NULL
.	NULL

Affolter	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Coté	NULL
,	NULL
J.	NULL
Renaud	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
histone	NULL
and	NULL
gene	NULL
expression	NULL
during	NULL
differentiation	NULL
of	NULL
chicken	NULL
erythroid	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:3663-3672	NULL
.	NULL

3	NULL
.	NULL

Banville	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Y.	NULL
Boie	NULL
.	NULL

1989	NULL
.	NULL

Retroviral	NULL
long	NULL
terminal	NULL
repeat	NULL
is	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
tumor-associated	NULL
calcium-binding	NULL
protein	NULL
oncomodulin	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

207:481-490	NULL
.	NULL

4	NULL
.	NULL

Barik	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
A.	NULL
K.	NULL
Banerjee	NULL
.	NULL

1992	NULL
.	NULL

Phosphorylation	NULL
by	NULL
cellular	NULL
casein	NULL
kinase	NULL
II	NULL
is	NULL
essential	NULL
for	NULL
transcriptional	NULL
activity	NULL
of	NULL
vesicular	NULL
stomatitis	NULL
virus	NULL
phos-phoprotein	NULL
P.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:6570-6574	NULL
.	NULL

5	NULL
.	NULL

Bates	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
J.	NULL
O.	NULL
Thomas	NULL
.	NULL

1981	NULL
.	NULL

Histones	NULL
H1	NULL
and	NULL
HS	NULL
:	NULL
one	NULL
or	NULL
two	NULL
molecules	NULL
per	NULL
nucleosome	NULL
?	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

9:5883-5894	NULL
.	NULL

6	NULL
.	NULL

Blanar	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
cloning	NULL
:	NULL
identification	NULL
of	NULL
a	NULL
helix-loop-helix	NULL
zipper	NULL
protein	NULL
that	NULL
interacts	NULL
with	NULL
c-Fos	NULL
.	NULL

Science	NULL
256:1014-1018	NULL
.	NULL

7	NULL
.	NULL

Bodmer	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
Ashburner	NULL
.	NULL

1984	NULL
.	NULL

Conservation	NULL
and	NULL
change	NULL
in	NULL
the	NULL
DNA	NULL
sequences	NULL
coding	NULL
for	NULL
alcohol	NULL
dehydrogenase	NULL
in	NULL
sibling	NULL
species	NULL
of	NULL
Drosophila	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
309:425-430	NULL
.	NULL

8	NULL
.	NULL

Bousset	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Henriksson	NULL
,	NULL
J.	NULL
M.	NULL
Luscher-Firzlaff	NULL
,	NULL
D.	NULL
W.	NULL
Litchfield	NULL
,	NULL
and	NULL
B.	NULL
Luscher	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
casein	NULL
kinase	NULL
II	NULL
phosphorylation	NULL
sites	NULL
in	NULL
Max	NULL
:	NULL
effects	NULL
on	NULL
DNA-binding	NULL
kinetics	NULL
of	NULL
homo-	NULL
and	NULL
Myc/Max	NULL
heterodimers	NULL
.	NULL

Oncogene	NULL
8:3211-3220	NULL
.	NULL

9	NULL
.	NULL

Braidotti	NULL
,	NULL
G.	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
Borthwick	NULL
,	NULL
and	NULL
B.	NULL
K.	NULL
May	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
gene	NULL
for	NULL
5-aminolevulinate	NULL
synthase	NULL
from	NULL
rat	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:1109-1117	NULL
.	NULL

10	NULL
.	NULL

Brayton	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Z.	NULL
Chen	NULL
,	NULL
G.	NULL
Zhou	NULL
,	NULL
P.	NULL
L.	NULL
Nagy	NULL
,	NULL
A.	NULL
Gavalas	NULL
,	NULL
J.	NULL
M.	NULL
Trent	NULL
,	NULL
L.	NULL
L.	NULL
Deaven	NULL
,	NULL
J.	NULL
E.	NULL
Dixon	NULL
,	NULL
and	NULL
H.	NULL
Zalkin	NULL
.	NULL

1994	NULL
.	NULL

Two	NULL
genes	NULL
for	NULL
de	NULL
novo	NULL
purine	NULL
nucleotide	NULL
synthesis	NULL
on	NULL
human	NULL
chromosome	NULL
4	NULL
are	NULL
closely	NULL
linked	NULL
and	NULL
diver-gently	NULL
transcribed	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:5313-5321	NULL
.	NULL

11	NULL
.	NULL

Calzone	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
C.	NULL
Hoog	NULL
,	NULL
D.	NULL
B.	NULL
Teplow	NULL
,	NULL
A.	NULL
E.	NULL
Cutting	NULL
,	NULL
R.	NULL
W.	NULL
Zeller	NULL
,	NULL
R.	NULL
J.	NULL
Britten	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Davidson	NULL
.	NULL

1991	NULL
.	NULL

Gene	NULL
regulatory	NULL
factors	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
embryo	NULL
.	NULL

I.	NULL
Purification	NULL
by	NULL
affinity	NULL
chromatography	NULL
and	NULL
cloning	NULL
of	NULL
P3A2	NULL
,	NULL
a	NULL
novel	NULL
DNA-binding	NULL
protein	NULL
.	NULL

Development	NULL
112:335-350	NULL
.	NULL

6684	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

GOMEZ-CUADRADO	NULL
ET	NULL
AL	NULL
.	NULL

Chang	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Clayton	NULL
.	NULL

1989	NULL
.	NULL

Mouse	NULL
RNase	NULL
MRP	NULL
RNA	NULL
is	NULL
encoded	NULL
by	NULL
a	NULL
nuclear	NULL
gene	NULL
and	NULL
contains	NULL
a	NULL
decamer	NULL
sequence	NULL
complementary	NULL
to	NULL
a	NULL
conserved	NULL
region	NULL
of	NULL
mitochondrial	NULL
RNA	NULL
substrate	NULL
.	NULL

Cell	NULL
56:131-139	NULL
.	NULL

Chau	NULL
,	NULL
C.	NULL
M.	NULL
A.	NULL
,	NULL
M.	NULL
J.	NULL
Evans	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Scarpulla	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
respiratory	NULL
factor	NULL
1	NULL
activation	NULL
sites	NULL
in	NULL
genes	NULL
encoding	NULL
the	NULL
y-subunit	NULL
of	NULL
ATP	NULL
synthase	NULL
,	NULL
eukaryotic	NULL
initiation	NULL
factor	NULL
24	NULL
,	NULL
and	NULL
tyrosine	NULL
aminotransferase	NULL
:	NULL
specific	NULL
interaction	NULL
of	NULL
purified	NULL
NRF-1	NULL
with	NULL
multiple	NULL
target	NULL
genes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
:	NULL
6999-7006	NULL
.	NULL

Cooke	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
L.	NULL
A.	NULL
Bankert	NULL
,	NULL
C.	NULL
T.	NULL
Roberts	NULL
,	NULL
D.	NULL
Leroith	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Casella	NULL
.	NULL

1991	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
human	NULL
type-I	NULL
insulin-like	NULL
growth	NULL
factor	NULL
receptor	NULL
promoter	NULL
region	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

177:1113-1120	NULL
.	NULL

Coté	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1993	NULL
.	NULL

Primers	NULL
for	NULL
mitochondrial	NULL
DNA	NULL
replication	NULL
generated	NULL
by	NULL
endonuclease	NULL
G.	NULL
Science	NULL
261:765-769	NULL
.	NULL

Crimmins	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
D.	NULL
W.	NULL
McCourt	NULL
,	NULL
R.	NULL
S.	NULL
Thoma	NULL
,	NULL
M.	NULL
G.	NULL
Scott	NULL
,	NULL
K.	NULL
Macke	NULL
,	NULL
and	NULL
B.	NULL
D.	NULL
Schwartz	NULL
.	NULL

1990	NULL
.	NULL

In	NULL
situ	NULL
chemical	NULL
cleavage	NULL
of	NULL
proteins	NULL
immobilized	NULL
to	NULL
glass-fiber	NULL
and	NULL
polyvinylidenedifluoride	NULL
membranes	NULL
:	NULL
cleavage	NULL
at	NULL
tryptophan	NULL
residues	NULL
with	NULL
2-	NULL
(	NULL
2'-nitrophenylsulfeny	NULL
!	NULL
)	NULL

-3-methyl-3'-bromoindolenine	NULL
to	NULL
obtain	NULL
internal	NULL
amino	NULL
acid	NULL
sequence	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

187:27-38	NULL
.	NULL

DeSimone	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
K.	NULL
White	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Drosophile	NULL
erect	NULL
wing	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
important	NULL
for	NULL
both	NULL
neuronal	NULL
and	NULL
muscle	NULL
development	NULL
,	NULL
encodes	NULL
a	NULL
protein	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
sea	NULL
urchin	NULL
P3A2	NULL
DNA	NULL
binding	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3641-3649	NULL
.	NULL

Efiok	NULL
,	NULL
B.	NULL
J.	NULL
S.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Chiorini	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Safer	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
key	NULL
transcription	NULL
factor	NULL
for	NULL
eukaryotic	NULL
initiation	NULL
factor-2	NULL
«	NULL
is	NULL
strongly	NULL
homologous	NULL
to	NULL
developmental	NULL
transcription	NULL
factors	NULL
and	NULL
may	NULL
link	NULL
metabolic	NULL
genes	NULL
to	NULL
cellular	NULL
growth	NULL
and	NULL
development	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:18921-18939	NULL
.	NULL

Evans	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Scarpulla	NULL
.	NULL

1990	NULL
.	NULL

NRF-1	NULL
:	NULL
a	NULL
trans-activator	NULL
of	NULL
nuclear-encoded	NULL
respiratory	NULL
genes	NULL
in	NULL
animal	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1023-1034	NULL
.	NULL

Forrest	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
S.	NULL
Akman	NULL
,	NULL
J.	NULL
Doroshow	NULL
,	NULL
H.	NULL
Rivera	NULL
,	NULL
and	NULL
W.	NULL
D.	NULL
Kaplan	NULL
.	NULL

1991	NULL
.	NULL

Genomic	NULL
sequence	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
cloned	NULL
human	NULL
carbonyl	NULL
reductase	NULL
gene	NULL
with	NULL
daunorubicin	NULL
reductase	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

40:502-507	NULL
.	NULL

Furuno	NULL
,	NULL
N.	NULL
,	NULL
K.	NULL
Nakagawa	NULL
,	NULL
U.	NULL
Eguchi	NULL
,	NULL
M.	NULL
Ohtsubo	NULL
,	NULL
T.	NULL
Nishimoto	NULL
,	NULL
E.	NULL
Soeda	NULL
,	NULL
and	NULL
M.	NULL
O.	NULL
Ohtubo	NULL
.	NULL

1991	NULL
.	NULL

Complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
RCC1	NULL
gene	NULL
involved	NULL
in	NULL
coupling	NULL
between	NULL
DNA	NULL
replication	NULL
and	NULL
mitosis	NULL
.	NULL

Genomics	NULL
11:459-461	NULL
.	NULL

Gaeta	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
I.	NULL
Borthwick	NULL
,	NULL
and	NULL
K.	NULL
K.	NULL
Stanley	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
o-2MR/LRP	NULL
gene	NULL
contains	NULL
an	NULL
enhancer-like	NULL
cluster	NULL
of	NULL
SP1	NULL
binding-sites	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1219:307-313	NULL
.	NULL

Ge	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Zhao	NULL
,	NULL
B.	NULL
T.	NULL
Chait	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1994	NULL
.	NULL

Phosphorylation	NULL
negatively	NULL
regulates	NULL
the	NULL
function	NULL
of	NULL
coactivator	NULL
PC4	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:12691-12695	NULL
.	NULL

Gehring	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
homeobox	NULL
in	NULL
perspective	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17	NULL
:	NULL
277-280	NULL
.	NULL

242.Gomez-Cuadrado	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Batchvarova	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

Unpublished	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36.	NULL
data	NULL
.	NULL

Gomez-Cuadrado	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Rousseau	NULL
,	NULL
J.	NULL
Renaud	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1992	NULL
.	NULL

Repression	NULL
of	NULL
the	NULL
H5	NULL
histone	NULL
gene	NULL
by	NULL
a	NULL
factor	NULL
from	NULL
erythrocytes	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
region	NULL
of	NULL
transcription	NULL
initiation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:1857-1866	NULL
.	NULL

Graf	NULL
,	NULL
T.	NULL
1992	NULL
.	NULL

Myb	NULL
:	NULL
a	NULL
transcriptional	NULL
activator	NULL
linking	NULL
proliferation	NULL
and	NULL
differentiation	NULL
in	NULL
hematopoictic	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2249-255	NULL
.	NULL

Hagen	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Muller	NULL
,	NULL
M.	NULL
Beato	NULL
,	NULL
and	NULL
G.	NULL
Suske	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
by	NULL
recognition	NULL
site	NULL
screening	NULL
of	NULL
two	NULL
novel	NULL
GT	NULL
box	NULL
binding	NULL
proteins	NULL
:	NULL
a	NULL
family	NULL
of	NULL
SP1	NULL
related	NULL
genes	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:5519-5525	NULL
.	NULL

Hai	NULL
,	NULL
T.	NULL
,	NULL
F.	NULL
Lin	NULL
,	NULL
W.	NULL
J.	NULL
Coukos	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1989	NULL
.	NULL

Transcription	NULL
factor	NULL
ATF	NULL
cDNA	NULL
clones	NULL
:	NULL
an	NULL
extensive	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
able	NULL
to	NULL
selectively	NULL
form	NULL
DNA-binding	NULL
heterodimers	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:2083-2090	NULL
.	NULL

Hardin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
C.	NULL
D.	NULL
Carpenter	NULL
,	NULL
P.	NULL
E.	NULL
Hardin	NULL
,	NULL
A.	NULL
M.	NULL
Bruskin	NULL
,	NULL
and	NULL
W.	NULL
H.	NULL
Klein	NULL
.	NULL

1985	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
Spec	NULL
?	NULL

gene	NULL
encoding	NULL
a	NULL
major	NULL
calcium-binding	NULL
protein	NULL
in	NULL
the	NULL
embryonic	NULL
ectoderm	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
Strongylocentrotus	NULL
purpuratus	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

186:243-255	NULL
.	NULL

Hart	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
R.	NULL
S.	NULL
Haltiwanger	NULL
,	NULL
G.	NULL
D.	NULL
Holt	NULL
,	NULL
and	NULL
W.	NULL
G.	NULL
Kelly	NULL
.	NULL

1989	NULL
.	NULL

Glycosylation	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58:841-874	NULL
.	NULL

Hata	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Ohno	NULL
,	NULL
Y.	NULL
Akita	NULL
,	NULL
and	NULL
K.	NULL
Suzuki	NULL
.	NULL

1989	NULL
.	NULL

Tandemly	NULL
reiterated	NULL
negative	NULL
enhancer-like	NULL
elements	NULL
regulate	NULL
transcription	NULL
of	NULL
a	NULL
human	NULL
gene	NULL
for	NULL
large	NULL
subunit	NULL
of	NULL
calcium-dependent	NULL
protease	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:6404-6411	NULL
.	NULL

Hayashizaki	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Shibata	NULL
,	NULL
S.	NULL
Hirotsune	NULL
,	NULL
H.	NULL
Sugino	NULL
,	NULL
Y.	NULL
Okazaki	NULL
,	NULL
N.	NULL
Sasaki	NULL
,	NULL
K.	NULL
Hirose	NULL
,	NULL
H.	NULL
Imoto	NULL
,	NULL
H.	NULL
Okuizumi	NULL
,	NULL
M.	NULL
Muramatsu	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
imprinted	NULL
UzZaf	NULL
binding	NULL
protein	NULL
related	NULL
sequence	NULL
on	NULL
mouse	NULL
chromosome	NULL
11	NULL
using	NULL
the	NULL
RLGS	NULL
method	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

6:33-40	NULL
.	NULL

Hess	NULL
,	NULL
N.	NULL
,	NULL
B.	NULL
Merz	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Gundelfinger	NULL
.	NULL

1994	NULL
.	NULL

Acetylcholine	NULL
receptors	NULL
of	NULL
the	NULL
Drosophila	NULL
brain	NULL
:	NULL
a	NULL
900	NULL
bp	NULL
promoter	NULL
fragment	NULL
contains	NULL
the	NULL
essential	NULL
information	NULL
for	NULL
specific	NULL
expression	NULL
of	NULL
the	NULL
ard	NULL
gene	NULL
in	NULL
vivo	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

346	NULL
:	NULL
135-140	NULL
.	NULL

Howe	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
S.	NULL
J.	NULL
Leevers	NULL
,	NULL
N.	NULL
Gomez	NULL
,	NULL
S.	NULL
Nakielny	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Marshall	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
by	NULL
the	NULL
protein	NULL
kinase	NULL
raf	NULL
.	NULL

Cell	NULL
71:335-342	NULL
.	NULL

Humbelin	NULL
,	NULL
M.	NULL
,	NULL
B	NULL
.	NULL

Safer	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Chiorini	NULL
,	NULL
J.	NULL
W.	NULL
B.	NULL
Hershey	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Cohen	NULL
.	NULL

1989	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
and	NULL
flanking	NULL
regions	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
human	NULL
protein-synthesis-initiation	NULL
factor	NULL
2	NULL
«	NULL
.	NULL

Gene	NULL
81:315-324	NULL
.	NULL

Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
transcription	NULL
by	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
70:375-387	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Issinger	NULL
,	NULL
0.-G.	NULL
1993	NULL
.	NULL

Casein	NULL
kinases	NULL
:	NULL
pleiotropic	NULL
mediators	NULL
of	NULL
cellular	NULL
regulation	NULL
.	NULL

Pharmacol	NULL
.	NULL

Ther	NULL
.	NULL

59:1-30	NULL
.	NULL

Jackson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1988	NULL
.	NULL

O-glycosylation	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
factors	NULL
:	NULL
implication	NULL
for	NULL
mechanisms	NULL
of	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Cell	NULL
55:125-133	NULL
.	NULL

Jacob	NULL
,	NULL
W.	NULL
F.	NULL
,	NULL
T.	NULL
A.	NULL
Silverman	NULL
,	NULL
R.	NULL
B.	NULL
Cohen	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Safer	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel-transcription	NULL
factor	NULL
participating	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
eukaryotic	NULL
initiation	NULL
factor	NULL
2	NULL
«	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:20372-20384	NULL
.	NULL

Jacobs	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Gorse	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Westin	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
second	NULL
promoter	NULL
in	NULL
the	NULL
human	NULL
c-myb	NULL
proto-oncogene	NULL
.	NULL

Oncogene	NULL
9:227-235	NULL
.	NULL

Kearse	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hart	NULL
.	NULL

1991	NULL
.	NULL

Lymphocyte	NULL
activation	NULL
induces	NULL
rapid	NULL
changes	NULL
in	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
glycoproteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:1701-1705	NULL
.	NULL

Kho	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
H.	NULL
Zarbl	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
efficient	NULL
protocol	NULL
for	NULL
sequencing	NULL
plasmid	NULL
DNA	NULL
.	NULL

Biotechniques	NULL
12:228-230	NULL
.	NULL

Koller	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Schnyder	NULL
,	NULL
and	NULL
E.	NULL
E.	NULL
Strehler	NULL
.	NULL

1990	NULL
.	NULL

Structural	NULL
organization	NULL
of	NULL
the	NULL
human	NULL
CaMIF	NULL
calmodulin	NULL
gene	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1087:180-189	NULL
.	NULL

Kozak	NULL
,	NULL
M.	NULL
1980	NULL
.	NULL

Evaluation	NULL
of	NULL
the	NULL
scanning	NULL
model	NULL
for	NULL
initiation	NULL
of	NULL
protein	NULL
synthesis	NULL
in	NULL
eukaryotes	NULL
.	NULL

Cell	NULL
22:7-8	NULL
.	NULL

Kunze	NULL
,	NULL
N.	NULL
,	NULL
G.	NULL
C.	NULL
Yang	NULL
,	NULL
M.	NULL
Dolberg	NULL
,	NULL
R.	NULL
Sundarp	NULL
,	NULL
R.	NULL
Knippers	NULL
,	NULL
and	NULL
A.	NULL
Richter	NULL
.	NULL

1991	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
human	NULL
type	NULL
I	NULL
DNA	NULL
topoisomerase	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:9610-9616	NULL
.	NULL

Kurihara	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Moneh	NULL
,	NULL
K.	NULL
Sakimura	NULL
,	NULL
and	NULL
Y.	NULL
Takahashi	NULL
.	NULL

1990	NULL
.	NULL

Alternative	NULL
splicing	NULL
of	NULL
mouse	NULL
brain	NULL
2',3'-cyclic-nucleotide	NULL
3'-phosphodiesterase	NULL
mRNA	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

170:1074-1081	NULL
.	NULL

Li	NULL
,	NULL
Y.	NULL
,	NULL
R.	NULL
Mortensen	NULL
,	NULL
and	NULL
E.	NULL
J.	NULL
Neer	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
a	NULL
,	NULL
expression	NULL
by	NULL
the	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
«	NULL
,	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:27589-27594	NULL
.	NULL

Lowndes	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
J.	NULL
Paul	NULL
,	NULL
J.	NULL
Wu	NULL
,	NULL
and	NULL
M.	NULL
Allan	NULL
.	NULL

1989.	NULL
c-Ha-ras	NULL
gene	NULL
bidirectional	NULL
promoter	NULL
expressed	NULL
in	NULL
vitro	NULL
:	NULL
location	NULL
and	NULL
regulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:3758-3770	NULL
.	NULL

Macarthur	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
G.	NULL
Walter	NULL
.	NULL

1984	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
simian	NULL
virus	NULL
40	NULL
large	NULL
T	NULL
antigen	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

52:483-491	NULL
.	NULL

Manak	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
N.	NULL
de	NULL
Bisschop	NULL
,	NULL
R.	NULL
M.	NULL
Kris	NULL
,	NULL
and	NULL
R.	NULL
Prywes	NULL
.	NULL

1990	NULL
.	NULL

Casein	NULL
kinase	NULL
II	NULL
enhances	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
serum	NULL
response	NULL
factor	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:955-967.	NULL
.	NULL

Mandrup	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Hummel	NULL
,	NULL
S.	NULL
Ravn	NULL
,	NULL
G.	NULL
Jensen	NULL
,	NULL
P.	NULL
H.	NULL
Andreasen	NULL
,	NULL
N.	NULL
Gre-	NULL
gersen	NULL
,	NULL
J.	NULL
Knudsen	NULL
,	NULL
and	NULL
K.	NULL
Kristiansen	NULL
.	NULL

1992	NULL
.	NULL

Acyl-CoA-binding	NULL
protein/	NULL
diazepam-binding	NULL
inhibitor	NULL
gene	NULL
and	NULL
pseudogenes	NULL
:	NULL
a	NULL
typical	NULL
housekeeping	NULL
gene	NULL
family	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

228:1011-1022	NULL
.	NULL

Maragos	NULL
,	NULL
C.	NULL
,	NULL
W.	NULL
M.	NULL
Hutchison	NULL
,	NULL
K.	NULL
Hayasaka	NULL
,	NULL
G.	NULL
K.	NULL
Brown	NULL
,	NULL
and	NULL
H.-H.	NULL
Dahl	NULL
.	NULL

1989	NULL
.	NULL

Structural	NULL
organization	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
the	NULL
El	NULL
«	NULL
subunit	NULL
of	NULL
the	NULL
human	NULL
pyruvate	NULL
dehydrogenase	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:12294-12298	NULL
.	NULL

Marais	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
J.	NULL
J.	NULL
Hsuan	NULL
,	NULL
C.	NULL
McGuigan	NULL
,	NULL
J.	NULL
Wynne	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1992	NULL
.	NULL

Casein	NULL
kinase	NULL
II	NULL
phosphorylation	NULL
increases	NULL
the	NULL
rate	NULL
of	NULL
serum	NULL
response	NULL
fac-tor-binding	NULL
site	NULL
exchange	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:97-105	NULL
.	NULL

Matsuda	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
Endo	NULL
,	NULL
S.	NULL
Ohta	NULL
,	NULL
and	NULL
Y.	NULL
Kagawa	NULL
.	NULL

1993	NULL
.	NULL

Gene	NULL
structure	NULL
of	NULL
human	NULL
mitochondrial	NULL
ATP	NULL
synthase	NULL
y-subunit	NULL
:	NULL
tissue	NULL
specificity	NULL
produced	NULL
by	NULL
alternative	NULL
RNA	NULL
splicing	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:24950-24958	NULL
.	NULL

Mayer	NULL
Jackel	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
H.	NULL
Ohkura	NULL
,	NULL
R.	NULL
Gomes	NULL
,	NULL
C.	NULL
E.	NULL
Sunkel	NULL
,	NULL
S.	NULL
Baumgartner	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Hemmings	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Glover	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
55	NULL
kd	NULL
regulatory	NULL
subunit	NULL
of	NULL
Drosophila	NULL
protein	NULL
phosphatase	NULL
2A	NULL
is	NULL
required	NULL
for	NULL
anaphase	NULL
.	NULL

Cell	NULL
72:621-633	NULL
.	NULL

Melton	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
C.	NULL
McEwan	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
McKie	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Reid	NULL
.	NULL

1986	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
mouse	NULL
HPRT	NULL
gene	NULL
:	NULL
deletional	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
an	NULL
X-chromosome	NULL
linked	NULL
housekeeping	NULL
gene	NULL
.	NULL

Cell	NULL
44:319-328	NULL
.	NULL

Morrissey	NULL
,	NULL
J.	NULL
H.	NULL
1981	NULL
.	NULL

Silver	NULL
stain	NULL
for	NULL
proteins	NULL
in	NULL
polyacrylamide	NULL
gels	NULL
:	NULL
a	NULL
modified	NULL
procedure	NULL
with	NULL
enhanced	NULL
uniform	NULL
sensitivity	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

117	NULL
:	NULL
307-310	NULL
.	NULL

Morrissey	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Tollervey	NULL
.	NULL

1995	NULL
.	NULL

Birth	NULL
of	NULL
the	NULL
snoRNPs	NULL
:	NULL
the	NULL
evolution	NULL
of	NULL
RNase	NULL
MRP	NULL
and	NULL
the	NULL
eukaryotic	NULL
pre-rRNA-processing	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20:78-82	NULL
.	NULL

Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
B.	NULL
Wold	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
a	NULL
muscle	NULL
specific	NULL
enhancer	NULL
by	NULL
ligation	NULL
mediated	NULL
PCR	NULL
.	NULL

Science	NULL
246:780-786	NULL
.	NULL

Nuell	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
D.	NULL
A.	NULL
Stewart	NULL
,	NULL
L.	NULL
Walker	NULL
,	NULL
V.	NULL
Friedman	NULL
,	NULL
C.	NULL
M.	NULL
Wood	NULL
,	NULL
G.	NULL
A.	NULL
Owens	NULL
,	NULL
J.	NULL
R.	NULL
Smith	NULL
,	NULL
E.	NULL
D.	NULL
Schneider	NULL
,	NULL
R.	NULL
DelFOrco	NULL
,	NULL
C.	NULL
K.	NULL
Lumpkin	NULL
,	NULL
D.	NULL
B.	NULL
Danner	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
McClung	NULL
.	NULL

1991	NULL
.	NULL

Prohibitin	NULL
,	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
intracellular	NULL
protein	NULL
that	NULL
blocks	NULL
DNA	NULL
synthesis	NULL
in	NULL
normal	NULL
fibroblasts	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:1372-1381	NULL
.	NULL

Parisi	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Clayton	NULL
.	NULL

1991	NULL
.	NULL

Similarity	NULL
of	NULL
human	NULL
mitochondrial	NULL
transcription	NULL
factor-1	NULL
to	NULL
high	NULL
mobility	NULL
group	NULL
proteins	NULL
.	NULL

Science	NULL
252:965-969	NULL
.	NULL

Park	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
J.	NULL
D.	NULL
Luethy	NULL
,	NULL
M.	NULL
G.	NULL
Wang	NULL
,	NULL
J.	NULL
Fargnoli	NULL
,	NULL
A.	NULL
J.	NULL
J.	NULL
Fornace	NULL
,	NULL
O.	NULL
W.	NULL
McBride	NULL
,	NULL
and	NULL
N.	NULL
J.	NULL
Holbrook	NULL
.	NULL

1992	NULL
.	NULL

Isolation	NULL
,	NULL
characterization	NULL
and	NULL
chromo-somal	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
GADDI53	NULL
gene	NULL
.	NULL

Gene	NULL
116:259-267	NULL
.	NULL

Pearson	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
H.	NULL
P.	NULL
Nasheuer	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Wang	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
DNA	NULL
polymerase	NULL
«	NULL
gene	NULL
:	NULL
sequences	NULL
controlling	NULL
expression	NULL
in	NULL
cycling	NULL
and	NULL
serum-stim-ulated	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2081-2095	NULL
.	NULL

Perucho	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
V.	NULL
Molgaard	NULL
,	NULL
A.	NULL
Shevack	NULL
,	NULL
T.	NULL
Pataryas	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1979	NULL
.	NULL

An	NULL
improved	NULL
method	NULL
for	NULL
preparation	NULL
of	NULL
undegraded	NULL
polysomes	NULL
and	NULL
active	NULL
mRNA	NULL
from	NULL
immature	NULL
chicken	NULL
erythrocytes	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

98:464-471	NULL
.	NULL

Pfeifer	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
E.	NULL
E.	NULL
Furth	NULL
,	NULL
T.	NULL
Ohba	NULL
,	NULL
Y.	NULL
J.	NULL
Chang	NULL
,	NULL
H.	NULL
Rennert	NULL
,	NULL
N.	NULL
Sakuragi	NULL
,	NULL
J.	NULL
T.	NULL
Billheimer	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Strauss	NULL
.	NULL

1993	NULL
.	NULL

Sterol	NULL
carrier	NULL
protein	NULL
2	NULL
:	NULL
a	NULL
role	NULL
in	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80.	NULL
steroid	NULL
hormone	NULL
synthesis	NULL
?	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

47:167-172	NULL
.	NULL

Piaggio	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Farina	NULL
,	NULL
D.	NULL
Perrotti	NULL
,	NULL
I.	NULL
Manni	NULL
,	NULL
P.	NULL
Fuschi	NULL
,	NULL
A.	NULL
Sacchi	NULL
,	NULL
and	NULL
C.	NULL
Gaetano	NULL
.	NULL

1995	NULL
.	NULL

Structure	NULL
and	NULL
growth-dependent	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
cyclin	NULL
B1	NULL
promoter	NULL
.	NULL

Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

216:396-402	NULL
.	NULL

Prats	NULL
,	NULL
E.	NULL
,	NULL
L.	NULL
Cornudella	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1989	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
a	NULL
cDNA	NULL
for	NULL
$	NULL
o	NULL
,	NULL
a	NULL
histone	NULL
to	NULL
protamine	NULL
transition	NULL
protein	NULL
from	NULL
sea	NULL
cucumber	NULL
spermatozoa	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:10097	NULL
.	NULL

Reason	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
H.	NULL
R.	NULL
Morris	NULL
,	NULL
M.	NULL
Panico	NULL
,	NULL
R.	NULL
Marais	NULL
,	NULL
R.	NULL
H.	NULL
Treisman	NULL
,	NULL
R.	NULL
S.	NULL
Haltiwanger	NULL
,	NULL
G.	NULL
W.	NULL
Hart	NULL
,	NULL
W.	NULL
G.	NULL
Kelly	NULL
,	NULL
and	NULL
A.	NULL
Dell	NULL
.	NULL

1992	NULL
.	NULL

Localization	NULL
of	NULL
O-GIeNAc	NULL
modification	NULL
on	NULL
the	NULL
serum	NULL
response	NULL
transcription	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:16911-16921	NULL
.	NULL

Renaud	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1986	NULL
.	NULL

Fine	NULL
analysis	NULL
of	NULL
the	NULL
active	NULL
A5	NULL
gene	NULL
chromatin	NULL
of	NULL
chicken	NULL
erythroid	NULL
cells	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
differentiation	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

189:217-226	NULL
.	NULL

Ribs	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
D.	NULL
A.	NULL
Jans	NULL
,	NULL
H.	NULL
Fan	NULL
,	NULL
and	NULL
R.	NULL
Peters	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
nuclear	NULL
cytoplasmic	NULL
protein	NULL
transport	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
casein	NULL
kinase-II	NULL
site	NULL
flanking	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
of	NULL
the	NULL
SV40	NULL
T-antigen	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:633-639	NULL
.	NULL

Rohrer	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
R.	NULL
Hartong	NULL
,	NULL
and	NULL
W.	NULL
H.	NULL
Dillmann	NULL
.	NULL

1991	NULL
.	NULL

Influence	NULL
of	NULL
thyroid	NULL
hormone	NULL
and	NULL
retinoic	NULL
acid	NULL
on	NULL
slow	NULL
sarcoplasmic	NULL
reticulum	NULL
Ca**	NULL
ATPase	NULL
and	NULL
myosin	NULL
heavy	NULL
chain	NULL
alpha	NULL
gene	NULL
expression	NULL
in	NULL
cardiac	NULL
myocytes	NULL
:	NULL
delineation	NULL
of	NULL
cis-active	NULL
DNA	NULL
elements	NULL
that	NULL
confer	NULL
responsiveness	NULL
to	NULL
thyroid	NULL
hormone	NULL
but	NULL
not	NULL
to	NULL
retinoic	NULL
acid	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:8638-8646	NULL
.	NULL

Rousseau	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Asselin	NULL
,	NULL
J.	NULL
Renaud	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
histone	NULL
A5	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
three	NULL
differentiation-specific	NULL
enhancers	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4904-4917	NULL
.	NULL

Rousseau	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Renaud	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1989	NULL
.	NULL

Basal	NULL
expression	NULL
of	NULL
the	NULL
histone	NULL
#	NULL
5	NULL
gene	NULL
is	NULL
controlled	NULL
by	NULL
positive	NULL
and	NULL
negative	NULL
cis-acting	NULL
sequence	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:7495-7511	NULL
.	NULL

Rozalski	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Lafleur	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1985	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
against	NULL
histone	NULL
H5	NULL
:	NULL
epitope	NULL
mapping	NULL
and	NULL
binding	NULL
to	NULL
chromatin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

260:14379-14385	NULL
.	NULL

Ruiz-Carrillo	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Affolter	NULL
,	NULL
and	NULL
J.	NULL
Renaud	NULL
.	NULL

1983	NULL
.	NULL

Genomic	NULL
organization	NULL
of	NULL
the	NULL
genes	NULL
coding	NULL
for	NULL
the	NULL
six	NULL
main	NULL
histones	NULL
of	NULL
the	NULL
chicken	NULL
:	NULL
complete	NULL
sequence	NULL
of	NULL
the	NULL
25	NULL
gene	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

170:843-859	NULL
.	NULL

Rupp	NULL
,	NULL
R.	NULL
A.	NULL
W.	NULL
,	NULL
U.	NULL
Kruse	NULL
,	NULL
G.	NULL
Multhaup	NULL
,	NULL
U.	NULL
Gobel	NULL
,	NULL
K.	NULL
Beyreuther	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
Sippel	NULL
.	NULL

1990	NULL
.	NULL

Chicken	NULL
NFI/GGCA	NULL
proteins	NULL
are	NULL
encoded	NULL
by	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
genes	NULL
:	NULL
NFI-A	NULL
,	NULL
NFI-B	NULL
and	NULL
NFI-C	NULL
with	NULL
homologues	NULL
in	NULL
mammalian	NULL
genomes	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:2607-2616	NULL
.	NULL

Sauerwald	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Hoesche	NULL
,	NULL
R.	NULL
Oschwald	NULL
,	NULL
and	NULL
M.	NULL
W.	NULL
Kilimann	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
5	NULL
'	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
synapsin	NULL
I	NULL
gene	NULL
:	NULL
a	NULL
G+C-rich	NULL
,	NULL
TATA-	NULL
and	NULL
CAAT-less	NULL
,	NULL
phylogenetically	NULL
conserved	NULL
sequence	NULL
with	NULL
cell	NULL
type-specific	NULL
promoter	NULL
function	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:14932-14937	NULL
.	NULL

Schneider	NULL
,	NULL
C.	NULL
,	NULL
R.	NULL
A.	NULL
Newman	NULL
,	NULL
D.	NULL
R.	NULL
Sutherland	NULL
,	NULL
U.	NULL
Asser	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Greaves	NULL
.	NULL

1982	NULL
.	NULL

A	NULL
one-step	NULL
purification	NULL
of	NULL
membrane	NULL
proteins	NULL
using	NULL
a	NULL
high	NULL
efficiency	NULL
immunomatrix	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

257:10766-10769	NULL
.	NULL

Studier	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
and	NULL
B	NULL
.	NULL

A.	NULL
Moffatt	NULL
.	NULL

1986	NULL
.	NULL

Use	NULL
of	NULL
bacteriophage	NULL
T7	NULL
RNA	NULL
polymerase	NULL
to	NULL
direct	NULL
selective	NULL
high-level	NULL
expression	NULL
of	NULL
cloned	NULL
genes	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

189:113-130	NULL
.	NULL

Sullivan	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Y.	NULL
M.	NULL
Wang	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Joseph	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
alternate	NULL
promoter	NULL
in	NULL
the	NULL
rat	NULL
androgen-binding	NULL
protein/sex	NULL
hormone-binding	NULL
MOLECULAR	NULL
CHARACTERIZATION	NULL
OF	NULL
IBR/F	NULL
(	NULL
GRF-1	NULL
)	NULL
81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

89	NULL
.	NULL

90	NULL
.	NULL

91	NULL
.	NULL

92	NULL
.	NULL

93	NULL
.	NULL

94	NULL
.	NULL

6685	NULL
globulin	NULL
gene	NULL
that	NULL
regulates	NULL
synthesis	NULL
of	NULL
a	NULL
messenger	NULL
RNA	NULL
encoding	NULL
a	NULL
protein	NULL
with	NULL
altered	NULL
function	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

7:702-715	NULL
.	NULL

Sun	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Z.	NULL
Ali	NULL
,	NULL
R.	NULL
Lurz	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1990	NULL
.	NULL

Replacement	NULL
of	NULL
histone	NULL
H1	NULL
by	NULL
H5	NULL
in	NULL
vivo	NULL
does	NULL
not	NULL
change	NULL
the	NULL
nucleosome	NULL
repeat	NULL
length	NULL
of	NULL
chromatin	NULL
but	NULL
increases	NULL
its	NULL
stability	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1651-1658	NULL
.	NULL

Sun	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
R.	NULL
Wiaderkiewicz	NULL
,	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
.	NULL

1989	NULL
.	NULL

Histone	NULL
H5	NULL
in	NULL
the	NULL
control	NULL
of	NULL
DNA	NULL
synthesis	NULL
and	NULL
cell	NULL
proliferation	NULL
.	NULL

Science	NULL
245:68-71	NULL
.	NULL

Sun	NULL
,	NULL
X.	NULL
H.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
inhibitory	NULL
domain	NULL
of	NULL
E12	NULL
transcription	NULL
factor	NULL
prevents	NULL
DNA	NULL
binding	NULL
in	NULL
E12	NULL
homodimers	NULL
but	NULL
not	NULL
in	NULL
E12	NULL
heterodimers	NULL
.	NULL

Cell	NULL
64:459-470	NULL
.	NULL

Tamura	NULL
,	NULL
T.	NULL
,	NULL
F.	NULL
Osaka	NULL
,	NULL
Y.	NULL
Kawamura	NULL
,	NULL
T.	NULL
Higuti	NULL
,	NULL
N.	NULL
Ishida	NULL
,	NULL
H.	NULL
G.	NULL
Nothwang	NULL
,	NULL
C.	NULL
Tsurumi	NULL
,	NULL
K.	NULL
Tanaka	NULL
,	NULL
and	NULL
A.	NULL
Ichihara	NULL
.	NULL

1994	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
«	NULL
-type	NULL
HCS	NULL
subunit	NULL
genes	NULL
of	NULL
human	NULL
proteasomes	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

244:117-124	NULL
.	NULL

TAng	NULL
,	NULL
A.	NULL
,	NULL
K.-J	NULL
.	NULL

Wu	NULL
,	NULL
T.	NULL
Hashimoto	NULL
,	NULL
W.-Y	NULL
.	NULL

Liu	NULL
,	NULL
R.	NULL
Takahashi	NULL
,	NULL
X.-H.	NULL
Shi	NULL
,	NULL
K.	NULL
Mihara	NULL
,	NULL
F.-H.	NULL
Zhang	NULL
,	NULL
Y.	NULL
Y.	NULL
Chen	NULL
,	NULL
C.	NULL
Du	NULL
,	NULL
J.	NULL
Qian	NULL
,	NULL
Y.-G.	NULL
Lin	NULL
,	NULL
A.	NULL
L.	NULL
Murphree	NULL
,	NULL
W.-R.	NULL
Qiu	NULL
,	NULL
T.	NULL
Thompson	NULL
,	NULL
W.	NULL
F.	NULL
Benedict	NULL
,	NULL
and	NULL
Y.-K.	NULL
Fung	NULL
.	NULL

1989	NULL
.	NULL

Genomic	NULL
organization	NULL
of	NULL
the	NULL
human	NULL
retinoblastoma	NULL
gene	NULL
.	NULL

Oncogene	NULL
4:401-407	NULL
.	NULL

Tasanen	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
Oikarinen	NULL
,	NULL
K.	NULL
I.	NULL
Kivirikko	NULL
,	NULL
and	NULL
T.	NULL
Piblajaniemi	NULL
.	NULL

1992	NULL
.	NULL

Promoter	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
the	NULL
multifunctional	NULL
protein	NULL
disulphide	NULL
isomerase	NULL
polypeptide	NULL
:	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
six	NULL
CCAAT	NULL
boxes	NULL
and	NULL
other	NULL
promoter	NULL
elements	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:11513-11519	NULL
.	NULL

Terao	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Watanabe	NULL
,	NULL
M.	NULL
Mishina	NULL
,	NULL
and	NULL
S.	NULL
Numa	NULL
.	NULL

1983	NULL
.	NULL

Sequence	NULL
requirement	NULL
for	NULL
transcription	NULL
in	NULL
vivo	NULL
of	NULL
the	NULL
human	NULL
preprocnkefalin	NULL
A	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

22223-2228	NULL
.	NULL

Virbasius	NULL
,	NULL
C.	NULL
M.	NULL
A.	NULL
,	NULL
J.	NULL
V.	NULL
Virbasius	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Scarpulla	NULL
.	NULL

1993	NULL
.	NULL

NRF-1	NULL
,	NULL
an	NULL
activator	NULL
involved	NULL
in	NULL
nuclear-mitochondrial	NULL
interactions	NULL
,	NULL
utilizes	NULL
a	NULL
new	NULL
DNA-binding	NULL
domain	NULL
conserved	NULL
in	NULL
a	NULL
family	NULL
of	NULL
developmental	NULL
regulators	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2431-2445	NULL
.	NULL

Wagner	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
P.	NULL
Perry	NULL
.	NULL

1985	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
multigene	NULL
family	NULL
encoding	NULL
the	NULL
mouse	NULL
S16	NULL
ribosomal	NULL
protein	NULL
:	NULL
strategy	NULL
for	NULL
distinguishing	NULL
an	NULL
expressed	NULL
gene	NULL
from	NULL
its	NULL
processed	NULL
pseudogene	NULL
counterparts	NULL
by	NULL
an	NULL
analysis	NULL
of	NULL
total	NULL
genomic	NULL
DNA	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

53560-3576	NULL
.	NULL

Weber	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
E.	NULL
P.	NULL
Salazar	NULL
,	NULL
S.	NULL
A.	NULL
Stewart	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Thompson	NULL
.	NULL

1990	NULL
.	NULL

ERCC2	NULL
:	NULL
cDNA	NULL
cloning	NULL
and	NULL
molecular	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
nucleotide	NULL
excision	NULL
repair	NULL
gene	NULL
with	NULL
high	NULL
homology	NULL
to	NULL
yeast	NULL
RAD3	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9	NULL
:	NULL
1437-1447	NULL
.	NULL

Wells	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
S.	NULL
Amirhaeri	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Blaho	NULL
,	NULL
D.	NULL
A.	NULL
Collier	NULL
,	NULL
A.	NULL
Dobrman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Griffin	NULL
,	NULL
J.	NULL
C.	NULL
Hanvey	NULL
,	NULL
A.	NULL
Jaworski	NULL
,	NULL
J.	NULL
E.	NULL
Larson	NULL
,	NULL
A.	NULL
Rahmouni	NULL
,	NULL
M.	NULL
Rajago-palan	NULL
,	NULL
and	NULL
W.	NULL
Shimizu	NULL
.	NULL

1990	NULL
.	NULL

Z	NULL
DNA	NULL
and	NULL
triplexes	NULL
,	NULL
p.	NULL
79-91	NULL
.	NULL

In	NULL
F.	NULL
Richardson	NULL
and	NULL
R.	NULL
Lehman	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Molecular	NULL
mechanisms	NULL
in	NULL
DNA	NULL
replication	NULL
and	NULL
recombination	NULL
.	NULL

Wiley-Liss	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Woodward	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
W.	NULL
W.	NULL
Young	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Bloodgood	NULL
.	NULL

1985	NULL
.	NULL

Detection	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
carbohydrate	NULL
epitopes	NULL
using	NULL
periodate	NULL
oxidation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
78:143-153	NULL
.	NULL

Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
J.	NULL
Ko	NULL
,	NULL
M.	NULL
W.	NULL
Leonard	NULL
,	NULL
H.	NULL
Beug	NULL
,	NULL
S.	NULL
H.	NULL
Orkin	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Engel	NULL
.	NULL

1990	NULL
.	NULL

Activity	NULL
and	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-E1	NULL
multigene	NULL
family	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1650-1662	NULL
.	NULL

Zimmermann	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
J.	NULL
Spychala	NULL
,	NULL
and	NULL
B.	NULL
S.	NULL
Mitchell	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
inosine-5'-monophosphate	NULL
dehydrogenase	NULL
type	NULL
II	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:6808-6814	NULL
.	NULL

